Notes on the financial statements |
Contents |
||
341 |
1 |
Basis of preparation and material accounting policies |
355 |
2 |
Net fee income |
356 |
3 |
Net income/(expense) from financial instruments measured at fair value through profit or loss |
356 |
4 |
Insurance business |
363 |
5 |
Employee compensation and benefits |
368 |
6 |
Auditor's remuneration |
368 |
7 |
Tax |
371 |
8 |
Dividends |
372 |
9 |
Earnings per share |
372 |
10 |
Segmental analysis |
375 |
11 |
Trading assets |
375 |
12 |
Fair values of financial instruments carried at fair value |
382 |
13 |
Fair values of financial instruments not carried at fair value |
383 |
14 |
Financial assets designated and otherwise mandatorily measured at fair value through profit or loss |
384 |
15 |
Derivatives |
389 |
16 |
Financial investments |
390 |
17 |
Assets pledged, collateral received and assets transferred |
391 |
18 |
Interests in associates and joint ventures |
395 |
19 |
Investments in subsidiaries |
397 |
20 |
Structured entities |
399 |
21 |
Goodwill and intangible assets Goodwill and intangible assets |
|
|
|
|
|
|
400 |
22 |
Prepayments, accrued income and other assets |
401 |
23 |
Assets held for sale, liabilities of disposal groups held for sale and business acquisitions |
404 |
24 |
Trading liabilities |
404 |
25 |
Financial liabilities designated at fair value |
404 |
26 |
Debt securities in issue |
405 |
27 |
Accruals, deferred income and other liabilities |
405 |
28 |
Provisions |
406 |
29 |
Subordinated liabilities |
408 |
30 |
Maturity analysis of assets, liabilities and off-balance sheet commitments |
413 |
31 |
Offsetting of financial assets and financial liabilities |
415 |
32 |
Interest rate benchmark reform |
415 |
33 |
Called up share capital and other equity instruments |
417 |
34 |
Contingent liabilities, contractual commitments and guarantees |
417 |
35 |
Finance lease receivables |
418 |
36 |
Legal proceedings and regulatory matters |
421 |
37 |
Related party transactions |
423 |
38 |
Effects of adoption of IFRS 17 |
427 |
39 |
Events after the balance sheet date |
427 |
40 |
HSBC Holdings' subsidiaries, joint ventures and associates |
1 |
Basis of preparation and material accounting policies |
1.1 Basis of preparation
(a) Compliance with International Financial Reporting Standards
The consolidated financial statements of HSBC and the separate financial statements of HSBC Holdings comply with UK-adopted international accounting standards and with the requirements of the Companies Act 2006, and have also applied international financial reporting standards adopted pursuant to Regulation (EC) No 1606/2002 as it applies in the European Union. These financial statements are also prepared in accordance with International Financial Reporting Standards as issued by the International Accounting Standards Board ('IFRS Accounting Standards'), including interpretations issued by the IFRS Interpretations Committee, as there are no applicable differences from IFRS Accounting Standards for the periods presented. There were no unendorsed standards effective for the year ended 31 December 2023 affecting these consolidated and separate financial statements.
Standards adopted during the year ended 31 December 2023
IFRS 17 'Insurance Contracts'
On 1 January 2023, the Group adopted the requirements of IFRS 17 'Insurance Contracts' retrospectively with comparatives restated from the transition date, 1 January 2022. At transition, the Group's total equity reduced by $10,459m.
On adoption of IFRS 17, balances based on IFRS 4, including the present value of in-force long-term insurance business ('PVIF') asset in relation to the upfront recognition of future profits of in-force insurance contracts, were derecognised. Insurance contract liabilities have been remeasured under IFRS 17 based on groups of insurance contracts, which include the fulfilment cash flows comprising the best estimate of the present value of the future cash flows (for example premiums and payouts for claims, benefits and expenses), together with a risk adjustment for non-financial risk, as well as the contractual service margin ('CSM'). The CSM represents the unearned profits that will be released and systematically recognised in insurance revenue as services are provided over the expected coverage period.
In addition, the Group has made use of the option under the standard to re-designate certain eligible financial assets held to support insurance contract liabilities, which were predominantly measured at amortised cost, as financial assets measured at fair value through profit or loss, with comparatives restated from the transition date. The effects of adoption of IFRS 17 are set out in Note 38 with a description of the policy in Note 1.2(j).
The key differences between IFRS 4 and IFRS 17 are summarised in the following table:
|
||
Balance sheet |
- Insurance contract liabilities for non-linked life insurance contracts are calculated by local actuarial principles. Liabilities under unit-linked life insurance contracts are at least equivalent to the surrender or transfer value, by reference to the value of the relevant underlying funds or indices. Grouping requirements follow local regulations. - An intangible asset for the PVIF is recognised, representing the upfront recognition of future profits associated with in-force insurance contracts. |
- Insurance contract liabilities are measured for groups of insurance contracts at current value, comprising the fulfilment cash flows and the CSM. - The fulfilment cash flows comprise the best estimate of the present value of the future cash flows, together with a risk adjustment for non-financial risk. - The CSM represents the unearned profit. |
Profit emergence/ recognition |
- The value of new business is reported as revenue on Day 1 as an increase in PVIF. - The impact of the majority of assumption changes is recognised immediately in the income statement. - Variances between actual and expected cash flows are recognised in the period they arise. |
- The CSM is systematically recognised in revenue as services are provided over the expected coverage period of the group of contracts (i.e. no Day 1 profit). - Contracts are measured using the general measurement model ('GMM') or the variable fee approach ('VFA') model for insurance contracts with direct participation features upon meeting the eligibility criteria. Under the VFA model, the Group's share of the investment experience and assumption changes are absorbed by the CSM and released over time to profit or loss. For contracts measured under GMM, the Group's share of the investment volatility is recorded in profit or loss as it arises. - Losses from onerous contracts are recognised in the income statement immediately. |
Investment return assumptions (discount rate) |
- PVIF is calculated based on long-term investment return assumptions based on assets held. It therefore includes investment margins expected to be earned in future. |
- Under the market consistent approach, expected future investment spreads are not included in the investment return assumption. Instead, the discount rate includes an illiquidity premium that reflects the nature of the associated insurance contract liabilities. |
Expenses |
- Total expenses to acquire and maintain the contract over its lifetime are included in the PVIF calculation. - Expenses are recognised across operating expenses and fee expense as incurred and the allowances for those expenses are released from the PVIF simultaneously. |
- Projected lifetime expenses that are directly attributable costs are included in the insurance contract liabilities and recognised in the insurance service result. - Non-attributable costs are reported in operating expenses. |
Transition
In applying IFRS 17 for insurance contracts retrospectively, the full retrospective approach ('FRA') has been used unless it was impracticable. When the FRA is impracticable such as when there is a lack of sufficient and reliable data, an entity has an accounting policy choice to use either the modified retrospective approach ('MRA') or the fair value approach ('FVA'). The Group has applied the FRA for new business from 2018 at the earliest, subject to practicability, and the FVA for the majority of contracts for which the FRA is impracticable.
Under the FVA, the valuation of insurance liabilities on transition is based on the applicable requirements of IFRS 13 'Fair Value Measurement'. This requires consideration of the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (an exit price). The CSM is calculated as the difference between what a market participant would demand for assuming the unexpired risk associated with insurance contracts, including required profit, and the fulfilment cash flows that are determined using IFRS 17 principles.
In determining the fair value, the Group considered the estimated profit margin that a market participant would demand in return for assuming the insurance liabilities with the consideration of the level of capital that a market participant would be required to hold, and the discount rate with an allowance for an illiquidity premium that takes into account the level of 'matching' between the Group's assets and related liabilities. These assumptions were set taking into account the assumptions that a hypothetical market participant operating in each local jurisdiction would consider.
Amendments to IAS 12 'International Tax Reform - Pillar Two Model Rules'
On 23 May 2023, the International Accounting Standards Board ('IASB') issued amendments to IAS 12 'International Tax Reform - Pillar Two Model Rules', which became effective immediately and were approved for adoption by all members of the UK Endorsement Board on 19 July 2023 and by the European Union on 8 November 2023. On 20 June 2023, legislation was substantively enacted in the UK to introduce the OECD's Pillar Two global minimum tax rules and a UK qualified domestic minimum top-up tax, with effect from 1 January 2024. The Group has applied the IAS 12 exception from recognising and disclosing information on associated deferred tax assets and liabilities.
There were no other new standards or amendments to standards that had an effect on these financial statements.
(b) Differences between IFRS Accounting Standards and Hong Kong Financial Reporting Standards
There are no significant differences between IFRS Accounting Standards and Hong Kong Financial Reporting Standards in terms of their application to HSBC, and consequently there would be no significant differences had the financial statements been prepared in accordance with Hong Kong Financial Reporting Standards. The 'Notes on the financial statements', taken together with the 'Report of the Directors', include the aggregate of all disclosures necessary to satisfy IFRS Accounting Standards and Hong Kong Financial Reporting Standards.
(c) Future accounting developments
Minor amendments to IFRS Accounting Standards
The IASB has published a number of minor amendments to IFRS Accounting Standards that are effective from 1 January 2024. HSBC expects they will have an insignificant effect, when adopted, on the consolidated financial statements of HSBC and the separate financial statements of HSBC Holdings. Additionally, in August 2023, the IASB published amendments to IAS 21 'Lack of Exchangeability' effective from 1 January 2025. The Group is undertaking an assessment of the potential impact, which is not expected to be significant.
(d) Foreign currencies
HSBC's consolidated financial statements are presented in US dollars because the US dollar and currencies linked to it form the major currency bloc in which HSBC transacts and funds its business. The US dollar is also HSBC Holdings' functional currency because the US dollar and currencies linked to it are the most significant currencies relevant to the underlying transactions, events and conditions of its subsidiaries, as well as representing a significant proportion of its funds generated from financing activities.
Transactions in foreign currencies are recorded at the rate of exchange at the date of the transaction. Assets and liabilities denominated in foreign currencies are translated at the rate of exchange at the balance sheet date, except non-monetary assets and liabilities measured at historical cost, which are translated using the rate of exchange at the initial transaction date. Exchange differences are included in other comprehensive income or in the income statement depending on where the gain or loss on the underlying item is recognised. Except for subsidiaries operating in hyperinflationary economies (see Note 1.2(p)), in the consolidated financial statements, the assets and liabilities of branches, subsidiaries, joint ventures and associates whose functional currency is not US dollars are translated into the Group's presentation currency at the rate of exchange at the balance sheet date, while their results are translated into US dollars at the average rates of exchange for the reporting period. Exchange differences arising are recognised in other comprehensive income. On disposal of a foreign operation, exchange differences previously recognised in other comprehensive income are reclassified to the income statement.
(e) Presentation of information
Certain disclosures required by IFRS Accounting Standards have been included in the sections marked as ('Audited') in the Annual Report and Accounts 2023 as follows:
- Disclosures concerning the nature and extent of risks relating to insurance contracts and financial instruments are included in the 'Risk review' on pages 135 to 237.
- The 'Own funds disclosure' is included in the 'Risk review' on page 207.
HSBC follows the UK Finance Disclosure Code. The UK Finance Disclosure Code aims to increase the quality and comparability of UK banks' disclosures and sets out five disclosure principles together with supporting guidance agreed in 2010. In line with the principles of the UK Finance Disclosure Code, HSBC assesses good practice recommendations issued from time to time by relevant regulators and standard setters, and will assess the applicability and relevance of such guidance, enhancing disclosures where appropriate.
(f) Critical estimates and judgements
The preparation of financial information requires the use of estimates and judgements about future conditions. In view of the inherent uncertainties and the high level of subjectivity involved in the recognition or measurement of items, highlighted as the 'critical estimates and judgements' in section 1.2 below, it is possible that the outcomes in the next financial year could differ from those on which management's estimates are based. This could result in materially different estimates and judgements from those reached by management for the purposes of these financial statements. Management's selection of HSBC's accounting policies that contain critical estimates and judgements reflects the materiality of the items to which the policies are applied and the high degree of judgement and estimation uncertainty involved.
Management has considered the impact of climate-related risks on HSBC's financial position and performance. While the effects of climate change are a source of uncertainty, as at 31 December 2023 management did not consider there to be a material impact on our critical judgements and estimates from the physical, transition and other climate-related risks in the short to medium term. In particular management has considered the known and observable potential impacts of climate-related risks of associated judgements and estimates in our value in use calculations.
(g) Going concern
The financial statements are prepared on a going concern basis, as the Directors are satisfied that the Group and parent company have the resources to continue in business for the foreseeable future. In making this assessment, the Directors have considered a wide range of information relating to present and future conditions, including future projections of profitability, liquidity, capital requirements and capital resources.
These considerations include stressed scenarios that reflect the uncertainty in the macroeconomic environment following rising inflation, slower Chinese economic activity, and disrupted supply chains as a result of the ongoing Russia-Ukraine and Israel-Hamas wars. They also included other top and emerging risks, including climate change, as well as the related impacts on profitability, capital and liquidity.
1.2 Summary of material accounting policies
(a) Consolidation and related policies
Investments in subsidiaries
Where an entity is governed by voting rights, HSBC consolidates when it holds - directly or indirectly - the necessary voting rights to pass resolutions by the governing body. In all other cases, the assessment of control is more complex and requires judgement of other factors, including having exposure to variability of returns, power to direct relevant activities, and whether power is held as agent or principal.
Business combinations are accounted for using the acquisition method. The amount of non-controlling interest is measured either at fair value or at the non-controlling interest's proportionate share of the acquiree's identifiable net assets. This election is made for each business combination.
HSBC Holdings' investments in subsidiaries are stated at cost less impairment losses.
Impairment testing is performed where there is an indication of impairment, by comparing the recoverable amount of the relevant investment to its carrying amount. Indicators of impairment include both external and internal sources of information. Similarly, assessments are made as to whether an impairment loss recognised in prior periods may no longer exist or may have decreased. Where this is the case, such an impairment loss is reversed if there has been a change in the estimate used to determine the relevant recoverable amount since the last impairment loss was recognised, and to the extent that it does not increase the carrying amount above that had no impairment loss been previously recognised.
Critical estimates and judgements
Investments in subsidiaries are tested for impairment when there is an indication that the investment may be impaired, which involves estimations of value in use reflecting management's best estimate of the future cash flows of the investment and the rates used to discount these cash flows, both of which are subject to uncertain factors as follows: |
|
- The accuracy of forecast cash flows is subject to a high degree of uncertainty in volatile market conditions. Where such circumstances are determined to exist, management re-tests for impairment or reversal more frequently than once a year when indicators exist. This ensures that the assumptions on which the cash flow forecasts are based continue to reflect current market conditions and management's best estimate of future business prospects. |
- The future cash flows of each investment are sensitive to the cash flows projected for the periods for which detailed forecasts are available and to assumptions regarding the long-term pattern of sustainable cash flows thereafter. Forecasts are compared with actual performance and verifiable economic data, but they reflect management's view of future business prospects at the time of the assessment. - The rates used to discount future expected cash flows can have a significant effect on their valuation, and are based on the costs of equity assigned to the investment. The cost of equity percentage is generally derived from a capital asset pricing model and the market implied cost of equity, which incorporates inputs reflecting a number of financial and economic variables, including the risk-free interest rate in the country concerned and a premium for the risk of the business being evaluated. These variables are subject to fluctuations in external market rates and economic conditions beyond management's control. - Key assumptions used in estimating impairment in subsidiaries and their reversal where relevant are described in Note 19. |
Goodwill
Goodwill is allocated to cash-generating units ('CGUs') for the purpose of impairment testing, which is undertaken at the lowest level at which goodwill is monitored for internal management purposes. HSBC's CGUs are based on its main legal entities subdivided by global business, except for Global Banking and Markets, for which goodwill is monitored on a global basis.
Impairment testing is performed at least once a year, or whenever there is an indication of impairment, by comparing the recoverable amount of a CGU with its carrying amount.
Goodwill is included in a disposal group if the disposal group is a CGU to which goodwill has been allocated or it is an operation within such a CGU. The amount of goodwill included in a disposal group is measured on the basis of the relative values of the operation disposed of and the portion of the CGU retained.
Critical estimates and judgements
The review of goodwill and non-financial assets (see Note 1.2(n)) for impairment reflects management's best estimate of the future cash flows of the CGUs and the rates used to discount these cash flows, both of which are subject to uncertain factors as follows: |
|
- The accuracy of forecast cash flows is subject to a high degree of uncertainty in volatile market conditions. Where such circumstances are determined to exist, management re-tests goodwill for impairment more frequently than once a year when indicators of impairment exist. This ensures that the assumptions on which the cash flow forecasts are based continue to reflect current market conditions and management's best estimate of future business prospects. |
- The future cash flows of the CGUs are sensitive to the cash flows projected for the periods for which detailed forecasts are available and to assumptions regarding the long-term pattern of sustainable cash flows thereafter. Forecasts are compared with actual performance and verifiable economic data, but they reflect management's view of future business prospects at the time of the assessment. - The rates used to discount future expected cash flows can have a significant effect on their valuation, and are based on the costs of equity assigned to individual CGUs. The cost of equity percentage is generally derived from a capital asset pricing model and market implied cost of equity, which incorporates inputs reflecting a number of financial and economic variables, including the risk-free interest rate in the country concerned and a premium for the risk of the business being evaluated. These variables are subject to fluctuations in external market rates and economic conditions beyond management's control. - Key assumptions used in estimating goodwill and non-financial asset impairment are described in Note 21. |
The Group does not consider there to be a significant risk of a material adjustment to the carrying amount of goodwill in the next financial year, but does consider this to be an area that is inherently judgemental.
HSBC sponsored structured entities
HSBC is considered to sponsor another entity if, in addition to ongoing involvement with the entity, it had a key role in establishing that entity or in bringing together relevant counterparties so the transaction that is the purpose of the entity could occur. HSBC is generally not considered a sponsor if the only involvement with the entity is merely administrative.
Interests in associates and joint arrangements
Joint arrangements are investments in which HSBC, together with one or more parties, has joint control. Depending on HSBC's rights and obligations, the joint arrangement is classified as either a joint operation or a joint venture.
HSBC classifies investments in entities over which it has significant influence, and which are neither subsidiaries nor joint arrangements, as associates.
HSBC recognises its share of the assets, liabilities and results in a joint operation. Investments in associates and interests in joint ventures are recognised using the equity method. The attributable share of the results and reserves of joint ventures and associates is included in the consolidated financial statements of HSBC based on either financial statements made up to 31 December or pro-rated amounts adjusted for any material transactions or events occurring between the date the financial statements are available and 31 December.
Investments in associates and joint ventures are assessed at each reporting date and tested for impairment when there is an indication that the investment may be impaired, by comparing the recoverable amount of the relevant investment to its carrying amount. Goodwill on acquisitions of interests in joint ventures and associates is not tested separately for impairment, but is assessed as part of the carrying amount of the investment. Previously recognised impairments are assessed for reversal when there are indicators that they may no longer exist or have decreased. Any reversal, which may arise only from changes in estimates used to determine the prior impairment loss, is recognised to the extent that it does not increase the carrying amount above that had no impairment loss been previously recognised.
Critical estimates and judgements
The most significant critical estimates relate to the assessment of impairment of our investment in Bank of Communications Co., Limited ('BoCom'), which involves estimations of value in use: |
|
|
- The value in use calculation uses discounted cash flow projections based on management's best estimate of future earnings available to ordinary shareholders prepared in accordance with IAS 36 'Impairment of Assets'. - Key assumptions used in estimating BoCom's value in use and the sensitivity of the value in use calculations to different assumptions are described in Note 18. |
(b) Income and expense
Operating income
Interest income and expense
Interest income and expense for all financial instruments, excluding those classified as held for trading or designated at fair value, are recognised in 'Interest income' and 'Interest expense' in the income statement using the effective interest method. However, as an exception to this, interest on debt instruments issued by HSBC for funding purposes that are designated under the fair value option to reduce an accounting mismatch and on derivatives managed in conjunction with those debt instruments is included in interest expense.
Interest on credit-impaired financial assets is recognised by applying the effective interest rate to the amortised cost (i.e. gross carrying amount of the asset less allowance for expected credit losses).
Non-interest income and expense
HSBC generates fee income from services provided at a fixed price over time, such as account service and card fees, or when HSBC delivers a specific transaction at a point in time, such as broking services and import/export services. With the exception of certain fund management and performance fees, all other fees are generated at a fixed price. Fund management and performance fees can be variable depending on the size of the customer portfolio and HSBC's performance as fund manager. Variable fees are recognised when all uncertainties are resolved. Fee income is generally earned from short-term contracts with payment terms that do not include a significant financing component.
HSBC acts as principal in the majority of contracts with customers, with the exception of broking services. For most brokerage trades, HSBC acts as agent in the transaction and recognises broking income net of fees payable to other parties in the arrangement.
HSBC recognises fees earned on transaction-based arrangements at a point in time when it has fully provided the service to the customer. Where the contract requires services to be provided over time, income is recognised on a systematic basis over the life of the agreement.
Where HSBC offers a package of services that contains multiple non-distinct performance obligations, such as those included in account service packages, the promised services are treated as a single performance obligation. If a package of services contains distinct performance obligations, the corresponding transaction price is allocated to each performance obligation based on the estimated stand-alone selling prices.
Dividend income is recognised when the right to receive payment is established. This is the ex-dividend date for listed equity securities, and usually the date when shareholders approve the dividend for unlisted equity securities.
Net income/(expense) from financial instruments measured at fair value through profit or loss includes the following:
- 'Net income from financial instruments held for trading or managed on a fair value basis': This comprises net trading income, which includes all gains and losses from changes in the fair value of financial assets and financial liabilities held for trading and other financial instruments managed on a fair value basis, together with the related interest income, expense and dividends, excluding the effect of changes in the credit risk of liabilities managed on a fair value basis. It also includes all gains and losses from changes in the fair value of derivatives that are managed in conjunction with financial assets and liabilities measured at fair value through profit or loss.
- 'Net income/(expense) from assets and liabilities of insurance businesses, including related derivatives, measured at fair value through profit or loss': This includes all gains and losses from changes in the fair value, together with related interest income, expense and dividends in respect of financial assets and liabilities measured at fair value through profit or loss, and those derivatives managed in conjunction with the above that can be separately identifiable from other trading derivatives.
- 'Changes in fair value of designated debt instruments and related derivatives': Interest paid on debt instruments and interest cash flows on related derivatives is presented in interest expense where doing so reduces an accounting mismatch.
- 'Changes in fair value of other financial instruments mandatorily measured at fair value through profit or loss': This includes interest on instruments that fail the solely payments of principal and interest test, see (d) below.
The accounting policies for insurance service result and insurance finance income/(expenses) are disclosed in Note 1.2(j).
(c) Valuation of financial instruments
All financial instruments are initially recognised at fair value. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value of a financial instrument on initial recognition is generally its transaction price (that is, the fair value of the consideration given or received). However, if there is a difference between the transaction price and the fair value of financial instruments whose fair value is based on a quoted price in an active market or a valuation technique that uses only data from observable markets, HSBC recognises the difference as a trading gain or loss at inception (a 'day 1 gain or loss'). In all other cases, the entire day 1 gain or loss is deferred and recognised in the income statement over the life of the transaction until the transaction matures, is closed out, the valuation inputs become observable or HSBC enters into an offsetting transaction. The fair value of financial instruments is generally measured on an individual basis. However, in cases where HSBC manages a group of financial assets and liabilities according to its net market or credit risk exposure, the fair value of the group of financial instruments is measured on a net basis but the underlying financial assets and liabilities are presented separately in the financial statements, unless they satisfy the IFRS offsetting criteria.
Critical estimates and judgements
The majority of valuation techniques employ only observable market data. However, certain financial instruments are classified on the basis of valuation techniques that feature one or more significant market inputs that are unobservable, and for them, the measurement of fair value is more judgemental: |
|
- An instrument in its entirety is classified as valued using significant unobservable inputs if, in the opinion of management, greater than 5% of the instrument's valuation is driven by unobservable inputs. - 'Unobservable' in this context means that there is little or no current market data available from which to determine the price at which an arm's length transaction would be likely to occur. It generally does not mean that there is no data available at all upon which to base a determination of fair value (consensus pricing data may, for example, be used). |
- Details on the Group's Level 3 financial instruments and the sensitivity of their valuation to the effect of applying reasonably possible alternative assumptions in determining their fair value are set out in Note 12. |
(d) Financial instruments measured at amortised cost
Financial assets that are held to collect the contractual cash flows and which contain contractual terms that give rise on specified dates to cash flows that are solely payments of principal and interest are measured at amortised cost. Such financial assets include most loans and advances to banks and customers and some debt securities. In addition, most financial liabilities are measured at amortised cost. HSBC accounts for regular way amortised cost financial instruments using trade date accounting. The carrying amount of these financial assets at initial recognition includes any directly attributable transactions costs.
HSBC may commit to underwriting loans on fixed contractual terms for specified periods of time. When the loan arising from the lending commitment is expected to be sold shortly after origination, the commitment to lend is recorded as a derivative. When HSBC intends to hold the loan, the loan commitment is included in the impairment calculations set out below.
Non-trading reverse repurchase, repurchase and similar agreements
When debt securities are sold subject to a commitment to repurchase them at a predetermined price ('repos'), they remain on the balance sheet and a liability is recorded in respect of the consideration received. Securities purchased under commitments to resell ('reverse repos') are not recognised on the balance sheet and an asset is recorded in respect of the initial consideration paid. Non-trading repos and reverse repos are measured at amortised cost. The difference between the sale and repurchase price or between the purchase and resale price is treated as interest and recognised in net interest income over the life of the agreement.
Contracts that are economically equivalent to reverse repo or repo agreements (such as sales or purchases of debt securities entered into together with total return swaps with the same counterparty) are accounted for similarly to, and presented together with, reverse repo or repo agreements.
(e) Financial assets measured at fair value through other comprehensive income
Financial assets managed within a business model that is achieved by both collecting contractual cash flows and selling and which contain contractual terms that give rise on specified dates to cash flows that are solely payments of principal and interest are measured at fair value through other comprehensive income ('FVOCI'). These comprise primarily debt securities. They are recognised on trade date when HSBC enters into contractual arrangements to purchase and are generally derecognised when they are either sold or redeemed. They are subsequently remeasured at fair value with changes therein (except for those relating to impairment, interest income and foreign currency exchange gains and losses) recognised in other comprehensive income until the assets are sold. Upon disposal, the cumulative gains or losses in other comprehensive income are recognised in the income statement as 'Gains less losses from financial instruments'. Financial assets measured at FVOCI are included in the impairment calculations set out below and impairment is recognised in profit or loss.
(f) Equity securities measured at fair value with fair value movements presented in other comprehensive income
The equity securities for which fair value movements are shown in other comprehensive income are business facilitation and other similar investments where HSBC holds the investments other than to generate a capital return. Dividends from such investments are recognised in profit or loss. Gains or losses on the derecognition of these equity securities are not transferred to profit or loss. Otherwise, equity securities are measured at fair value through profit or loss.
(g) Financial instruments designated at fair value through profit or loss
Financial instruments, other than those held for trading, are classified in this category if they meet one or more of the criteria set out below and are so designated irrevocably at inception:
- The use of the designation removes or significantly reduces an accounting mismatch.
- A group of financial assets and liabilities or a group of financial liabilities is managed and its performance is evaluated on a fair value basis, in accordance with a documented risk management or investment strategy.
- The financial liability contains one or more non-closely related embedded derivatives.
Designated financial assets are recognised when HSBC enters into contracts with counterparties, which is generally on trade date, and are normally derecognised when the rights to the cash flows expire or are transferred. Designated financial liabilities are recognised when HSBC enters into contracts with counterparties, which is generally on settlement date, and are normally derecognised when extinguished. Subsequent changes in fair values are recognised in the income statement in 'Net income from financial instruments held for trading or managed on a fair value basis' or 'Net income/(expense) from assets and liabilities of insurance businesses, including related derivatives, measured at fair value through profit or loss' or 'Changes in fair value of designated debt and related derivatives' except for the effect of changes in the liabilities' credit risk, which is presented in 'Other comprehensive income', unless that treatment would create or enlarge an accounting mismatch in profit or loss.
Under the above criteria, the main classes of financial instruments designated by HSBC are:
- Debt instruments for funding purposes that are designated to reduce an accounting mismatch: The interest and/or foreign exchange exposure on certain fixed-rate debt securities issued has been matched with the interest and/or foreign exchange exposure on certain swaps as part of a documented risk management strategy.
- Financial assets and financial liabilities under unit-linked and non-linked investment contracts: A contract under which HSBC does not accept significant insurance risk from another party is not classified as an insurance contract, other than investment contracts with discretionary participation features ('DPF'), but is accounted for as a financial liability. Customer liabilities under linked and certain non-linked investment contracts issued by insurance subsidiaries are determined based on the fair value of the assets held in the linked funds or by a valuation method. The related financial assets and liabilities are managed and reported to management on a fair value basis. Designation at fair value of the financial assets and related liabilities allows changes in fair values to be recorded in the income statement and presented in the same line.
- Financial liabilities that contain both deposit and derivative components: These financial liabilities are managed and their performance evaluated on a fair value basis.
(h) Derivatives
Derivatives are financial instruments that derive their value from the price of underlying items such as equities, interest rates or other indices. Derivatives are recognised initially and are subsequently measured at fair value through profit or loss. Derivatives are classified as assets when their fair value is positive or as liabilities when their fair value is negative. This includes embedded derivatives in financial liabilities, which are bifurcated from the host contract when they meet the definition of a derivative on a stand-alone basis.
Where the derivatives are managed with debt securities issued by HSBC that are designated at fair value where doing so reduces an accounting mismatch, the contractual interest is shown in 'Interest expense' together with the interest payable on the issued debt.
Hedge accounting
When derivatives are not part of fair value designated relationships, if held for risk management purposes they are designated in hedge accounting relationships where the required criteria for documentation and hedge effectiveness are met. HSBC uses these derivatives or, where allowed, other non-derivative hedging instruments in fair value hedges, cash flow hedges or hedges of net investments in foreign operations as appropriate to the risk being hedged.
Fair value hedge
Fair value hedge accounting does not change the recording of gains and losses on derivatives and other hedging instruments, but results in recognising changes in the fair value of the hedged assets or liabilities attributable to the hedged risk that would not otherwise be recognised in the income statement. If a hedge relationship no longer meets the criteria for hedge accounting, hedge accounting is discontinued and the cumulative adjustment to the carrying amount of a hedged item for which the effective interest rate method is used is amortised to the income statement on a recalculated effective interest rate, unless the hedged item has been derecognised, in which case it is recognised in the income statement immediately.
Cash flow hedge
The effective portion of gains and losses on hedging instruments is recognised in other comprehensive income and the ineffective portion of the change in fair value of derivative hedging instruments that are part of a cash flow hedge relationship is recognised immediately in the income statement within 'Net income from financial instruments held for trading or managed on a fair value basis'. The accumulated gains and losses recognised in other comprehensive income are reclassified to the income statement in the same periods in which the hedged item affects profit or loss. When a hedge relationship is discontinued, or partially discontinued, any cumulative gain or loss recognised in other comprehensive income remains in equity until the forecast transaction is recognised in the income statement. When a forecast transaction is no longer expected to occur, the cumulative gain or loss previously recognised in other comprehensive income is immediately reclassified to the income statement.
Net investment hedge
Hedges of net investments in foreign operations are accounted for in a similar way to cash flow hedges. The effective portion of gains and losses on the hedging instrument is recognised in other comprehensive income and other gains and losses are recognised immediately in the income statement. Gains and losses previously recognised in other comprehensive income are reclassified to the income statement on the disposal, or part-disposal, of the foreign operation.
Derivatives that do not qualify for hedge accounting
Non-qualifying hedges are derivatives entered into as economic hedges of assets and liabilities for which hedge accounting was not applied.
(i) Impairment of amortised cost and FVOCI financial assets
Expected credit losses ('ECL') are recognised for loans and advances to banks and customers, non-trading reverse repurchase agreements, other financial assets held at amortised cost, debt instruments measured at FVOCI, and certain loan commitments and financial guarantee contracts. At initial recognition, an allowance (or provision in the case of some loan commitments and financial guarantees) is recognised for ECL resulting from possible default events within the next 12 months, or less, where the remaining life is less than 12 months ('12-month ECL'). In the event of a significant increase in credit risk, an allowance (or provision) is recognised for ECL resulting from all possible default events over the expected life of the financial instrument ('lifetime ECL'). Financial assets where 12-month ECL is recognised are considered to be 'stage 1'; financial assets which are considered to have experienced a significant increase in credit risk are in 'stage 2'; and financial assets for which there is objective evidence of impairment, and so are considered to be in default or otherwise credit impaired are in 'stage 3'. Purchased or originated credit-impaired financial assets ('POCI') are treated differently as set out below.
Credit impaired (stage 3)
HSBC determines that a financial instrument is credit impaired and in stage 3 by considering relevant objective evidence, primarily whether contractual payments of either principal or interest are past due for more than 90 days, there are other indications that the borrower is unlikely to pay such as that a concession has been granted to the borrower for economic or legal reasons relating to the borrower's financial condition, or the loan is otherwise considered to be in default.
If such unlikeliness to pay is not identified at an earlier stage, it is deemed to occur when an exposure is 90 days past due. Therefore, the definitions of credit impaired and default are aligned as far as possible so that stage 3 represents all loans that are considered defaulted or otherwise credit impaired.
Interest income is recognised by applying the effective interest rate to the amortised cost (i.e. gross carrying amount less allowance for ECL).
Write-off
Financial assets (and the related impairment allowances) are normally written off, either partially or in full, when there is no realistic prospect of recovery. Where loans are secured, this is generally after receipt of any proceeds from the realisation of security. In circumstances where the net realisable value of any collateral has been determined and there is no reasonable expectation of further recovery, write-off may be earlier.
Forbearance
Loans are identified as forborne and classified as either performing or non-performing when HSBC modifies the contractual terms due to financial difficulty of the borrower. Non-performing forborne loans are stage 3 and classified as non-performing until they meet the curing criteria, as specified by applicable credit risk policy (for example, when the loan is no longer in default and no other indicators of default have been present for at least 12 months). Any amount written off as a result of any modification of contractual terms upon entering forbearance would not be reversed.
The Group applies the EBA Guidelines on the application of definition of default for our retail portfolios, which affect credit risk policies and our reporting in respect of the status of loans as credit impaired principally due to forbearance (or curing thereof). Further details are provided under 'Forborne loans and advances' on page 148.
Performing forborne loans are initially stage 2 and remain classified as forborne until they meet applicable curing criteria (for example, they continue to not be in default and no other indicators of default are present for a period of at least 24 months). At this point, the loan is either stage 1 or stage 2 as determined by comparing the risk of a default occurring at the reporting date (based on the modified contractual terms) and the risk of a default occurring at initial recognition (based on the original, unmodified contractual terms).
A forborne loan is derecognised if the existing agreement is cancelled and a new agreement is made on substantially different terms, or if the terms of an existing agreement are modified such that the forborne loan is a substantially different financial instrument. Any new loans that arise following derecognition events in these circumstances would generally be classified as POCI and will continue to be disclosed as forborne.
Loan modifications other than forborne loans
Loan modifications that are not identified as forborne are considered to be commercial restructurings. Where a commercial restructuring results in a modification (whether legalised through an amendment to the existing terms or the issuance of a new loan contract) such that HSBC's rights to the cash flows under the original contract have expired, the old loan is derecognised and the new loan is recognised at fair value. The rights to cash flows are generally considered to have expired if the commercial restructuring is at market rates and no payment-related concession has been provided. Modifications of certain higher credit risk wholesale loans are assessed for derecognition, having regard to changes in contractual terms that either individually or in combination are judged to result in a substantially different financial instrument. Mandatory and general offer loan modifications that are not borrower specific, for example market-wide customer relief programmes, generally do not result in derecognition, but their stage allocation is determined considering all available and supportable information under our ECL impairment policy. Changes made to these financial instruments that are economically equivalent and required by interest rate benchmark reform do not result in the derecognition or a change in the carrying amount of the financial instrument, but instead require the effective interest rate to be updated to reflect the change of the interest rate benchmark.
Significant increase in credit risk (stage 2)
An assessment of whether credit risk has increased significantly since initial recognition is performed at each reporting period by considering the change in the risk of default occurring over the remaining life of the financial instrument. The assessment explicitly or implicitly compares the risk of default occurring at the reporting date compared with that at initial recognition, taking into account reasonable and supportable information, including information about past events, current conditions and future economic conditions. The assessment is unbiased, probability-weighted, and to the extent relevant, uses forward-looking information consistent with that used in the measurement of ECL. The analysis of credit risk is multifactor. The determination of whether a specific factor is relevant and its weight compared with other factors depends on the type of product, the characteristics of the financial instrument and the borrower, and the geographical region. Therefore, it is not possible to provide a single set of criteria that will determine what is considered to be a significant increase in credit risk, and these criteria will differ for different types of lending, particularly between retail and wholesale. However, unless identified at an earlier stage, all financial assets are deemed to have suffered a significant increase in credit risk when 30 days past due. In addition, wholesale loans that are individually assessed, which are typically corporate and commercial customers, and included on a watch or worry list, are included in stage 2.
For wholesale portfolios, the quantitative comparison assesses default risk using a lifetime probability of default ('PD'), which encompasses a wide range of information including the obligor's customer risk rating ('CRR'), macroeconomic condition forecasts and credit transition probabilities. For origination CRRs up to 3.3, significant increase in credit risk is measured by comparing the average PD for the remaining term estimated at origination with the equivalent estimation at the reporting date. The quantitative measure of significance varies depending on the credit quality at origination as follows:
0.1-1.2 |
15bps |
2.1-3.3 |
30bps |
For CRRs greater than 3.3 that are not impaired, a significant increase in credit risk is considered to have occurred when the origination PD has doubled. The significance of changes in PD was informed by expert credit risk judgement, referenced to historical credit migrations and to relative changes in external market rates.
For loans originated prior to the implementation of IFRS 9, the origination PD does not include adjustments to reflect expectations of future macroeconomic conditions since these are not available without the use of hindsight. In the absence of this data, origination PD must be approximated assuming through-the-cycle PDs and through-the-cycle migration probabilities, consistent with the instrument's underlying modelling approach and the CRR at origination. For these loans, the quantitative comparison is supplemented with additional CRR deterioration-based thresholds, as set out in the table below:
0.1 |
5 notches |
1.1-4.2 |
4 notches |
4.3-5.1 |
3 notches |
5.2-7.1 |
2 notches |
7.2-8.2 |
1 notch |
8.3 |
0 notch |
Further information about the 23-grade scale used for CRR can be found on page 148.
For retail portfolios, default risk is assessed using a reporting date 12-month PD derived from internal models, which incorporate all available information about the customer. This PD is adjusted for the effect of macroeconomic forecasts for periods longer than 12 months and is considered to be a reasonable approximation of a lifetime PD measure. Retail exposures are first segmented into homogenous portfolios, generally by country, product and brand. Within each portfolio, the stage 2 accounts are defined as accounts with an adjusted 12-month PD greater than the average 12-month PD of loans in that portfolio 12 months before they become 30 days past due. The expert credit risk judgement is that no prior increase in credit risk is significant. This portfolio-specific threshold therefore identifies loans with a PD higher than would be expected from loans that are performing as originally expected and higher than that which would have been acceptable at origination. It therefore approximates a comparison of origination to reporting date PDs.
We continue to refine the retail transfer criteria approach for certain portfolios as additional data becomes available, in order to utilise a more relative approach. These enhancements take advantage of the increase in origination-related data in the assessment of significant increases in credit risk by comparing remaining lifetime PD to the comparable remaining term lifetime PD at origination based on portfolio-specific origination segments.
Unimpaired and without significant increase in credit risk (stage 1)
ECL resulting from default events that are possible within the next 12 months ('12-month ECL') are recognised for financial instruments that remain in stage 1.
Purchased or originated credit impaired
Financial assets that are purchased or originated at a deep discount that reflects the incurred credit losses are considered to be POCI. This population includes new financial instruments recognised in most cases following the derecognition of forborne loans. The amount of change in lifetime ECL for a POCI loan is recognised in profit or loss until the POCI loan is derecognised, even if the lifetime ECL are less than the amount of ECL included in the estimated cash flows on initial recognition.
Movement between stages
Financial assets can be transferred between the different categories (other than POCI) depending on their relative increase in credit risk since initial recognition. Financial instruments are transferred out of stage 2 if their credit risk is no longer considered to be significantly increased since initial recognition based on the assessments described above. In the case of non-performing forborne loans, such financial instruments are transferred out of stage 3 when they no longer exhibit any evidence of credit impairment and meet the curing criteria as described above.
Measurement of ECL
The assessment of credit risk and the estimation of ECL are unbiased and probability-weighted, and incorporate all available information which is relevant to the assessment including information about past events, current conditions and reasonable and supportable forecasts of future events and economic conditions at the reporting date. In addition, the estimation of ECL should take into account the time value of money and considers other factors such as climate-related risks.
In general, HSBC calculates ECL using three main components: a probability of default ('PD'), a loss given default ('LGD') and the exposure at default ('EAD').
The 12-month ECL is calculated by multiplying the 12-month PD, LGD and EAD. Lifetime ECL is calculated using the lifetime PD instead. The
12-month and lifetime PDs represent the probability of default occurring over the next 12 months and the remaining maturity of the instrument respectively.
The EAD represents the expected balance at default, taking into account the repayment of principal and interest from the balance sheet date to the default event together with any expected drawdowns of committed facilities. The LGD represents expected losses on the EAD given the event of default, taking into account, among other attributes, the mitigating effect of collateral value at the time it is expected to be realised and the time value of money.
HSBC makes use of the IRB framework where possible, with recalibration to meet the differing IFRS 9 requirements as set out in the following table:
PD |
- Through the cycle (represents long-run average PD throughout a full economic cycle) - The definition of default includes a backstop of 90+ days past due |
- Point in time (based on current conditions, adjusted to take into account estimates of future conditions that will impact PD) - Default backstop of 90+ days past due for all portfolios |
EAD |
- Cannot be lower than current balance |
- Amortisation captured for term products |
LGD |
- Downturn LGD (consistent losses expected to be suffered during a severe but plausible economic downturn) - Regulatory floors may apply to mitigate risk of underestimating downturn LGD due to lack of historical data - Discounted using cost of capital - All collection costs included |
- Expected LGD (based on estimate of loss given default including the expected impact of future economic conditions such as changes in value of collateral) - No floors - Discounted using the original effective interest rate of the loan - Only costs associated with obtaining/selling collateral included |
Other |
|
- Discounted back from point of default to balance sheet date |
While 12-month PDs are recalibrated from IRB models where possible, the lifetime PDs are determined by projecting the 12-month PD using a term structure. For the wholesale methodology, the lifetime PD also takes into account credit migration, i.e. a customer migrating through the CRR bands over its life.
The ECL for wholesale stage 3 is determined primarily on an individual basis using a discounted cash flow ('DCF') methodology. The expected future cash flows are based on estimates as of the reporting date, reflecting reasonable and supportable assumptions and projections of future recoveries and expected future receipts of interest.
Collateral is taken into account if it is likely that the recovery of the outstanding amount will include realisation of collateral based on its estimated fair value of collateral at the time of expected realisation, less costs for obtaining and selling the collateral.
The cash flows are discounted at a reasonable approximation of the original effective interest rate. For significant cases, cash flows under up to four different scenarios are probability-weighted by reference to the status of the borrower, economic scenarios applied more generally by the Group and judgement in relation to the likelihood of the work-out strategy succeeding or receivership being required. For less significant cases where an individual assessment is undertaken, the effect of different economic scenarios and work-out strategies results in an ECL calculation based on a most likely outcome which is adjusted to capture losses resulting from less likely but possible outcomes. For certain less significant cases, the bank may use a LGD-based modelled approach to ECL assessment, which factors in a range of economic scenarios.
Period over which ECL is measured
Expected credit loss is measured from the initial recognition of the financial asset. The maximum period considered when measuring ECL (be it 12-month or lifetime ECL) is the maximum contractual period over which HSBC is exposed to credit risk. However, where the financial instrument includes both a drawn and undrawn commitment and the contractual ability to demand repayment and cancel the undrawn commitment does not serve to limit HSBC's exposure to credit risk to the contractual notice period, the contractual period does not determine the maximum period considered. Instead, ECL is measured over the period HSBC remains exposed to credit risk that is not mitigated by credit risk management actions. This applies to retail overdrafts and credit cards, where the period is the average time taken for stage 2 exposures to default or close as performing accounts, determined on a portfolio basis and ranging from between two and six years. In addition, for these facilities it is not possible to identify the ECL on the loan commitment component separately from the financial asset component. As a result, the total ECL is recognised in the loss allowance for the financial asset unless the total ECL exceeds the gross carrying amount of the financial asset, in which case the ECL is recognised as a provision. For wholesale overdraft facilities, credit risk management actions are taken no less frequently than on an annual basis.
Forward-looking economic inputs
HSBC applies multiple forward-looking global economic scenarios determined with reference to external forecast distributions representative of its view of forecast economic conditions. This approach is considered sufficient to calculate unbiased expected credit losses in most economic environments. In certain economic environments, additional analysis may be necessary and may result in additional scenarios or adjustments, to reflect a range of possible economic outcomes sufficient for an unbiased estimate. The detailed methodology is disclosed in 'Measurement uncertainty and sensitivity analysis of ECL estimates' on page 156.
Critical estimates and judgements
The calculation of the Group's ECL under IFRS 9 requires the Group to make a number of judgements, assumptions and estimates. The most significant are set out below: |
|
- Defining what is considered to be a significant increase in credit risk - Determining the lifetime and point of initial recognition of overdrafts and credit cards - Selecting and calibrating the PD, LGD and EAD models, which support the calculations, including making reasonable and supportable judgements about how models react to current and future economic conditions - Selecting model inputs and economic forecasts, including determining whether sufficient and appropriately weighted economic forecasts are incorporated to calculate unbiased expected credit loss - Making management adjustments to account for late-breaking events, model and data limitations and deficiencies, and expert credit judgements - Selecting applicable recovery strategies for certain wholesale credit-impaired loans |
- The section 'Measurement uncertainty and sensitivity analysis of ECL estimates', marked as audited from page 156, sets out the assumptions used in determining ECL, and provides an indication of the sensitivity of the result to the application of different weightings being applied to different economic assumptions
|
(j) Insurance contracts
A contract is classified as an insurance contract where the Group accepts significant insurance risk from another party by agreeing to compensate that party if it is adversely affected by a specified uncertain future event. An insurance contract may also transfer financial risk, but is accounted for as an insurance contract if the insurance risk is significant. In addition, the Group issues investment contracts with DPF, which are also accounted under IFRS 17 'Insurance Contracts'.
Aggregation of insurance contracts
Individual insurance contracts that are managed together and subject to similar risks are identified as a portfolio. Contracts that are managed together usually belong to the same product group, and have similar characteristics such as being subject to a similar pricing framework or similar product management, and are issued by the same legal entity. If a contract is exposed to more than one risk, the dominant risk of the contract is used to assess whether the contract features similar risks. Each portfolio is further separated by the contract's expected profitability. The portfolios are split by their profitability into: (i) contracts that are onerous at initial recognition; (ii) contracts that at initial recognition have no significant possibility of becoming onerous subsequently; and (iii) the remaining contracts. These profitability groups are then divided by issue date, with most contracts the Group issues after the transition date being grouped into calendar quarter cohorts. For multi-currency groups of contracts, the Group considers its groups of contracts as being denominated in a single currency.
The measurement of the insurance contract liability is based on groups of insurance contracts as established at initial recognition, and will include fulfilment cash flows as well as the CSM representing the unearned profit. The Group has elected to update the estimates used in the measurement on a year-to-date basis.
Fulfilment cash flows
The fulfilment cash flows comprise the following:
Best estimates of future cash flows
The cash flows within the contract boundary of each contract in the Group include amounts expected to be collected from premiums and payouts for claims, benefits and expenses, and are projected using a range of scenarios and assumptions in an unbiased way based on the Group's demographic and operating experience along with external mortality data where the Group's own experience data is not sufficiently large in size to be credible.
Adjustment for the time value of money and financial risks associated with the future cash flows
The estimates of future cash flows are adjusted to reflect the time value of money (i.e. discounting) and the financial risks to derive an expected present value. The Group generally makes use of stochastic modelling techniques in the estimation for products with options and guarantees.
A bottom-up approach is used to determine the discount rate to be applied to a given set of expected future cash flows. This is derived as the sum of the risk-free yield and an illiquidity premium. The risk-free yield is determined based on observable market data, where such markets are considered to be deep, liquid and transparent. When information is not available, management judgement is applied to determine the appropriate risk-free yield. Illiquidity premiums reflect the liquidity characteristics of the associated insurance contracts.
Risk adjustment for non-financial risk
The risk adjustment reflects the compensation required for bearing the uncertainty about the amount and timing of future cash flows that arises from non-financial risk. It is calculated as a 75th percentile level of stress over a one-year period. The level of the stress is determined with reference to external regulatory stresses and internal economic capital stresses.
For the main insurance manufacturing entity in these locations, the one-year 75th percentile level of stress corresponds to the following percentiles based on an ultimate view of risk over all future years:
- Asia-Pacific (Hong Kong): 60th percentile (2022: 59th percentile).
- Europe (France): 60th percentile (2022: 60th percentile).
- Latin America (Mexico): 65th percentile (2022: 66th percentile).
The Group does not disaggregate changes in the risk adjustment between insurance service result (comprising insurance revenue and insurance service expense) and insurance finance income or expenses. All changes are included in the insurance service result.
Measurement models
The variable fee approach ('VFA') measurement model is used for most of the contracts issued by the Group, which is mandatory upon meeting the following eligibility criteria at inception:
- the contractual terms specify that the policyholder participates in a share of a clearly identified pool of underlying items;
- the Group expects to pay to the policyholder a substantial share of the fair value returns on the underlying items. The Group considers that a substantial share is a majority of returns; and
- the Group expects a substantial proportion of any change in the amounts to be paid to the policyholder to vary with the change in fair value of the underlying items. The Group considers that a substantial proportion is a majority proportion of change on a present value probability-weighted average of all scenarios.
For some contracts measured under VFA, the other comprehensive income ('OCI') option is used. The OCI option is applied where the underlying items held by the Group are not accounted for at fair value through profit or loss. Under this option, only the amount that matches income or expenses recognised in profit or loss on underlying items is included in finance income or expenses for these insurance contracts, and hence results in the elimination of accounting mismatches. The remaining amount of finance income or expenses for these insurance contracts issued for the period is recognised in OCI. In addition, the risk mitigation option is used for a number of economic offsets against the instruments that meet specific requirements.
The remaining contracts issued and the reinsurance contracts held are accounted for under the general measurement model ('GMM').
CSM and coverage units
The CSM represents the unearned profit and results in no income or expense at initial recognition when the group of contracts is profitable. The CSM is adjusted at each subsequent reporting period for changes in fulfilment cash flows relating to future service (e.g. changes in non-economic assumptions, including mortality and morbidity rates). For initial recognition of onerous groups of contracts and when groups of contracts become onerous subsequently, losses are recognised in insurance service expense immediately.
For groups of contracts measured using the VFA, changes in the Group's share of the underlying items, and economic experience and economic assumption changes adjust the CSM, whereas these changes do not adjust the CSM under the GMM, but are recognised in profit or loss as they arise. However, under the risk mitigation option for VFA contracts, the changes in the fulfilment cash flows and the changes in the Group's share in the fair value return on underlying items that the instruments mitigate are not adjusted in CSM but recognised in profit or loss. The risk mitigating instruments are primarily reinsurance contracts held.
The CSM is systematically recognised in insurance revenue to reflect the insurance contract services provided, based on the coverage units of the group of contracts. Coverage units are determined by the quantity of benefits and the expected coverage period of the contracts.
The Group identifies the quantity of the benefits provided as follows:
- Insurance coverage: This is based on the expected net policyholder insurance benefit at each period after allowance for decrements, where net policyholder insurance benefit refers to the amount of sum assured less the fund value or surrender value.
- Investment services (including both investment-return service and investment-related service): This is based on a constant measure basis which reflects the provision of access for the policyholder to the facility.
For contracts that provide both insurance coverage and investment services, coverage units are weighted according to the expected present value of the future cash outflows for each service.
Insurance service result
Insurance revenue reflects the consideration to which the Group expects to be entitled in exchange for the provision of coverage and other insurance contract services (excluding any investment components). Insurance service expenses comprise the incurred claims and other incurred insurance service expenses (excluding any investment components), and losses on onerous groups of contracts and reversals of such losses.
Insurance finance income and expenses
Insurance finance income and expenses comprise the change in the carrying amount of the group of insurance contracts arising from the effects of the time value of money, financial risk and changes therein. For VFA contracts, changes in the fair value of underlying items (excluding additions and withdrawals) are recognised in insurance finance income or expenses.
(k) Employee compensation and benefits
Share-based payments
HSBC enters into both equity-settled and cash-settled share-based payment arrangements with its employees as compensation for the provision of their services.
The vesting period for these schemes may commence before the legal grant date if the employees have started to render services in respect of the award before the legal grant date, where there is a shared understanding of the terms and conditions of the arrangement. Expenses are recognised when the employee starts to render service to which the award relates.
Cancellations result from the failure to meet a non-vesting condition during the vesting period, and are treated as an acceleration of vesting recognised immediately in the income statement. Failure to meet a vesting condition by the employee is not treated as a cancellation, and the amount of expense recognised for the award is adjusted to reflect the number of awards expected to vest.
Post-employment benefit plans
HSBC operates a number of pension schemes including defined benefit, defined contribution and post-employment benefit schemes.
Payments to defined contribution schemes are charged as an expense as the employees render service.
Defined benefit pension obligations are calculated using the projected unit credit method. The net charge to the income statement mainly comprises the service cost and the net interest on the net defined benefit asset or liability, and is presented in operating expenses. Remeasurements of the net defined benefit asset or liability, which comprise actuarial gains and losses, return on plan assets excluding interest and the effect of the asset ceiling (if any, excluding interest), are recognised immediately in other comprehensive income. The net defined benefit asset or liability represents the present value of defined benefit obligations reduced by the fair value of plan assets (see Note 1.2(c)), after applying the asset ceiling test, where the net defined benefit surplus is limited to the present value of available refunds and reductions in future contributions to the plan.
The costs of obligations arising from other post-employment plans are accounted for on the same basis as defined benefit pension plans.
Critical estimates and judgements
The most significant critical estimates relate to the determination of key assumptions applied in calculating the defined benefit pension obligation for the principal plan. |
|
|
- A range of assumptions could be applied, and different assumptions could significantly alter the defined benefit obligation and the amounts recognised in profit or loss or OCI. - The calculation of the defined benefit pension obligation includes assumptions with regard to the discount rate, inflation rate, pension payments and deferred pensions, pay and mortality. Management determines these assumptions in consultation with the plan's actuaries. - Key assumptions used in calculating the defined benefit pension obligation for the principal plan and the sensitivity of the calculation to different assumptions are described in Note 5. |
(l) Tax
Income tax comprises current tax and deferred tax. Income tax is recognised in the income statement except to the extent that it relates to items recognised in other comprehensive income or directly in equity, in which case the tax is recognised in the same statement as the related item appears.
Current tax is the tax expected to be payable on the taxable profit for the year and on any adjustment to tax payable in respect of previous years. HSBC provides for potential current tax liabilities that may arise on the basis of the amounts expected to be paid to the tax authorities.
Deferred tax is recognised on temporary differences between the carrying amounts of assets and liabilities in the balance sheet, and the amounts attributed to such assets and liabilities for tax purposes. Deferred tax is calculated using the tax rates expected to apply in the periods in which the assets will be realised or the liabilities settled.
In assessing the probability and sufficiency of future taxable profit, management considers the availability of evidence to support the recognition of deferred tax assets, taking into account the inherent risks in long-term forecasting, including climate change-related, and drivers of recent history of tax losses where applicable. Management also considers the future reversal of existing taxable temporary differences and tax planning strategies, including corporate reorganisations.
Current and deferred tax are calculated based on tax rates and laws enacted, or substantively enacted, by the balance sheet date.
Critical estimates and judgements
The recognition of deferred tax assets depends on judgements and estimates. |
|
- Specific judgements supporting deferred tax assets are described in Note 7. |
- The recognition of deferred tax assets is sensitive to estimates of future cash flows projected for periods for which detailed forecasts are available and to assumptions regarding the long-term pattern of cash flows thereafter, on which forecasts of future taxable profit are based, and which affect the expected recovery periods and the pattern of utilisation of tax losses and tax credits. See Note 7 for further detail. |
The Group does not consider there to be a significant risk of a material adjustment to the carrying amount of deferred tax assets in the next financial year, but does consider this to be an area that is inherently judgemental.
(m) Provisions, contingent liabilities and guarantees
Provisions
Provisions are recognised when it is probable that an outflow of economic benefits will be required to settle a present legal or constructive obligation that has arisen as a result of past events and for which a reliable estimate can be made.
Critical estimates and judgements
The recognition and measurement of provisions requires the Group to make a number of judgements, assumptions and estimates. The most significant are set out below: |
|
- Determining whether a present obligation exists. Professional advice is taken on the assessment of litigation and similar obligations. - Provisions for legal proceedings and regulatory matters typically require a higher degree of judgement than other types of provisions. When matters are at an early stage, accounting judgements can be difficult because of the high degree of uncertainty associated with determining whether a present obligation exists, and estimating the probability and amount of any outflows that may arise. As matters progress, management and legal advisers evaluate on an ongoing basis whether provisions should be recognised, revising previous estimates as appropriate. At more advanced stages, it is typically easier to make estimates around a better defined set of possible outcomes. |
- Provisions for legal proceedings and regulatory matters remain very sensitive to the assumptions used in the estimate. There could be a wider range of possible outcomes for any pending legal proceedings, investigations or inquiries. As a result it is often not practicable to quantify a range of possible outcomes for individual matters. It is also not practicable to meaningfully quantify ranges of potential outcomes in aggregate for these types of provisions because of the diverse nature and circumstances of such matters and the wide range of uncertainties involved. |
Contingent liabilities, contractual commitments and guarantees
Contingent liabilities
Contingent liabilities, which include certain guarantees and letters of credit pledged as collateral security, and contingent liabilities related to legal proceedings or regulatory matters, are not recognised in the financial statements but are disclosed unless the probability of settlement is remote.
Financial guarantee contracts
Liabilities under financial guarantee contracts that are not classified as insurance contracts are recorded initially at their fair value, which is generally the fee received or present value of the fee receivable.
(n) Impairment of non-financial assets
Software under development is tested for impairment at least annually. Other non-financial assets are property, plant and equipment, intangible assets (excluding goodwill) and right-of-use assets. They are tested for impairment at the individual asset level when there is indication of impairment at that level, or at the CGU level for assets that do not have a recoverable amount at the individual asset level. In addition, impairment is also tested at the CGU level when there is indication of impairment at that level. For this purpose, CGUs are considered to be the principal operating legal entities divided by global business.
Impairment testing compares the carrying amount of the non-financial asset or CGU with its recoverable amount, which is the higher of the fair value less costs of disposal or the value in use. The carrying amount of a CGU comprises the carrying amount of its assets and liabilities, including non-financial assets that are directly attributable to it and non-financial assets that can be allocated to it on a reasonable and consistent basis. Non-financial assets that cannot be allocated to an individual CGU are tested for impairment at an appropriate grouping of CGUs. The recoverable amount of the CGU is the higher of the fair value less costs of disposal of the CGU, which is determined by independent and qualified valuers where relevant, and the value in use, which is calculated based on appropriate inputs (see Note 21).
When the recoverable amount of a CGU is less than its carrying amount, an impairment loss is recognised in the income statement to the extent that the impairment can be allocated on a pro-rata basis to the non-financial assets by reducing their carrying amounts to the higher of their respective individual recoverable amount or nil. Impairment is not allocated to the financial assets in a CGU.
Impairment losses recognised in prior periods for non-financial assets are reversed when there has been a change in the estimate used to determine the recoverable amount. The impairment loss is reversed to the extent that the carrying amount of the non-financial assets would not exceed the amount that would have been determined (net of amortisation or depreciation) had no impairment loss been recognised in prior periods.
Critical estimates and judgements
The review of goodwill and other non-financial assets for impairment reflects management's best estimate of the future cash flows of the CGUs and the rates used to discount these cash flows, both of which are subject to uncertain factors as described in the 'Critical estimates and judgements' in Note 1.2(a). |
The Group does not consider there to be a significant risk of a material adjustment to the carrying amount of goodwill and non-financial assets in the next financial year, but does consider this to be an area that is inherently judgemental.
(o) Non-current assets and disposal groups held for sale
HSBC classifies non-current assets or disposal groups (including assets and liabilities) as held for sale when their carrying amounts will be recovered principally through sale rather than through continuing use. To be classified as held for sale, the non-current asset or disposal group must be available for immediate sale in its present condition subject only to terms that are usual and customary for sales of such assets (or disposal groups), and the sale must be highly probable. For a sale to be highly probable, the appropriate level of management must be committed to a plan to sell the asset (or disposal group) and an active programme to locate a buyer and complete the plan must have been initiated. Further, the asset (or disposal group) must be actively marketed for sale at a price that is reasonable in relation to its current fair value. In addition, the sale should be expected to qualify as a completed sale within one year from the date of classification and actions required to complete the plan should indicate that it is unlikely that significant changes to the plan will be made or that the plan will be withdrawn.
Held for sale assets and disposal groups are measured at the lower of their carrying amount and fair value less costs to sell except for those assets and liabilities that are not within the scope of the measurement requirements of IFRS 5. If the carrying amount of the non-current asset (or disposal group) is greater than the fair value less costs to sell, an impairment loss for any initial or subsequent write-down of the asset or disposal group to fair value less costs to sell is recognised. Any such impairment loss is first allocated against the non-current assets that are in scope of IFRS 5 for measurement. This first reduces the carrying amount of any goodwill allocated to the disposal group, and then to the other non-current assets of the disposal group pro rata on the basis of the carrying amount of each asset in the disposal group. Thereafter, any impairment loss in excess of the carrying amount of the non-current assets in scope of IFRS 5 for measurement is recognised against the total assets of the disposal group.
Critical judgements
The classification as held for sale depends on certain judgements: |
Management judgement is required in determining whether the IFRS 5 held for sale criteria are met, including whether a sale is highly probable and expected to complete within one year of classification. The exercise of judgement will normally consider the likelihood of successfully securing any necessary regulatory or governmental approvals, which are almost always required for sales of banking businesses, and sanctions risk. For large and complex plans, judgement will also include an assessment of the enforceability of any binding sale agreement, the nature and magnitude of any disincentives for non-performance, and the ability of the counterparty to undertake necessary pre-completion preparatory work, comply with conditions precedent, and otherwise be able to comply with contractual undertakings to achieve completion within the expected timescale. Once classified as held for sale, judgement is required to be applied on a continuous basis to ensure that classification remains appropriate in future accounting periods. |
(p) Hyperinflationary accounting
Hyperinflationary accounting is applied to those subsidiary operations in countries where the three-year cumulative inflation rate is approaching or exceeding 100%. In 2023, this affected the Group's operations in Argentina and Türkiye. The Group applies IAS 29 to the underlying financial information of relevant subsidiaries to restate their local currency results and financial position so as to be stated in terms of the measuring unit current at the end of the reporting period. Those restated results are translated into the Group's presentation currency of US dollars for consolidation at the closing rate at the balance sheet date. Group comparatives are not restated for inflation and consequential adjustments to the opening balance sheet in relation to hyperinflationary subsidiaries are presented in other comprehensive income. The hyperinflationary gain or loss in respect of the net monetary position of the relevant subsidiary is included in profit or loss.
When applying hyperinflation accounting for the first time, the underlying financial information is restated in terms of the measuring unit current at the end of the reporting period as if the relevant economy had always been hyperinflationary. Group comparatives are not restated for such historical adjustments.
2 |
Net fee income |
Net fee income by global business |
|||||
|
2023 |
||||
|
Wealth and Personal Banking |
Commercial Banking |
Global Banking and Markets |
Corporate Centre |
Total |
|
$m |
$m |
$m |
$m |
$m |
Funds under management |
1,763 |
71 |
539 |
- |
2,373 |
Cards |
2,385 |
353 |
38 |
- |
2,776 |
Credit facilities |
103 |
856 |
615 |
- |
1,574 |
Broking income |
463 |
22 |
592 |
- |
1,077 |
Account services |
402 |
788 |
347 |
- |
1,537 |
Unit trusts |
727 |
10 |
1 |
- |
738 |
Underwriting |
- |
3 |
583 |
- |
586 |
Global custody |
128 |
6 |
730 |
- |
864 |
Remittances |
86 |
389 |
347 |
1 |
823 |
Imports/exports |
- |
470 |
154 |
- |
624 |
Insurance agency commission |
280 |
18 |
- |
- |
298 |
Other |
1,433 |
1,161 |
2,458 |
(2,706) |
2,346 |
Fee income |
7,770 |
4,147 |
6,404 |
(2,705) |
15,616 |
Less: fee expense |
(2,416) |
(210) |
(3,858) |
2,713 |
(3,771) |
Net fee income |
5,354 |
3,937 |
2,546 |
8 |
11,845 |
|
20221 |
||||
|
Wealth and Personal Banking |
Commercial Banking2 |
Global Banking and Markets2 |
Corporate Centre |
Total |
|
$m |
$m |
$m |
$m |
$m |
Funds under management |
1,765 |
107 |
500 |
(12) |
2,360 |
Cards |
2,146 |
313 |
32 |
- |
2,491 |
Credit facilities |
100 |
783 |
591 |
- |
1,474 |
Broking income |
576 |
40 |
635 |
- |
1,251 |
Account services |
337 |
730 |
344 |
1 |
1,412 |
Unit trusts |
682 |
14 |
- |
- |
696 |
Underwriting |
1 |
2 |
443 |
(5) |
441 |
Global custody |
140 |
19 |
762 |
- |
921 |
Remittances |
72 |
380 |
346 |
1 |
799 |
Imports/exports |
- |
493 |
141 |
- |
634 |
Insurance agency commission |
283 |
16 |
1 |
- |
300 |
Other |
1,330 |
1,102 |
2,376 |
(2,463) |
2,345 |
Fee income |
7,432 |
3,999 |
6,171 |
(2,478) |
15,124 |
Less: fee expense |
(2,128) |
(212) |
(3,459) |
2,445 |
(3,354) |
Net fee income |
5,304 |
3,787 |
2,712 |
(33) |
11,770 |
|
2021 |
||||
|
Wealth and Personal Banking |
Commercial Banking |
Global Banking and Markets |
Corporate Centre |
Total |
|
$m |
$m |
$m |
$m |
$m |
Funds under management |
1,984 |
126 |
546 |
- |
2,656 |
Cards |
1,949 |
240 |
23 |
1 |
2,213 |
Credit facilities |
103 |
833 |
690 |
1 |
1,627 |
Broking income |
863 |
69 |
669 |
- |
1,601 |
Account services |
429 |
677 |
340 |
6 |
1,452 |
Unit trusts |
1,065 |
23 |
- |
- |
1,088 |
Underwriting |
4 |
6 |
1,009 |
(2) |
1,017 |
Global custody |
167 |
24 |
787 |
- |
978 |
Remittances |
75 |
357 |
343 |
- |
775 |
Imports/exports |
1 |
474 |
145 |
- |
620 |
Insurance agency commission |
324 |
17 |
- |
- |
341 |
Other |
1,305 |
1,077 |
2,503 |
(2,465) |
2,420 |
Fee income |
8,269 |
3,923 |
7,055 |
(2,459) |
16,788 |
Less: fee expense |
(2,375) |
(284) |
(3,452) |
2,420 |
(3,691) |
Net fee income |
5,894 |
3,639 |
3,603 |
(39) |
13,097 |
1 From 1 January 2023, we adopted IFRS 17 'Insurance Contracts', which replaced IFRS 4 'Insurance Contracts'. Comparative data for the financial year ended 31 December 2022 have been restated accordingly. Comparative data for the year ended 31 December 2021 are prepared on an IFRS 4 basis.
2 In the first quarter of 2023, following an internal review to assess which global businesses were best suited to serve our customers' respective needs, a portfolio of our customers within our entities in Latin America was transferred from GBM to CMB for reporting purposes. Comparative data have been re-presented accordingly.
Net fee income included $6,971m of fees earned on financial assets that were not at fair value through profit or loss, other than amounts included in determining the effective interest rate (2022: $6,410m; 2021: $6,742m), $1,872m of fees payable on financial liabilities that were not at fair value through profit or loss, other than amounts included in determining the effective interest rate (2022: $1,613m; 2021: $1,520m), $3,452m of fees earned on trust and other fiduciary activities (2022: $3,492m; 2021: $3,849m) and $333m of fees payable relating to trust and other fiduciary activities (2022: $370m; 2021: $305m).
3 |
Net income/(expense) from financial instruments measured at fair value through profit or loss |
|
2023 |
20221 |
2021 |
|
$m |
$m |
$m |
Net income/(expense) arising on: |
|
|
|
Net trading activities |
20,391 |
2,372 |
6,668 |
Other instruments managed on a fair value basis |
(3,730) |
7,906 |
1,076 |
Net income from financial instruments held for trading or managed on a fair value basis |
16,661 |
10,278 |
7,744 |
Financial assets held to meet liabilities under insurance and investment contracts |
8,086 |
(14,392) |
4,134 |
Liabilities to customers under investment contracts |
(199) |
561 |
(81) |
Net income/(expense) from assets and liabilities of insurance businesses, including related derivatives, measured at fair value through profit or loss |
7,887 |
(13,831) |
4,053 |
1 From 1 January 2023, we adopted IFRS 17 'Insurance Contracts', which replaced IFRS 4 'Insurance Contracts'. Comparative data for the financial year ended 31 December 2022 have been restated accordingly. Comparative data for the year ended 31 December 2021 are prepared on an IFRS 4 basis.
HSBC Holdings
|
2023 |
2022 |
2021 |
|
$m |
$m |
$m |
Net income/(expense) arising on: |
|
|
|
- trading activities |
(546) |
2,094 |
87 |
- other instruments managed on a fair value basis |
1,609 |
35 |
23 |
Net income from financial instruments held for trading or managed on a fair value basis |
1,063 |
2,129 |
110 |
Derivatives managed in conjunction with HSBC Holdings-issued debt securities |
426 |
(1,529) |
(625) |
Other changes in fair value |
(1,894) |
3,673 |
974 |
Changes in fair value of designated debt and related derivatives |
(1,468) |
2,144 |
349 |
Changes in fair value of other financial instruments mandatorily measured at fair value through profit or loss |
3,692 |
(2,409) |
(420) |
Year ended 31 Dec |
3,287 |
1,864 |
39 |
4 |
Insurance business |
Insurance service result |
||||||
|
Year ended 31 Dec 2023 |
Year ended 31 Dec 2022¹ |
||||
|
Life direct participating and investment DPF contracts2 |
Life other contracts3 |
Total |
Life direct participating and investment DPF contracts2 |
Life other contracts3 |
Total |
|
$m |
$m |
$m |
$m |
$m |
$m |
Insurance revenue |
|
|
|
|
|
|
Amounts relating to changes in liabilities for remaining coverage |
1,626 |
470 |
2,096 |
1,399 |
446 |
1,845 |
Contractual service margin recognised for services provided |
975 |
151 |
1,126 |
781 |
151 |
932 |
Change in risk adjustment for non-financial risk for risk expired |
21 |
15 |
36 |
17 |
17 |
34 |
Expected incurred claims and other insurance service expenses |
594 |
304 |
898 |
528 |
278 |
806 |
Other |
36 |
- |
36 |
73 |
- |
73 |
Recovery of insurance acquisition cash flows |
109 |
54 |
163 |
102 |
30 |
132 |
Total insurance revenue |
1,735 |
524 |
2,259 |
1,501 |
476 |
1,977 |
Insurance service expenses |
|
|
|
|
|
|
Incurred claims and other insurance service expenses |
(615) |
(292) |
(907) |
(573) |
(280) |
(853) |
Losses and reversal of losses on onerous contracts |
(32) |
(77) |
(109) |
(84) |
(86) |
(170) |
Amortisation of insurance acquisition cash flows |
(109) |
(54) |
(163) |
(102) |
(30) |
(132) |
Adjustments to liabilities for incurred claims |
(1) |
(1) |
(2) |
(2) |
(11) |
(13) |
Total insurance service expenses |
(757) |
(424) |
(1,181) |
(761) |
(407) |
(1,168) |
Total insurance service results |
978 |
100 |
1,078 |
740 |
69 |
809 |
1 From 1 January 2023, we adopted IFRS 17 'Insurance Contracts', which replaced IFRS 4 'Insurance Contracts'. Comparative data have been restated accordingly.
2 'Life direct participating and investment DPF contracts' are substantially measured under the variable fee approach measurement model.
3 'Life other contracts' are measured under the general measurement model and excludes reinsurance contracts.
Net investment return |
||||||
|
Year ended 31 Dec 2023 |
Year ended 31 Dec 2022¹ |
||||
|
Life direct participating and investment DPF contracts |
Life other contracts |
Total |
Life direct participating and investment DPF contracts |
Life other contracts |
Total |
|
$m |
$m |
$m |
$m |
$m |
$m |
Investment return |
|
|
|
|
|
|
Amounts recognised in profit or loss2 |
7,663 |
214 |
7,877 |
(13,520) |
(181) |
(13,701) |
Amounts recognised in OCI3 |
493 |
- |
493 |
(2,392) |
- |
(2,392) |
Total investment return (memorandum) |
8,156 |
214 |
8,370 |
(15,912) |
(181) |
(16,093) |
Net finance income/(expense) |
|
|
|
|
|
|
Changes in fair value of underlying items of direct participating contracts |
(7,995) |
- |
(7,995) |
15,937 |
- |
15,937 |
Effect of risk mitigation option |
(35) |
- |
(35) |
99 |
- |
99 |
Interest accreted |
- |
(127) |
(127) |
- |
(80) |
(80) |
Effect of changes in interest rates and other financial assumptions |
(12) |
(121) |
(133) |
- |
233 |
233 |
Effect of measuring changes in estimates at current rates and adjusting the CSM at rates on initial recognition |
- |
(10) |
(10) |
- |
3 |
3 |
Total net finance income/(expense) from insurance contracts |
(8,042) |
(258) |
(8,300) |
16,036 |
156 |
16,192 |
Represented by: |
|
|
|
|
|
|
Amounts recognised in profit or loss |
(7,551) |
(258) |
(7,809) |
13,643 |
156 |
13,799 |
Amounts recognised in OCI |
(491) |
- |
(491) |
2,393 |
- |
2,393 |
Total net investment results |
114 |
(44) |
70 |
124 |
(25) |
99 |
Represented by: |
|
|
|
|
|
|
Amounts recognised in profit or loss |
112 |
(44) |
68 |
123 |
(25) |
98 |
Amounts recognised in OCI |
2 |
- |
2 |
1 |
- |
1 |
1 From 1 January 2023, we adopted IFRS 17 'Insurance Contracts', which replaced IFRS 4 'Insurance Contracts'. Comparative data have been restated accordingly.
2 Total Group 'Net income/(expense) from assets and liabilities of insurance business, including related derivatives, measured at fair value through profit or loss' of $7,886m gain (2022: $13,831m loss) includes returns on assets and liabilities supporting insurance policies of $7,627m (2022: $13,949m loss) and on shareholder assets of $259m (2022: $118m gain). Investment returns of $7,877m (2022: $13,701m loss) include gains of $7,627m (2022: $13,949m loss) on underlying assets supporting insurance liabilities reported in 'Net income/(expense) from assets and liabilities of insurance businesses, including related derivatives, measured at fair value through profit or loss', $257m gains (2022: $248m gain) reported in 'Net interest income' and $7m loss (2022: nil) reported in 'Other operating income'.
3 'Amounts recognised in OCI' gross of tax for the year ended 31 December 2023 included fair value gains of $497m (2022: $2,396m loss) and impairment of $4m (2022: $4m impairment reversals).
Reconciliation of amounts included in other comprehensive income for financial assets measured at fair value through other comprehensive income - assets supporting contracts measured under the modified retrospective approach |
||
|
2023 |
2022 |
|
$m |
$m |
Balance at 1 Jan |
(973) |
622 |
Net change in fair value |
451 |
(2,099) |
Net amount reclassified to profit or loss |
(6) |
(2) |
Related income tax |
(115) |
543 |
Foreign exchange and other |
(27) |
(37) |
Balance at 31 Dec |
(670) |
(973) |
Movements in carrying amounts of insurance contracts - analysis by remaining coverage and incurred claims |
|||||||||
|
Year ended 31 Dec 2023 |
||||||||
|
Life direct participating and investment DPF contracts |
Life other contracts |
|
||||||
|
Liabilities for remaining coverage: |
|
|
Liabilities for remaining coverage: |
|
|
|
||
|
Excluding loss component |
Loss component |
Incurred claims |
Total |
Excluding loss component |
Loss component |
Incurred claims |
Total |
Total |
|
$m |
$m |
$m |
$m |
$m |
$m |
$m |
$m |
$m |
Opening assets |
(5) |
- |
- |
(5) |
(187) |
21 |
35 |
(131) |
(136) |
Opening liabilities |
104,676 |
114 |
355 |
105,145 |
3,359 |
109 |
203 |
3,671 |
108,816 |
Net opening balance at 1 Jan 2023 |
104,671 |
114 |
355 |
105,140 |
3,172 |
130 |
238 |
3,540 |
108,680 |
Changes in the statement of profit or loss and other comprehensive income |
|
|
|
|
|
|
|
|
|
Insurance revenue |
|
|
|
|
|
|
|
|
|
Contracts under the fair value approach |
(508) |
- |
- |
(508) |
(196) |
- |
- |
(196) |
(704) |
Contracts under the modified retrospective approach |
(148) |
- |
- |
(148) |
(22) |
- |
- |
(22) |
(170) |
Other contracts2 |
(1,079) |
- |
- |
(1,079) |
(306) |
- |
- |
(306) |
(1,385) |
Total insurance revenue |
(1,735) |
- |
- |
(1,735) |
(524) |
- |
- |
(524) |
(2,259) |
Insurance service expenses |
|
|
|
|
|
|
|
|
|
Incurred claims and other insurance service expenses |
- |
(6) |
621 |
615 |
- |
(24) |
316 |
292 |
907 |
Amortisation of insurance acquisition cash flows |
109 |
- |
- |
109 |
54 |
- |
- |
54 |
163 |
Losses and reversal of losses on onerous contracts |
- |
32 |
- |
32 |
- |
77 |
- |
77 |
109 |
Adjustments to liabilities for incurred claims |
- |
- |
1 |
1 |
- |
- |
1 |
1 |
2 |
Total insurance service expenses |
109 |
26 |
622 |
757 |
54 |
53 |
317 |
424 |
1,181 |
Investment components |
(8,104) |
- |
8,104 |
- |
(818) |
- |
818 |
- |
- |
Insurance service result |
(9,730) |
26 |
8,726 |
(978) |
(1,288) |
53 |
1,135 |
(100) |
(1,078) |
Net finance (income)/expense from insurance contracts3 |
8,042 |
- |
- |
8,042 |
254 |
3 |
1 |
258 |
8,300 |
Other movements recognised in the statement of profit or loss |
513 |
(5) |
(214) |
294 |
(8) |
4 |
(13) |
(17) |
277 |
Effect of movements in exchange rates |
942 |
1 |
6 |
949 |
25 |
(2) |
8 |
31 |
980 |
Total changes in the statement of profit or loss and other comprehensive income |
(233) |
22 |
8,518 |
8,307 |
(1,017) |
58 |
1,131 |
172 |
8,479 |
Cash flows |
|
|
|
|
|
|
|
|
|
Premiums received |
12,616 |
- |
- |
12,616 |
1,256 |
- |
- |
1,256 |
13,872 |
Claims and other insurance service expenses paid, including investment components, and other cash flows |
(15) |
- |
(8,502) |
(8,517) |
1 |
- |
(1,112) |
(1,111) |
(9,628) |
Insurance acquisition cash flows |
(522) |
- |
- |
(522) |
(282) |
- |
- |
(282) |
(804) |
Total cash flows |
12,079 |
- |
(8,502) |
3,577 |
975 |
- |
(1,112) |
(137) |
3,440 |
Other movements |
14 |
(14) |
- |
- |
(9) |
(13) |
22 |
- |
- |
Net closing balance at 31 Dec 2023 |
116,531 |
122 |
371 |
117,024 |
3,121 |
175 |
279 |
3,575 |
120,599 |
Closing assets |
(15) |
1 |
1 |
(13) |
(279) |
(16) |
56 |
(239) |
(252) |
Closing liabilities |
116,546 |
121 |
370 |
117,037 |
3,400 |
191 |
223 |
3,814 |
120,851 |
Net closing balance at 31 Dec 2023 |
116,531 |
122 |
371 |
117,024 |
3,121 |
175 |
279 |
3,575 |
120,599 |
Movements in carrying amounts of insurance contracts - analysis by remaining coverage and incurred claims (continued) |
|||||||||
|
Year ended 31 Dec 20221 |
||||||||
|
Life direct participating and investment DPF contracts |
Life other contracts |
|
||||||
|
Liabilities for remaining coverage: |
|
|
Liabilities for remaining coverage: |
|
|
|
||
|
Excluding loss component |
Loss component |
Incurred claims |
Total |
Excluding loss component |
Loss component |
Incurred claims |
Total |
Total |
|
$m |
$m |
$m |
$m |
$m |
$m |
$m |
$m |
$m |
Opening assets |
- |
- |
- |
- |
(159) |
7 |
36 |
(116) |
(116) |
Opening liabilities |
114,952 |
93 |
226 |
115,271 |
3,825 |
67 |
144 |
4,036 |
119,307 |
Net opening balance at 1 Jan 2022 |
114,952 |
93 |
226 |
115,271 |
3,666 |
74 |
180 |
3,920 |
119,191 |
Changes in the statement of profit or loss and other comprehensive income |
|
|
|
|
|
|
|
|
|
Insurance revenue |
|
|
|
|
|
|
|
|
|
Contracts under the fair value approach |
(571) |
- |
- |
(571) |
(234) |
- |
- |
(234) |
(805) |
Contracts under the modified retrospective approach |
(147) |
- |
- |
(147) |
(24) |
- |
- |
(24) |
(171) |
Other contracts2 |
(783) |
- |
- |
(783) |
(218) |
- |
- |
(218) |
(1,001) |
Total insurance revenue |
(1,501) |
- |
- |
(1,501) |
(476) |
- |
- |
(476) |
(1,977) |
Insurance service expenses |
|
|
|
|
|
|
|
|
|
Incurred claims and other insurance service expenses |
- |
5 |
568 |
573 |
- |
(6) |
286 |
280 |
853 |
Amortisation of insurance acquisition cash flows |
102 |
- |
- |
102 |
30 |
- |
- |
30 |
132 |
Losses and reversal of losses on onerous contracts |
- |
84 |
- |
84 |
- |
86 |
- |
86 |
170 |
Adjustments to liabilities for incurred claims |
- |
- |
2 |
2 |
- |
- |
11 |
11 |
13 |
Total insurance service expenses |
102 |
89 |
570 |
761 |
30 |
80 |
297 |
407 |
1,168 |
Investment components |
(5,487) |
- |
5,487 |
- |
(549) |
- |
549 |
- |
- |
Insurance service result |
(6,886) |
89 |
6,057 |
(740) |
(995) |
80 |
846 |
(69) |
(809) |
Net finance (income)/expense from insurance contracts3 |
(16,038) |
- |
2 |
(16,036) |
(154) |
2 |
(4) |
(156) |
(16,192) |
Effect of movements in exchange rates |
(2,159) |
(4) |
(11) |
(2,174) |
(88) |
(2) |
(3) |
(93) |
(2,267) |
Total changes in the statement of profit or loss and other comprehensive income |
(25,083) |
85 |
6,048 |
(18,950) |
(1,237) |
80 |
839 |
(318) |
(19,268) |
Cash flows |
|
|
|
|
|
|
|
|
|
Premiums received |
12,740 |
- |
- |
12,740 |
882 |
- |
- |
882 |
13,622 |
Claims and other insurance service expenses paid, including investment components, and other cash flows |
- |
- |
(5,783) |
(5,783) |
- |
- |
(880) |
(880) |
(6,663) |
Insurance acquisition cash flows |
(423) |
- |
- |
(423) |
(162) |
- |
- |
(162) |
(585) |
Total cash flows |
12,317 |
- |
(5,783) |
6,534 |
720 |
- |
(880) |
(160) |
6,374 |
Acquisition of subsidiaries and other movements |
2,485 |
(64) |
(136) |
2,285 |
23 |
(24) |
99 |
98 |
2,383 |
Net closing balance at 31 Dec 2022 |
104,671 |
114 |
355 |
105,140 |
3,172 |
130 |
238 |
3,540 |
108,680 |
Closing assets |
(5) |
- |
- |
(5) |
(187) |
21 |
35 |
(131) |
(136) |
Closing liabilities |
104,676 |
114 |
355 |
105,145 |
3,359 |
109 |
203 |
3,671 |
108,816 |
Net closing balance at 31 Dec 2022 |
104,671 |
114 |
355 |
105,140 |
3,172 |
130 |
238 |
3,540 |
108,680 |
1 From 1 January 2023, we adopted IFRS 17 'Insurance Contracts', which replaced IFRS 4 'Insurance Contracts'. Comparative data have been restated accordingly.
2 'Other contracts' are those contracts measured by applying IFRS 17 from inception of the contracts. These include contracts measured under the full retrospective approach at transition and contracts incepted after transition and excludes reinsurance contracts.
3 'Net finance (income)/expense from insurance contracts' expense of $8,300m (2022: $16,192m income) comprises expense of $7,809m (2022: $13,799m income) recognised in the statement of profit or loss and expense of $491m (2022: $2,393m income) recognised in the statement of other comprehensive income.
Movements in carrying amounts of insurance contracts - analysis by measurement component |
|
||||||||||
|
Year ended 31 Dec 2023 |
||||||||||
|
Life direct participating and investment DPF contracts |
Life other contracts |
|
||||||||
|
Estimates of present value of future cash flows and risk adjustment |
Contractual service margin |
|
Estimates of present value of future cash flows and risk adjustment |
Contractual service margin |
|
|
||||
|
Contracts under the fair value approach |
Contracts under the modified retros- pective approach |
Other contracts2 |
Total |
Contracts under the fair value approach |
Contracts under the modified retros- pective approach |
Other contracts2 |
Total |
Total |
||
|
$m |
$m |
$m |
$m |
$m |
$m |
$m |
$m |
$m |
$m |
$m |
Opening assets |
(18) |
3 |
- |
10 |
(5) |
(308) |
86 |
- |
91 |
(131) |
(136) |
Opening liabilities |
96,174 |
4,364 |
792 |
3,815 |
105,145 |
3,162 |
325 |
18 |
166 |
3,671 |
108,816 |
Net opening balance at 1 Jan 2023 |
96,156 |
4,367 |
792 |
3,825 |
105,140 |
2,854 |
411 |
18 |
257 |
3,540 |
108,680 |
Changes in the statement of profit or loss and other comprehensive income |
|
|
|
|
|
|
|
|
|
|
|
Changes that relate to current services |
|
|
|
|
|
|
|
|
|
|
|
Contractual service margin recognised for services provided |
- |
(188) |
(70) |
(717) |
(975) |
- |
(69) |
(6) |
(76) |
(151) |
(1,126) |
Change in risk adjustment for non-financial risk expired |
(21) |
- |
- |
- |
(21) |
(15) |
- |
- |
- |
(15) |
(36) |
Experience adjustments |
21 |
- |
- |
- |
21 |
(12) |
- |
- |
- |
(12) |
9 |
Changes that relate to future services |
|
|
|
|
|
|
|
|
|
|
|
Contracts initially recognised in the year |
(1,606) |
- |
- |
1,619 |
13 |
(176) |
- |
- |
207 |
31 |
44 |
Changes in estimates that adjust the contractual service margin |
(771) |
368 |
(33) |
436 |
- |
21 |
26 |
6 |
(53) |
- |
- |
Changes in estimates that result in losses and reversal of losses on onerous contracts |
19 |
- |
- |
- |
19 |
46 |
- |
- |
- |
46 |
65 |
Changes that relate to past services |
|
|
|
|
|
|
|
|
|
|
|
Adjustments to liabilities for incurred claims |
1 |
- |
- |
- |
1 |
1 |
- |
- |
- |
1 |
2 |
Other movements recognised in insurance service result |
(36) |
- |
- |
- |
(36) |
- |
- |
- |
- |
- |
(36) |
Insurance service result |
(2,393) |
180 |
(103) |
1,338 |
(978) |
(135) |
(43) |
- |
78 |
(100) |
(1,078) |
Net finance (income)/expense from insurance contracts3 |
8,042 |
- |
- |
- |
8,042 |
235 |
11 |
- |
12 |
258 |
8,300 |
Other movements recognised in the statement of profit or loss |
145 |
133 |
(1) |
17 |
294 |
(43) |
6 |
- |
20 |
(17) |
277 |
Effect of movements in exchange rates |
883 |
2 |
27 |
37 |
949 |
- |
12 |
1 |
18 |
31 |
980 |
Total changes in the statement of profit or loss and other comprehensive income |
6,677 |
315 |
(77) |
1,392 |
8,307 |
57 |
(14) |
1 |
128 |
172 |
8,479 |
Cash flows |
|
|
|
|
|
|
|
|
|
|
|
Premiums received |
12,616 |
- |
- |
- |
12,616 |
1,256 |
- |
- |
- |
1,256 |
13,872 |
Claims, other insurance service expenses paid (including investment components) and other cash flows |
(8,517) |
- |
- |
- |
(8,517) |
(1,111) |
- |
- |
- |
(1,111) |
(9,628) |
Insurance acquisition cash flows |
(522) |
- |
- |
- |
(522) |
(282) |
- |
- |
- |
(282) |
(804) |
Total cash flows |
3,577 |
- |
- |
- |
3,577 |
(137) |
- |
- |
- |
(137) |
3,440 |
Net closing balance at 31 Dec 2023 |
106,410 |
4,682 |
715 |
5,217 |
117,024 |
2,774 |
397 |
19 |
385 |
3,575 |
120,599 |
Closing assets |
(30) |
3 |
- |
14 |
(13) |
(339) |
36 |
- |
64 |
(239) |
(252) |
Closing liabilities |
106,440 |
4,679 |
715 |
5,203 |
117,037 |
3,113 |
361 |
19 |
321 |
3,814 |
120,851 |
Net closing balance at 31 Dec 2023 |
106,410 |
4,682 |
715 |
5,217 |
117,024 |
2,774 |
397 |
19 |
385 |
3,575 |
120,599 |
Movements in carrying amounts of insurance contracts - analysis by measurement component (continued) |
|
||||||||||
|
Year ended 31 Dec 20221 |
||||||||||
|
Life direct participating and investment DPF contracts |
Life other contracts |
|
||||||||
|
Estimates of present value of future cash flows and risk adjustment |
Contractual service margin |
|
Estimates of present value of future cash flows and risk adjustment |
Contractual service margin |
|
|
||||
|
Contracts under the fair value approach |
Contracts under the modified retros- pective approach |
Other contracts2 |
Total |
Contracts under the fair value approach |
Contracts under the modified retros- pective approach |
Other contracts2 |
Total |
Total |
||
|
$m |
$m |
$m |
$m |
$m |
$m |
$m |
$m |
$m |
$m |
$m |
Opening assets |
- |
- |
- |
- |
- |
(236) |
57 |
- |
63 |
(116) |
(116) |
Opening liabilities |
105,861 |
5,823 |
704 |
2,883 |
115,271 |
3,532 |
331 |
26 |
147 |
4,036 |
119,307 |
Net opening balance at 1 Jan 2022 |
105,861 |
5,823 |
704 |
2,883 |
115,271 |
3,296 |
388 |
26 |
210 |
3,920 |
119,191 |
Changes in the statement of profit or loss and other comprehensive income |
|
|
|
|
|
|
|
|
|
|
|
Changes that relate to current services |
|
|
|
|
|
|
|
|
|
|
|
Contractual service margin recognised for services provided |
- |
(297) |
(69) |
(415) |
(781) |
- |
(69) |
(6) |
(76) |
(151) |
(932) |
Change in risk adjustment for non-financial risk expired |
(17) |
- |
- |
- |
(17) |
(17) |
- |
- |
- |
(17) |
(34) |
Experience adjustments |
45 |
- |
- |
- |
45 |
2 |
- |
- |
- |
2 |
47 |
Changes that relate to future services |
|
|
|
|
|
|
|
|
|
|
|
Contracts initially recognised in the year |
(1,092) |
- |
- |
1,101 |
9 |
(110) |
- |
- |
117 |
7 |
16 |
Changes in estimates that adjust contractual service margin |
820 |
(1,349) |
208 |
321 |
- |
(7) |
23 |
- |
(16) |
- |
- |
Changes in estimates that result in losses and reversal of losses on onerous contracts |
75 |
- |
- |
- |
75 |
79 |
- |
- |
- |
79 |
154 |
Changes that relate to past services |
|
|
|
|
|
|
|
|
|
|
|
Adjustments to liabilities for incurred claims |
2 |
- |
- |
- |
2 |
11 |
- |
- |
- |
11 |
13 |
Other movements recognised in insurance service result |
(73) |
- |
- |
- |
(73) |
- |
- |
- |
- |
- |
(73) |
Insurance service result |
(240) |
(1,646) |
139 |
1,007 |
(740) |
(42) |
(46) |
(6) |
25 |
(69) |
(809) |
Net finance (income)/expense from insurance contracts3 |
(16,025) |
(10) |
- |
(1) |
(16,036) |
(169) |
7 |
- |
6 |
(156) |
(16,192) |
Effect of movements in exchange rates |
(2,082) |
(16) |
(51) |
(25) |
(2,174) |
(74) |
(17) |
(2) |
- |
(93) |
(2,267) |
Total changes in the statement of profit or loss and other comprehensive income |
(18,347) |
(1,672) |
88 |
981 |
(18,950) |
(285) |
(56) |
(8) |
31 |
(318) |
(19,268) |
Cash flows |
|
|
|
|
|
|
|
|
|
|
|
Premiums received |
12,740 |
- |
- |
- |
12,740 |
882 |
- |
- |
- |
882 |
13,622 |
Claims, other insurance service expenses paid (including investment components) and other cash flows |
(5,783) |
- |
- |
- |
(5,783) |
(880) |
- |
- |
- |
(880) |
(6,663) |
Insurance acquisition cash flows |
(423) |
- |
- |
- |
(423) |
(162) |
- |
- |
- |
(162) |
(585) |
Total cash flows |
6,534 |
- |
- |
- |
6,534 |
(160) |
- |
- |
- |
(160) |
6,374 |
Acquisition of subsidiaries and other movements |
2,108 |
216 |
- |
(39) |
2,285 |
3 |
79 |
- |
16 |
98 |
2,383 |
Net closing balance at 31 Dec 2022 |
96,156 |
4,367 |
792 |
3,825 |
105,140 |
2,854 |
411 |
18 |
257 |
3,540 |
108,680 |
Closing assets |
(18) |
3 |
- |
10 |
(5) |
(308) |
86 |
- |
91 |
(131) |
(136) |
Closing liabilities |
96,174 |
4,364 |
792 |
3,815 |
105,145 |
3,162 |
325 |
18 |
166 |
3,671 |
108,816 |
Net closing balance at 31 Dec 2022 |
96,156 |
4,367 |
792 |
3,825 |
105,140 |
2,854 |
411 |
18 |
257 |
3,540 |
108,680 |
1 From 1 January 2023, we adopted IFRS 17 'Insurance Contracts', which replaced IFRS 4 'Insurance Contracts'. Comparative data have been restated accordingly.
2 'Other contracts' are those contracts measured by applying IFRS 17 from inception of the contracts. These include contracts measured under the full retrospective approach at transition and contracts incepted after transition and excludes reinsurance contracts.
3 'Net finance (income)/expense from insurance contracts' expense of $8,300m (2022: $16,192m income) comprises expense of $7,809m (2022: $13,799m income) recognised in the statement of profit or loss and expense of $491m (2022: $2,393m income) recognised in the statement of other comprehensive income.
Effect of contracts initially recognised in the year |
||||||
|
Year ended 31 Dec 2023 |
Year ended 31 Dec 20221 |
||||
|
Profitable contracts issued |
Onerous contracts issued |
Total |
Profitable contracts issued |
Onerous contracts issued |
Total |
|
$m |
$m |
$m |
$m |
$m |
$m |
Life direct participating and investment DPF contracts |
|
|
|
|
|
|
Estimates of present value of cash outflows |
12,418 |
215 |
12,633 |
9,714 |
123 |
9,837 |
- insurance acquisition cash flows |
602 |
21 |
623 |
401 |
16 |
417 |
- claims and other insurance service expenses payable |
11,816 |
194 |
12,010 |
9,313 |
107 |
9,420 |
Estimates of present value of cash inflows |
(14,074) |
(204) |
(14,278) |
(10,844) |
(115) |
(10,959) |
Risk adjustment for non-financial risk |
37 |
2 |
39 |
29 |
1 |
30 |
Contractual service margin |
1,619 |
- |
1,619 |
1,101 |
- |
1,101 |
Losses recognised on initial recognition |
- |
(13) |
(13) |
- |
(9) |
(9) |
Life other contracts |
|
|
|
|
|
|
Estimates of present value of cash outflows |
1,116 |
464 |
1,580 |
640 |
111 |
751 |
- insurance acquisition cash flows |
106 |
50 |
156 |
57 |
9 |
66 |
- claims and other insurance service expenses payable |
1,010 |
414 |
1,424 |
583 |
102 |
685 |
Estimates of present value of cash inflows |
(1,350) |
(438) |
(1,788) |
(778) |
(105) |
(883) |
Risk adjustment for non-financial risk |
27 |
5 |
32 |
21 |
1 |
22 |
Contractual service margin |
207 |
- |
207 |
117 |
- |
117 |
Losses recognised on initial recognition |
- |
(31) |
(31) |
- |
(7) |
(7) |
1 From 1 January 2023, we adopted IFRS 17 'Insurance Contracts', which replaced IFRS 4 'Insurance Contracts'. Comparative data have been restated accordingly.
Present value of expected future cash flows of insurance contract liabilities and contractual service margin |
|||||||||
|
Less than 1 year |
1-2 years |
2-3 years |
3-4 years |
4-5 years |
5-10 years |
10-20 years |
Over 20 years |
Total |
|
$m |
$m |
$m |
$m |
$m |
$m |
$m |
$m |
$m |
Insurance liability future cash flows |
|
|
|
|
|
|
|
|
|
Life direct participating and investment DPF contracts |
(2,620) |
(545) |
2,321 |
2,419 |
3,344 |
11,695 |
23,351 |
65,897 |
105,862 |
Life other contracts |
1,276 |
362 |
(347) |
4 |
(45) |
36 |
102 |
1,628 |
3,016 |
Insurance liability future cash flows at 31 Dec 2023 |
(1,344) |
(183) |
1,974 |
2,423 |
3,299 |
11,731 |
23,453 |
67,525 |
108,878 |
Remaining contractual service margin |
|
|
|
|
|
|
|
|
|
Life direct participating and investment DPF contracts |
917 |
848 |
783 |
722 |
666 |
2,597 |
2,653 |
1,428 |
10,614 |
Life other contracts |
172 |
113 |
84 |
74 |
61 |
141 |
115 |
41 |
801 |
Remaining contractual service margin at 31 Dec 2023 |
1,089 |
961 |
867 |
796 |
727 |
2,738 |
2,768 |
1,469 |
11,415 |
Insurance liability future cash flows |
|
|
|
|
|
|
|
|
|
Life direct participating and investment DPF contracts |
(5,049) |
(1,891) |
180 |
1,417 |
1,685 |
9,585 |
30,108 |
59,762 |
95,797 |
Life other contracts |
695 |
770 |
395 |
(13) |
38 |
172 |
182 |
859 |
3,098 |
Insurance liability future cash flows at 31 Dec 20221 |
(4,354) |
(1,121) |
575 |
1,404 |
1,723 |
9,757 |
30,290 |
60,621 |
98,895 |
Remaining contractual service margin |
|
|
|
|
|
|
|
|
|
Life direct participating and investment DPF contracts |
757 |
689 |
638 |
590 |
547 |
2,177 |
2,293 |
1,293 |
8,984 |
Life other contracts |
194 |
64 |
56 |
48 |
42 |
134 |
99 |
49 |
686 |
Remaining contractual service margin at 31 Dec 20221 |
951 |
753 |
694 |
638 |
589 |
2,311 |
2,392 |
1,342 |
9,670 |
1 From 1 January 2023, we adopted IFRS 17 'Insurance Contracts', which replaced IFRS 4 'Insurance Contracts'. Comparative data have been restated accordingly.
Discount rates
The discount rates applied to expected future cash flows are determined through a bottom-up approach as set out in Note 1.2(j) 'Summary of material accounting policies - Insurance contracts' on page 351. The blended average of discount rates used within our most material manufacturing entities are as follows:
|
HSBC Life (International) Ltd |
Hang Seng Insurance Co Ltd |
HSBC Assurances Vie (France) |
||
|
HK$ |
US$ |
HK$ |
US$ |
€ |
At 31 Dec 2023 |
|
|
|
|
|
10-year discount rate (%) |
4.02 |
4.47 |
4.16 |
4.62 |
2.96 |
20-year discount rate (%) |
4.21 |
4.91 |
4.34 |
5.06 |
2.97 |
At 31 Dec 2022 |
|
|
|
|
|
10-year discount rate (%) |
4.56 |
4.59 |
4.70 |
4.80 |
3.66 |
20-year discount rate (%) |
4.63 |
4.96 |
4.76 |
5.17 |
3.33 |
5 |
Employee compensation and benefits |
|
2023 |
2022 |
2021 |
|
$m |
$m |
$m |
Employee compensation and benefits1 |
18,220 |
18,003 |
18,742 |
Capitalised wages and salaries2 |
1,403 |
1,285 |
870 |
Gross employee compensation and benefits for the year ended 31 Dec |
19,623 |
19,288 |
19,612 |
|
|
|
|
Consists of: |
|
|
|
Wages and salaries |
17,359 |
16,970 |
17,072 |
Social security costs |
1,507 |
1,403 |
1,503 |
Post-employment benefits |
757 |
915 |
1,037 |
Year ended 31 Dec |
19,623 |
19,288 |
19,612 |
1 In 2023 and 2022, employee compensation and benefits are presented in the income statement net of software capitalisation costs and costs included in the insurance contract fulfilment cash flow liabilities under IFRS 17. In 2021, employee compensation and benefits are presented net of software capitalisation costs in the income statement.
2 Comprises $1,043m (2022: $922m; 2021: $870m) software capitalisation costs and $360m (2022: $363m; 2021: n/a) costs included in the insurance contract fulfilment cash flow liabilities under IFRS 17.
Average number of persons employed by HSBC during the year by global business1 |
|||
|
2023 |
2022 |
2021 |
Wealth and Personal Banking |
132,336 |
135,676 |
138,026 |
Commercial Banking |
46,826 |
48,004 |
44,992 |
Global Banking and Markets |
48,043 |
48,597 |
48,179 |
Corporate Centre |
347 |
365 |
359 |
Year ended 31 Dec |
227,552 |
232,642 |
231,556 |
1 Average number of persons employed represents the number of persons with contracts of service with the Group.
Average number of persons employed by HSBC during the year by legal entity1 |
|||
|
2023 |
2022 |
2021 |
HSBC UK Bank plc |
20,415 |
20,501 |
21,447 |
HSBC Bank plc |
14,809 |
15,405 |
16,823 |
The Hongkong and Shanghai Banking Corporation Limited |
54,321 |
54,792 |
55,253 |
HSBC Bank Middle East Limited |
3,316 |
3,338 |
3,429 |
HSBC North America Holdings Inc. |
6,046 |
6,749 |
8,197 |
HSBC Bank Canada |
4,354 |
4,241 |
4,369 |
Grupo Financiero HSBC, S.A. de C.V. |
14,412 |
14,484 |
14,529 |
Other trading entities2 |
9,247 |
10,026 |
10,442 |
Holding companies, shared service centres and intra-Group eliminations |
100,632 |
103,106 |
97,067 |
Year ended 31 Dec |
227,552 |
232,642 |
231,556 |
1 Average number of persons employed represents the number of persons with contracts of service with the Group.
2 Other trading entities includes entities located in Oman, Türkiye, Egypt and Saudi Arabia.
Reconciliation of total incentive awards granted to income statement charge |
|||
|
2023 |
2022 |
2021 |
|
$m |
$m |
$m |
Total incentive awards approved for the current year |
3,774 |
3,359 |
3,495 |
Less: deferred bonuses awarded, expected to be recognised in future periods |
(353) |
(343) |
(379) |
Total incentives awarded and recognised in the current year |
3,421 |
3,016 |
3,116 |
Add: current year charges for deferred bonuses from previous years |
375 |
239 |
270 |
Other |
(56) |
(22) |
4 |
Income statement charge for incentive awards |
3,740 |
3,233 |
3,390 |
Share-based payments
'Wages and salaries' includes the effect of share-based payments arrangements, of which $482m was equity settled (2022: $400m; 2021: $467m), as follows:
|
2023 |
2022 |
2021 |
|
$m |
$m |
$m |
Conditional share awards |
499 |
402 |
479 |
Savings-related and other share award option plans |
23 |
22 |
27 |
Year ended 31 Dec |
522 |
424 |
506 |
HSBC share awards |
|
Deferred share awards (including annual incentive awards, long-term incentive ('LTI') awards delivered in shares) |
An assessment of performance over the relevant period ending on 31 December is used to determine the amount of the award to be granted. - Deferred awards generally require employees to remain in employment over the vesting period and are generally not subject to performance conditions after the grant date. An exception to these are LTI awards, which are subject to performance conditions. - Deferred share awards generally vest over a period of three, four, five or seven years. - Vested shares may be subject to a retention requirement post-vesting. - Awards are generally subject to malus and clawback provisions. |
International Employee Share Purchase Plan ('ShareMatch') |
The plan was first introduced in Hong Kong in 2013 and now includes employees based in 30 jurisdictions. - Shares are purchased in the market each quarter up to a maximum value of £750, or the equivalent in local currency. - Matching awards are added at a ratio of one free share for every three purchased. In mainland China, matching awards are settled in cash. - Matching awards vest subject to continued employment and the retention of the purchased shares for a maximum period of two years and nine months. |
Movement on HSBC share awards |
||
|
2023 |
2022 |
|
Number |
Number |
|
(000s) |
(000s) |
Conditional share awards outstanding at 1 Jan |
126,246 |
109,364 |
Additions during the year |
72,289 |
90,190 |
Released in the year |
(70,054) |
(67,718) |
Forfeited in the year |
(3,458) |
(5,590) |
Conditional share awards outstanding at 31 Dec |
125,023 |
126,246 |
Weighted average fair value of awards granted ($) |
5.84 |
5.60 |
HSBC share option plans |
|
Savings-related share option plans ('Sharesave') |
- From 2014, employees eligible for the UK plan could save up to £500 per month with the option to use the savings to acquire shares. - These are generally exercisable within six months following either the third or fifth anniversary of the commencement of a three-year or five-year contract, respectively. - The exercise price is set at a 20% (2022: 20%) discount to the market value immediately preceding the date of invitation. |
Calculation of fair values
The fair values of share options are calculated using a Black-Scholes model. The fair value of a share award is based on the share price at the date of the grant.
Movement on HSBC share option plans |
||
|
Savings-related share option plans |
|
|
Number |
WAEP1 |
|
(000s) |
£ |
Outstanding at 1 Jan 2023 |
115,651 |
2.89 |
Granted during the year2 |
23,382 |
4.70 |
Exercised during the year3 |
(49,007) |
2.73 |
Expired during the year |
(3,832) |
3.78 |
Forfeited during the year |
(2,200) |
2.88 |
Outstanding at 31 Dec 2023 |
83,994 |
3.42 |
- of which exercisable |
7,165 |
2.70 |
Weighted average remaining contractual life (years) |
2.41 |
|
|
|
|
Outstanding at 1 Jan 2022 |
123,197 |
2.85 |
Granted during the year2 |
8,928 |
4.24 |
Exercised during the year3 |
(3,483) |
3.49 |
Expired during the year |
(9,047) |
3.55 |
Forfeited during the year |
(3,944) |
2.79 |
Outstanding at 31 Dec 2022 |
115,651 |
2.89 |
- of which exercisable |
4,029 |
4.11 |
Weighted average remaining contractual life (years) |
2.26 |
|
1 Weighted average exercise price.
2 The weighted average fair value of options granted during the year was $1.92 (2022: $1.45).
3 The weighted average share price at the date the options were exercised was $7.39 (2022: $6.22).
Post-employment benefit plans
The Group operates pension plans throughout the world for its employees. 'Pension risk management processes' on page 206 contains details of the policies and practices associated with these pension plans, some of which are defined benefit plans. The largest defined benefit plan is the HBUK section of the HSBC Bank (UK) Pension Scheme ('the principal plan'), created as a result of the HSBC Bank (UK) Pension Scheme being fully sectionalised in 2018 to meet the requirements of the Banking Reform Act. For further details of how the trustee of the HSBC Bank (UK) Pension Scheme manages climate risk, see 'Managing climate risk' on page 65.
HSBC holds on its balance sheet the net surplus or deficit, which is the difference between the fair value of plan assets and the discounted value of scheme liabilities at the balance sheet date for each plan. Surpluses are only recognised to the extent that they are recoverable through reduced contributions in the future or through potential future refunds from the schemes. In assessing whether a surplus is recoverable, HSBC has considered its current right to obtain a future refund or a reduction in future contributions together with the rights of third parties such as trustees.
The principal plan
The principal plan has a defined benefit section and a defined contribution section. The defined benefit section was closed to future benefit accrual in 2015, with defined benefits earned by employees at that date continuing to be linked to their salary while they remain employed by HSBC. The plan is overseen by an independent corporate trustee, who has a fiduciary responsibility for the operation of the plan. Its assets are held separately from the assets of the Group.
The investment strategy of the plan is to hold the majority of assets in bonds, with the remainder in a diverse range of investments. It also includes some interest rate swaps to reduce interest rate risk, inflation swaps to reduce inflation risk and longevity swaps to reduce the impact of longer life expectancy.
The principal plan is subject to the statutory funding objective requirements of the UK Pensions Act 2004, which requires that it be funded to at least the level of technical provisions (an actuarial estimate of the assets needed to provide for the benefits already built up under the plan). Where a funding valuation is carried out and identifies a deficit, the employer and trustee are required to agree to a deficit recovery plan.
The latest funding valuation of the plan at 31 December 2019 was carried out by Colin G Singer of Willis Towers Watson Limited, who is a Fellow of the UK Institute and Faculty of Actuaries, using the projected unit credit method. At that date, the market value of the plan's assets was £31.1bn ($41.1bn) and this exceeded the value placed on its liabilities on an ongoing basis by £2.5bn ($3.3bn), giving a funding level of 109%. These figures include defined contribution assets amounting to £2.4bn ($3.2bn). The main differences between the assumptions used for assessing the defined benefit liabilities for this funding valuation and those used for IAS 19 are that an element of prudence is contained in the funding valuation assumptions for discount rate, inflation rate and life expectancy. The funding valuation is used to judge the amount of cash contributions the Group needs to put into the pension scheme. It will always be different to the IAS 19 accounting surplus, which is an accounting rule concerning employee benefits and shown on the balance sheet of our financial statements. The next funding valuation, with an effective date of 31 December 2022, is currently underway and will be concluded no later than the regulatory deadline of 31 March 2024. The plan is estimated to remain in a comfortable surplus relative to the funding liabilities as at the end of 2022, based on assumptions consistent with those used to determine the funding liabilities for the 2019 valuation.
The actuary also assessed the value of the liabilities if the plan were to have been stopped and an insurance company asked to secure all future pension payments. This is generally larger than the amount needed on the ongoing basis described above because an insurance company would use more prudent assumption, which would allow for reserves and include an explicit allowance for the future administrative expenses of the plan. Under this approach, the amount of assets needed was estimated to be £33bn ($44bn) at 31 December 2019.
The trust deed gives the ability for HSBC UK to take a refund of surplus assets after the plan has been run down such that no further beneficiaries remain. In assessing whether a surplus is recoverable, HSBC UK has considered its right to obtain a future refund together with the rights of third parties such as trustees. On this basis, any net surplus in the HBUK section of the plan is recognised in HSBC UK's financial statements and the Group's financial statements.
Income statement charge/(credit) |
|||
|
2023 |
2022 |
2021 |
|
$m |
$m |
$m |
Defined benefit pension plans |
(151) |
42 |
243 |
Defined contribution pension plans |
874 |
845 |
767 |
Pension plans |
723 |
887 |
1,010 |
Defined benefit and contribution healthcare plans |
34 |
28 |
27 |
Year ended 31 Dec |
757 |
915 |
1,037 |
Net assets/(liabilities) recognised on the balance sheet in respect of defined benefit plans |
||||
|
Fair value of plan assets |
Present value of defined benefit obligations |
Effect of limit on plan surpluses |
Total |
|
$m |
$m |
$m |
$m |
Defined benefit pension plans |
33,897 |
(27,011) |
- |
6,886 |
Defined benefit healthcare plans |
107 |
(403) |
- |
(296) |
At 31 Dec 2023 |
34,004 |
(27,414) |
- |
6,590 |
Total employee benefit liabilities (within Note 27 'Accruals, deferred income and other liabilities') |
|
|
|
(1,160) |
Total employee benefit assets (within Note 22 'Prepayments, accrued income and other assets') |
|
|
|
7,750 |
|
|
|
|
|
Defined benefit pension plans |
32,171 |
(25,693) |
- |
6,478 |
Defined benefit healthcare plans |
96 |
(388) |
- |
(292) |
At 31 Dec 2022 |
32,267 |
(26,081) |
- |
6,186 |
Total employee benefit liabilities (within Note 27 'Accruals, deferred income and other liabilities') |
|
|
|
(1,096) |
Total employee benefit assets (within Note 22 'Prepayments, accrued income and other assets') |
|
|
|
7,282 |
HSBC Holdings
Employee compensation and benefit expense in respect of HSBC Holdings' employees in 2023 amounted to $15m (2022: $41m). The average number of persons employed during 2023 was 29 (2022: 42). A small number of employees are members of defined benefit pension plans. These employees are members of the HSBC Bank (UK) Pension Scheme. HSBC Holdings pays contributions to such plan for its own employees in accordance with the schedules of contributions determined by the trustees of the plan and recognises these contributions as an expense as they fall due.
Defined benefit pension plans
Net asset/(liability) under defined benefit pension plans |
||||||||
|
Fair value of plan assets |
Present value of defined benefit obligations |
Effect of the asset ceiling |
Net defined benefit asset/(liability) |
||||
|
Principal1 plan |
Other |
Principal1 plan |
Other |
Principal1 plan |
Other |
Principal1 plan |
Other |
|
$m |
$m |
$m |
$m |
$m |
$m |
$m |
$m |
At 1 Jan 2023 |
25,121 |
7,050 |
(18,787) |
(6,906) |
- |
- |
6,334 |
144 |
Service cost |
- |
- |
(10) |
(150) |
- |
- |
(10) |
(150) |
- current service cost |
- |
- |
(14) |
(135) |
- |
- |
(14) |
(135) |
- past service cost and gains/(losses) from settlements |
|
- |
4 |
(15) |
- |
- |
4 |
(15) |
Net interest income/(cost) on the net defined benefit asset/(liability) |
1,247 |
298 |
(925) |
(286) |
- |
- |
322 |
12 |
Remeasurement effects recognised in other comprehensive income |
(225) |
110 |
7 |
(300) |
- |
- |
(218) |
(190) |
- return on plan assets (excluding interest income) |
(225) |
110 |
- |
- |
- |
- |
(225) |
110 |
- actuarial gains/(losses) financial assumptions |
- |
- |
(123) |
(327) |
- |
- |
(123) |
(327) |
- actuarial gains/(losses) demographic assumptions |
- |
- |
357 |
17 |
- |
- |
357 |
17 |
- actuarial gains/(losses) experience adjustments |
- |
- |
(227) |
10 |
- |
- |
(227) |
10 |
- other changes |
- |
- |
- |
- |
- |
- |
- |
- |
Exchange differences |
1,472 |
228 |
(1,098) |
(190) |
- |
- |
374 |
38 |
Benefits paid |
(1,063) |
(548) |
1,063 |
629 |
- |
- |
- |
81 |
Other movements2 |
38 |
169 |
(32) |
(26) |
- |
- |
6 |
143 |
At 31 Dec 2023 |
26,590 |
7,307 |
(19,782) |
(7,229) |
- |
- |
6,808 |
78 |
|
|
|
|
|
|
|
|
|
At 1 Jan 2022 |
41,384 |
10,047 |
(32,255) |
(10,022) |
- |
(23) |
9,129 |
2 |
Service cost |
- |
- |
(30) |
(170) |
- |
- |
(30) |
(170) |
- current service cost |
- |
- |
(12) |
(161) |
- |
- |
(12) |
(161) |
- past service cost and losses from settlements |
- |
- |
(18) |
(9) |
- |
- |
(18) |
(9) |
Net interest income/(cost) on the net defined benefit asset/(liability) |
703 |
198 |
(546) |
(202) |
- |
(1) |
157 |
(5) |
Remeasurement effects recognised in other comprehensive income |
(11,505) |
(2,181) |
9,532 |
2,360 |
- |
(3) |
(1,973) |
176 |
- return on plan assets (excluding interest income) |
(11,505) |
(2,181) |
- |
- |
- |
- |
(11,505) |
(2,181) |
- actuarial gains/(losses) financial assumptions |
- |
- |
10,543 |
2,383 |
- |
- |
10,543 |
2,383 |
- actuarial gains/(losses) demographic assumptions |
- |
- |
(123) |
24 |
- |
- |
(123) |
24 |
- actuarial gains/(losses) experience adjustments |
- |
- |
(888) |
(47) |
- |
- |
(888) |
(47) |
- other changes |
- |
- |
- |
- |
- |
(3) |
- |
(3) |
Exchange differences |
(4,288) |
(180) |
3,325 |
35 |
- |
2 |
(963) |
(143) |
Benefits paid |
(1,222) |
(616) |
1,222 |
686 |
- |
- |
- |
70 |
Other movements2 |
49 |
(218) |
(35) |
407 |
- |
25 |
14 |
214 |
At 31 Dec 2022 |
25,121 |
7,050 |
(18,787) |
(6,906) |
- |
- |
6,334 |
144 |
1 For further details of the principal plan, see page 365.
2 Other movements include contributions by HSBC, contributions by employees, administrative costs and taxes paid by plan.
HSBC expects to make $113m of contributions to defined benefit pension plans during 2024, consisting of $nil for the principal plan and $113m for other plans. Benefits expected to be paid from the plans to retirees over each of the next five years, and in aggregate for the five years thereafter, are as follows:
Benefits expected to be paid from plans |
||||||
|
2024 |
2025 |
2026 |
2027 |
2028 |
2029-2033 |
|
$m |
$m |
$m |
$m |
$m |
$m |
The principal plan1,2 |
1,125 |
1,160 |
1,196 |
1,234 |
1,273 |
6,988 |
Other plans1 |
465 |
473 |
456 |
478 |
476 |
2,403 |
1 The duration of the defined benefit obligation is 12.9 years for the principal plan under the disclosure assumptions adopted (2022: 13.2 years) and 10.3 years for all other plans combined (2022: 10.2 years).
2 For further details of the principal plan, see page 365.
Fair value of plan assets by asset classes |
||||||||
|
31 Dec 2023 |
31 Dec 2022 |
||||||
|
Value |
Quoted market price in active market |
No quoted market price in active market |
Thereof |
Value |
Quoted market price in active market |
No quoted market price in active market |
Thereof |
|
$m |
$m |
$m |
$m |
$m |
$m |
$m |
$m |
The principal plan2 |
|
|
|
|
|
|
|
|
Fair value of plan assets |
26,590 |
15,006 |
11,584 |
547 |
25,121 |
13,915 |
11,206 |
510 |
- equities3 |
83 |
- |
83 |
- |
112 |
- |
112 |
- |
- bonds fixed income |
5,262 |
4,739 |
523 |
- |
5,285 |
4,822 |
463 |
- |
- bonds index-linked |
10,300 |
10,300 |
- |
- |
9,479 |
9,479 |
- |
- |
- derivatives |
1,061 |
- |
1,061 |
547 |
1,203 |
- |
1,203 |
510 |
- property |
830 |
- |
830 |
- |
842 |
- |
842 |
- |
- pooled investment vehicles |
9,087 |
- |
9,087 |
- |
8,586 |
- |
8,586 |
- |
- other |
(33) |
(33) |
- |
- |
(386) |
(386) |
- |
- |
Other plans |
|
|
|
|
|
|
|
|
Fair value of plan assets |
7,307 |
5,361 |
1,946 |
39 |
7,050 |
5,848 |
1,202 |
37 |
- equities |
556 |
556 |
- |
3 |
639 |
486 |
153 |
2 |
- bonds fixed income |
3,624 |
3,623 |
1 |
5 |
3,571 |
3,472 |
99 |
4 |
- bonds index-linked |
90 |
90 |
- |
- |
58 |
58 |
- |
- |
- bonds other |
447 |
415 |
32 |
- |
1,357 |
1,007 |
350 |
- |
- derivatives |
2 |
(1) |
3 |
- |
4 |
(1) |
5 |
- |
- property |
112 |
108 |
4 |
- |
109 |
104 |
5 |
- |
- other |
2,476 |
570 |
1,906 |
31 |
1,312 |
722 |
590 |
31 |
1 The fair value of plan assets includes derivatives entered into with HSBC Bank plc as detailed in Note 37.
2 For further details of the principal plan, see page 365.
3 Includes $83m (2022: $112m) in relation to private equities.
Post-employment defined benefit plans' principal actuarial financial assumptions
HSBC determines the discount rates to be applied to its obligations in consultation with the plans' local actuaries, on the basis of current average yields of high-quality (AA-rated or equivalent) debt instruments with maturities consistent with those of the defined benefit obligations.
Key actuarial assumptions for the principal plan1 |
|||||
|
Discount rate |
Inflation rate (RPI) |
Inflation rate (CPI) |
Rate of increase for pensions |
Rate of pay increase |
|
% |
% |
% |
% |
% |
UK |
|
|
|
|
|
At 31 Dec 2023 |
4.65 |
3.23 |
2.67 |
3.14 |
3.42 |
At 31 Dec 2022 |
4.93 |
3.39 |
2.84 |
3.27 |
3.34 |
1 For further details of the principal plan, see page 365.
Mortality tables and average life expectancy at age 60 for the principal plan1 |
|||||
|
Mortality table |
Life expectancy at age 60 for a male member currently: |
Life expectancy at age 60 for a female member currently: |
||
|
Aged 60 |
Aged 40 |
Aged 60 |
Aged 40 |
|
UK |
|
|
|
|
|
At 31 Dec 2023 |
SAPS S32 |
26.2 |
27.7 |
28.3 |
29.8 |
At 31 Dec 2022 |
SAPS S3 |
27.1 |
28.6 |
28.4 |
29.9 |
1 For further details of the principal plan, see page 365.
2 Self-administered pension scheme ('SAPS') S3 table, with different tables and multipliers adopted based on gender, pension amount and member status, reflecting the Scheme's actual mortality experience. Improvements are projected in accordance with the Continuous Mortality Investigation's CMI 2022 core projection model with an initial addition to improvement of 0.25% per annum, a long-term rate of improvement of 1.25% per annum, a 0% weighting to 2020 and 2021 mortality experience, and a 25% weighting to 2022 mortality experience reflecting updated long-term view on mortality improvements post-pandemic.
The effect of changes in key assumptions on the principal plan1 |
||||
|
Impact on HBUK section of the HSBC Bank (UK) Pension Scheme obligation2 |
|||
|
Financial impact of increase |
Financial impact of decrease |
||
|
2023 |
2022 |
2023 |
2022 |
|
$m |
$m |
$m |
$m |
Discount rate - increase/decrease of 0.25% |
(599) |
(582) |
631 |
612 |
Inflation rate (RPI and CPI) - increase/decrease of 0.25% |
500 |
466 |
(497) |
(446) |
Pension payments and deferred pensions - increase/decrease of 0.25% |
622 |
551 |
(590) |
(519) |
Pay - increase/decrease of 0.25% |
8 |
10 |
(6) |
(10) |
Change in mortality - increase/decrease of 1 year |
613 |
470 |
(613) |
(489) |
1 For further details of the principal plan, see page 365.
2 Sensitivities allow for HSBC UK's convention of rounding pension assumptions during 2023 to the nearest 0.01% (2022: 0.01%).
The above sensitivity analyses are based on a change in an assumption while holding all other assumptions constant. In practice, this is unlikely to occur, and changes in some of the assumptions may be correlated. When calculating the sensitivity of the defined benefit obligation to significant actuarial assumptions the same method (present value of the defined benefit obligation calculated with the projected unit credit method at the end of the reporting period) has been applied as when calculating the defined benefit asset recognised in the balance sheet. The methods and types of assumptions used in preparing the sensitivity analysis did not change compared with the prior period.
Directors' emoluments
Details of Directors' emoluments, pensions and their interests are disclosed in the Directors' remuneration report on page 279.
6 |
Auditor's remuneration |
|
2023 |
2022 |
2021 |
|
$m |
$m |
$m |
Audit fees payable to PwC1 |
109.8 |
97.6 |
88.1 |
Other audit fees payable |
2.2 |
1.6 |
2.0 |
Year ended 31 Dec |
112.0 |
99.2 |
90.1 |
Fees payable by HSBC to PwC |
|||
|
2023 |
2022 |
2021 |
|
$m |
$m |
$m |
Fees for HSBC Holdings' statutory audit2 |
24.1 |
21.9 |
19.5 |
Fees for other services provided to HSBC |
131.8 |
126.2 |
109.9 |
- audit of HSBC's subsidiaries |
85.7 |
75.7 |
68.6 |
- audit-related assurance services3 |
26.0 |
26.4 |
18.7 |
- other assurance services4,5 |
20.1 |
24.1 |
22.6 |
Year ended 31 Dec |
155.9 |
148.1 |
129.4 |
1 Audit fees payable to PwC in 2023 included adjustments made to the prior year audit fee after finalisation of the 2022 financial statements.
2 Fees payable to PwC for the statutory audit of the consolidated financial statements of HSBC and the separate financial statements of HSBC Holdings. They include amounts payable for services relating to the consolidation returns of HSBC Holdings' subsidiaries, which are clearly identifiable as being in support of the Group audit opinion.
3 Including services for assurance and other services that relate to statutory and regulatory filings, including interim reviews.
4 Including permitted services relating to attestation reports on internal controls of a service organisation primarily prepared for and used by third-party end users, including comfort letters.
5 Includes reviews of PRA regulatory reporting returns.
No fees were payable by HSBC to PwC as principal auditor for the following types of services: internal audit services and services related to litigation, recruitment and remuneration.
Fees payable by HSBC's associated pension schemes to PwC |
||||
|
|
2023 |
2022 |
2021 |
|
|
$000 |
$000 |
$000 |
Audit of HSBC's associated pension schemes |
|
297 |
480 |
382 |
Year ended 31 Dec |
|
297 |
480 |
382 |
No fees were payable by HSBC's associated pension schemes to PwC as principal auditor for the following types of services: internal audit services, other assurance services, services related to corporate finance transactions, valuation and actuarial services, litigation, recruitment and remuneration, and information technology.
In addition to the above, the estimated fees paid to PwC by third parties associated with HSBC amounted to $12.3m (2022: $13.1m; 2021: $6.3m). In these cases, HSBC was connected with the contracting party and may therefore have been involved in appointing PwC. These fees arose from services such as auditing mutual funds managed by HSBC and reviewing the financial position of corporate concerns that borrow from HSBC.
Fees payable for non-audit services for HSBC Holdings are not disclosed separately because such fees are disclosed on a consolidated basis for the Group.
7 |
Tax |
Tax expense |
|||
|
2023 |
2022 |
2021 |
|
$m |
$m |
$m |
Current tax1 |
5,718 |
2,984 |
3,250 |
- for this year |
5,737 |
3,264 |
3,182 |
- adjustments in respect of prior years |
(19) |
(280) |
68 |
Deferred tax |
71 |
(2,175) |
963 |
- origination and reversal of temporary differences |
19 |
(2,278) |
874 |
- effect of changes in tax rates |
17 |
(293) |
132 |
- adjustments in respect of prior years |
35 |
396 |
(43) |
Year ended 31 Dec2 |
5,789 |
809 |
4,213 |
1 Current tax included Hong Kong profits tax of $1,328m (2022: $604m; 2021: $813m). The Hong Kong tax rate applying to the profits of subsidiaries assessable in Hong Kong was 16.5% (2022: 16.5%; 2021: 16.5%).
2 In addition to amounts recorded in the income statement, a tax credit of $41m (2022: credit of $145m) was recorded directly to equity.
Tax reconciliation
The tax charged to the income statement differs from the tax charge that would apply if all profits had been taxed at the UK corporation tax rate as follows:
|
2023 |
2022 |
2021 |
|||
|
$m |
% |
$m |
% |
$m |
% |
Profit before tax |
30,348 |
|
17,058 |
|
18,906 |
|
Tax expense |
|
|
|
|
|
|
Taxation at UK corporation tax rate of 23.5% (2022: 19.0%, 2021: 19.0%) |
7,132 |
23.5 |
3,241 |
19.0 |
3,592 |
19.0 |
Impact of differently taxed overseas profits in overseas locations |
(612) |
(2.0) |
459 |
2.7 |
280 |
1.5 |
UK banking surcharge |
350 |
1.2 |
283 |
1.7 |
332 |
1.8 |
Items increasing tax charge in 2023: |
|
|
|
|
|
|
- impairment of interest in associate |
705 |
2.3 |
- |
- |
- |
- |
- local taxes and overseas withholding taxes |
419 |
1.4 |
346 |
2.0 |
360 |
1.9 |
- impacts of hyperinflation |
348 |
1.1 |
171 |
1.0 |
68 |
0.4 |
- other permanent disallowables |
227 |
0.7 |
363 |
2.1 |
414 |
2.2 |
- bank levy |
112 |
0.4 |
59 |
0.3 |
93 |
0.5 |
- impact of changes in tax rates |
17 |
0.1 |
(293) |
(1.7) |
132 |
0.7 |
- adjustments in respect of prior period |
16 |
0.1 |
116 |
0.7 |
25 |
0.1 |
- tax impact of sale of French retail banking business |
- |
- |
115 |
0.7 |
(434) |
(2.3) |
- impact of differences between French tax basis and IFRSs |
- |
- |
- |
- |
434 |
2.3 |
Items reducing tax charge in 2023: |
|
|
|
|
|
|
- non-taxable income and gains |
(1,189) |
(3.9) |
(825) |
(4.8) |
(641) |
(3.4) |
- effect of profits in associates and joint ventures |
(571) |
(1.9) |
(504) |
(3.1) |
(414) |
(2.2) |
- movements in provisions for uncertain tax positions |
(472) |
(1.6) |
27 |
0.2 |
15 |
0.1 |
- accounting gain on acquisition of SVB UK |
(442) |
(1.5) |
- |
- |
- |
- |
- deductions for AT1 coupon payments |
(229) |
(0.7) |
(246) |
(1.4) |
(270) |
(1.4) |
- movements in unrecognised deferred tax |
(22) |
(0.1) |
(2,503) |
(14.7) |
227 |
1.1 |
Year ended 31 December |
5,789 |
19.1 |
809 |
4.7 |
4,213 |
22.3 |
The Group's profits are taxed at different rates depending on the country or territory in which the profits arise. The key applicable tax rates for 2023 include Hong Kong (16.5%), the US (21%) and the UK (23.5%). If the Group's profits were taxed at the statutory rates of the countries in which the profits arose, then the tax rate for the year would have been 22.6% (2022: 23.3%).
The effective tax rate for the year of 19.1% was higher than in the previous year (2022: 4.7%). The effective tax rate for the year was increased by 2.3% by the non-taxable impairment of the Group's interest in BoCom, reduced by 1.6% by the release of provisions for uncertain tax positions and reduced by 1.5% by the non-taxable accounting gain on the acquisition of SVB UK. The effective tax rate for 2022 was reduced by 14.7% as a result of the recognition of previously unrecognised losses in the UK of $2.2bn and France of $0.3bn, in light of improved forecast profitability.
On 20 June 2023, legislation was substantively enacted in the UK to introduce the 'Pillar Two' global minimum tax model rules of the OECD's Inclusive Framework on Base Erosion and Profit Shifting ('BEPS') and a UK qualified domestic minimum top-up tax, with effect from 1 January 2024. Under these rules, a top-up tax liability arises where the effective tax rate of the Group's operations in a jurisdiction, calculated using principles set out in the Pillar Two legislation, is below 15%. Any resulting tax is payable by HSBC Holdings plc, being the Group's ultimate parent, to HMRC. In response to the OECD's Pillar Two global minimum tax rules, many national governments have announced their intention to introduce domestic minimum tax rules that are closely aligned to the OECD's Pillar Two model rules. Where such qualifying domestic minimum tax rules are introduced, they may be expected to have the effect of increasing local tax liabilities to the 15% minimum rate, eliminating the top-up tax liability payable in the UK by HSBC Holdings plc in such cases. Based on the Group's forecasts, top-up tax liabilities are expected to arise in approximately 10 jurisdictions as a result of low or 0% statutory tax rates, in particular in respect of the Group's banking operations in Bermuda and the Channel Islands. Additionally, the application of local tax laws in Hong Kong and mainland China, particularly with regard to the non-taxation of dividend income and income on government bonds, has typically resulted in effective tax rates of below 15%. This is expected to create future top-up tax liabilities in these jurisdictions, which have statutory tax rates of 16.5% and 25%, respectively. The application of the Pillar Two global minimum tax rules and the introduction of new domestic minimum tax regimes are currently forecast to increase the Group's annual effective tax rate by around 0.5 and 1.0 percentage points.
Accounting for taxes involves some estimation because tax law is uncertain and its application requires a degree of judgement, which authorities may dispute. Liabilities are recognised based on best estimates of the probable outcome, taking into account external advice where appropriate. Exposures relating to legacy tax cases were reassessed during 2023, resulting in a credit of $472m to the income statement. We do not expect significant liabilities to arise in excess of the amounts provided. HSBC only recognises current and deferred tax assets where recovery is probable.
Movement of deferred tax assets and liabilities |
|||||||
|
Loan impairment provisions |
Unused tax losses and tax credits |
Financial assets at FVOCI |
Cash flow hedges |
Retirement obligations |
Other |
Total |
|
$m |
$m |
$m |
$m |
$m |
$m |
$m |
Assets |
1,062 |
4,397 |
850 |
1,271 |
- |
3,048 |
10,628 |
Liabilities |
- |
- |
- |
- |
(1,673) |
(1,567) |
(3,240) |
At 1 Jan 2023 |
1,062 |
4,397 |
850 |
1,271 |
(1,673) |
1,481 |
7,388 |
Income statement |
(39) |
102 |
541 |
1 |
(114) |
(562) |
(71) |
Other comprehensive income |
- |
- |
(598) |
(974) |
99 |
399 |
(1,074) |
Foreign exchange and other adjustments |
135 |
45 |
83 |
121 |
(126) |
15 |
273 |
At 31 Dec 2023 |
1,158 |
4,544 |
876 |
419 |
(1,814) |
1,333 |
6,516 |
Assets1 |
1,158 |
4,544 |
876 |
419 |
- |
2,933 |
9,930 |
Liabilities1 |
- |
- |
- |
- |
(1,814) |
(1,600) |
(3,414) |
|
|
|
|
|
|
|
|
Assets2 |
1,151 |
2,001 |
382 |
154 |
- |
1,744 |
5,432 |
Liabilities2 |
- |
- |
- |
- |
(2,819) |
(475) |
(3,294) |
At 1 Jan 2022 |
1,151 |
2,001 |
382 |
154 |
(2,819) |
1,269 |
2,138 |
Income statement |
7 |
2,425 |
(1,127) |
1 |
217 |
652 |
2,175 |
Other comprehensive income |
- |
- |
2,281 |
1,159 |
692 |
(1,260) |
2,872 |
Foreign exchange and other adjustments |
(96) |
(29) |
(686) |
(43) |
237 |
820 |
203 |
At 31 Dec 2022 |
1,062 |
4,397 |
850 |
1,271 |
(1,673) |
1,481 |
7,388 |
Assets1 |
1,062 |
4,397 |
850 |
1,271 |
- |
3,048 |
10,628 |
Liabilities1 |
- |
- |
- |
- |
(1,673) |
(1,567) |
(3,240) |
1 After netting off balances within countries, the balances as disclosed in the accounts are as follows: deferred tax assets of $7,754m (2022: $8,360m) and deferred tax liabilities of $1,238m (2022: $972m).
2 From 1 January 2023, we adopted IFRS 17 'Insurance Contracts', which replaced IFRS 4 'Insurance Contracts'. We have restated 2022 comparative data.
In applying judgement in recognising deferred tax assets, management has assessed all relevant information, including future business profit projections and the track record of meeting forecasts. Management's assessment of the likely availability of future taxable profits against which to recover deferred tax assets is based on the most recent financial forecasts approved by management, which cover a five-year period and are extrapolated where necessary, and takes into consideration the reversal of existing taxable temporary differences and past business performance. When forecasts are extrapolated beyond five years, a number of different scenarios are considered, reflecting different downward risk adjustments, in order to assess the sensitivity of our recognition and measurement conclusions in the context of such longer-term forecasts.
The Group's net deferred tax asset of $6.5bn (2022: $7.4bn) included $3.3bn (2022: $4.0bn) of deferred tax assets relating to the UK, $3.1bn (2022: $3.3bn) of deferred tax assets relating to the US and a net deferred asset of $0.9bn (2022: $1.0bn) in France.
The UK deferred tax asset of $3.3bn excluded a $1.9bn deferred tax liability arising on the UK pension scheme surplus, the reversal of which is not taken into account when estimating future taxable profits. The UK deferred tax assets are supported by forecasts of taxable profit, also taking into consideration the history of profitability in the relevant businesses. The majority of the deferred tax asset relates to tax attributes which do not expire and are forecast to be recovered within four years and as such are less sensitive to changes in long-term profit forecasts.
The net US deferred tax asset of $3.1bn included $1.3bn related to US tax losses, of which $1.0bn expire in 10 to 15 years. Management expects the US deferred tax asset to be substantially recovered within 14 years, with the majority recovered in the first nine years.
The net deferred tax asset in France of $0.9bn included $0.7bn related to tax losses, which are expected to be substantially recovered within 12 years.
Unrecognised deferred tax
The amount of gross temporary differences, unused tax losses and tax credits for which no deferred tax asset is recognised in the balance sheet was $10.4bn (2022: $9.2bn). This amount included unused US state tax losses of $4.0bn (2022: $4.1bn) which are forecast to expire before they are recovered and unused UK tax losses of $4.5bn (2022: $3.5bn), which arose prior to 1 April 2017 and can only be recovered against future taxable profits of HSBC Holdings. No deferred tax was recognised on these losses due to the absence of convincing evidence regarding the availability of sufficient future taxable profits against which to recover them. Deferred tax asset recognition is reassessed at each balance sheet date based on the available evidence. Of the total amounts unrecognised, $5.1bn (2022: $3.6bn) had no expiry date, $0.5bn (2022: $1.2bn) was scheduled to expire within 10 years and the remaining balance is expected to expire after 10 years.
Deferred tax is not recognised in respect of the Group's investments in subsidiaries and branches where HSBC is able to control the timing of remittance or other realisation and where remittance or realisation is not probable in the foreseeable future. The aggregate temporary differences relating to unrecognised deferred tax liabilities arising on investments in subsidiaries and branches was $14.4bn (2022: $11.7bn) and the corresponding unrecognised deferred tax liability was $0.7bn (2022: $0.7bn).
8 |
Dividends |
Dividends to shareholders of the parent company |
||||||
|
2023 |
2022 |
2021 |
|||
|
Per share |
Total |
Per share |
Total |
Per share |
Total |
|
$ |
$m |
$ |
$m |
$ |
$m |
Dividends paid on ordinary shares |
|
|
|
|
|
|
In respect of previous year: |
|
|
|
|
|
|
- second interim dividend |
0.23 |
4,589 |
0.18 |
3,576 |
0.15 |
3,059 |
In respect of current year: |
|
|
|
|
|
|
- first interim dividend |
0.10 |
2,001 |
0.09 |
1,754 |
0.07 |
1,421 |
- second interim dividend |
0.10 |
1,956 |
- |
- |
- |
- |
- third interim dividend |
0.10 |
1,946 |
- |
- |
- |
- |
Total |
0.53 |
10,492 |
0.27 |
5,330 |
0.22 |
4,480 |
Total dividends on preference shares classified as equity (paid quarterly)1 |
- |
- |
- |
- |
4.99 |
7 |
Total coupons on capital securities classified as equity |
|
1,101 |
|
1,214 |
|
1,303 |
Dividends to shareholders |
|
11,593 |
|
6,544 |
|
5,790 |
1 HSBC Holdings called $1,450m 6.20% non-cumulative US dollar preference shares on 10 December 2020. The security was redeemed and cancelled on 13 January 2021.
Total coupons on capital securities classified as equity |
|||||
|
|
2023 |
2022 |
2021 |
|
|
|
|
Total |
Total |
Total |
|
First call date |
Per security |
$m |
$m |
$m |
Perpetual subordinated contingent convertible securities1 |
|
|
|
|
|
$2,000m issued at 6.875%2 |
Jun 2021 |
$68.750 |
- |
- |
69 |
$2,250m issued at 6.375% |
Sep 2024 |
$63.750 |
143 |
143 |
143 |
$2,450m issued at 6.375% |
Mar 2025 |
$63.750 |
156 |
156 |
156 |
$3,000m issued at 6.000% |
May 2027 |
$60.000 |
180 |
180 |
180 |
$2,350m issued at 6.250%3 |
Mar 2023 |
$62.500 |
52 |
147 |
147 |
$1,800m issued at 6.500% |
Mar 2028 |
$65.000 |
117 |
117 |
117 |
$1,500m issued at 4.600% |
Dec 2030 |
$46.000 |
69 |
69 |
69 |
$1,000m issued at 4.000%4 |
Mar 2026 |
$40.000 |
40 |
40 |
20 |
$1,000m issued at 4.700%5 |
Mar 2031 |
$47.000 |
47 |
47 |
24 |
$2,000m issued at 8.000%6 |
Mar 2028 |
$80.000 |
80 |
- |
- |
€1,500m issued at 5.250%7 |
Sep 2022 |
€52.500 |
- |
76 |
93 |
€1,000m issued at 6.000%8 |
Sep 2023 |
€60.000 |
56 |
63 |
70 |
€1,250m issued at 4.750% |
Jul 2029 |
€47.500 |
64 |
65 |
72 |
£1,000m issued at 5.875% |
Sep 2026 |
£58.750 |
72 |
70 |
80 |
SGD1,000m issued at 4.700%9 |
Jun 2022 |
SGD47.000 |
- |
14 |
35 |
SGD750m issued at 5.000%10 |
Sep 2023 |
SGD50.000 |
25 |
27 |
28 |
Total |
|
|
1,101 |
1,214 |
1,303 |
1 Discretionary coupons are paid semi-annually, based on the denominations of each security.
2 This security was called by HSBC Holdings on 15 April 2021 and was redeemed and cancelled on 1 June 2021.
3 This security was called by HSBC Holdings on 30 January 2023 and was redeemed and cancelled on 23 March 2023.
4 This security was issued by HSBC Holdings on 9 March 2021. The first call period commences six calendar months prior to the reset date of 9 September 2026.
5 This security was issued by HSBC Holdings on 9 March 2021. The first call period commences six calendar months prior to the reset date of 9 September 2031.
6 This security was issued by HSBC Holdings on 7 March 2023. The first call period commences six calendar months prior to the reset date of 7 September 2028.
7 This security was called by HSBC Holdings on 9 August 2022 and was redeemed and cancelled on 16 September 2022.
8 This security was called by HSBC Holdings on 3 August 2023 and was redeemed and cancelled on 29 September 2023.
9 This security was called by HSBC Holdings on 4 May 2022 and was redeemed and cancelled on 8 June 2022.
10 This security was called by HSBC Holdings on 3 August 2023 and was redeemed and cancelled on 25 September 2023.
10
On 21 February 2024, the Directors approved a fourth interim dividend in respect of the financial year ended 31 December 2023 of $0.31 per ordinary share, a distribution of approximately $5,913m. The fourth interim dividend for 2023 will be payable on 25 April 2024 to holders on the Principal Register in the UK, the Hong Kong Overseas Branch Register or the Bermuda Overseas Branch Register on 8 March 2024. No liability was recorded in the financial statements in respect of the fourth interim dividend for 2023.
On 4 January 2024, HSBC paid a coupon on its €1,250m subordinated capital securities, representing a total distribution of €30m ($33m). No liability was recorded in the balance sheet at 31 December 2023 in respect of this coupon payment.
9 |
Earnings per share |
Basic earnings per ordinary share is calculated by dividing the profit attributable to ordinary shareholders of the parent company by the weighted average number of ordinary shares outstanding, excluding own shares held. Diluted earnings per ordinary share is calculated by dividing the basic earnings, which require no adjustment for the effects of dilutive potential ordinary shares, by the weighted average number of ordinary shares outstanding, excluding own shares held, plus the weighted average number of ordinary shares that would be issued on conversion of dilutive potential ordinary shares.
Basic and diluted earnings per share |
|||||||||
|
2023 |
2022¹ |
2021 |
||||||
|
Profit |
Number of shares |
Per share |
Profit |
Number of shares |
Per share |
Profit |
Number of shares |
Per share |
|
$m |
(millions) |
$ |
$m |
(millions) |
$ |
$m |
(millions) |
$ |
Basic2 |
22,432 |
19,478 |
1.15 |
14,346 |
19,849 |
0.72 |
12,607 |
20,197 |
0.62 |
Effect of dilutive potential ordinary shares |
|
122 |
|
|
137 |
|
|
105 |
|
Diluted2 |
22,432 |
19,600 |
1.14 |
14,346 |
19,986 |
0.72 |
12,607 |
20,302 |
0.62 |
1 From 1 January 2023, we adopted IFRS 17 'Insurance Contracts', which replaced IFRS 4 'Insurance Contracts'. Comparative data for the financial year ended 31 December 2022 have been restated accordingly. Comparative data for the year ended 31 December 2021 are prepared on an IFRS 4 basis.
2 Weighted average number of ordinary shares outstanding (basic) or assuming dilution (diluted).
The number of anti-dilutive employee share options excluded from the weighted average number of dilutive potential ordinary shares was
23 million (2022: 9.4 million; 2021: 8.6 million).
10 |
Segmental analysis |
The Group Chief Executive, supported by the rest of the Group Executive Committee ('GEC'), is considered the Chief Operating Decision Maker ('CODM') for the purposes of identifying the Group's reportable segments. Global business results are assessed by the CODM on the basis of constant currency performance that removes the effects of currency translation from reported results. Therefore, we disclose these results on a constant currency basis as required by IFRS Accounting Standards. The 2022 and 2021 income statements are converted at the average rates of exchange for 2023, and the balance sheets at 31 December 2022 and 31 December 2021 at the prevailing rates of exchange on 31 December 2023.
Our operations are closely integrated and, accordingly, the presentation of data includes internal allocations of certain items of income and expense. These allocations include the costs of certain support services and global functions to the extent that they can be meaningfully attributed to global businesses. While such allocations have been made on a systematic and consistent basis, they necessarily involve a degree of subjectivity. Costs that are not allocated to global businesses are included in Corporate Centre.
Where relevant, income and expense amounts presented include the results of inter-segment funding along with inter-company and inter-business line transactions. All such transactions are undertaken on arm's length terms. Measurement of segmental assets, liabilities, income and expenses is in accordance with the Group's accounting policies. Shared costs are included in segments on the basis of actual recharges. The intra-Group elimination items for the global businesses are presented in Corporate Centre.
Resegmentation
In the first quarter of 2023, following an internal review to assess which global businesses were best suited to serve our customers' respective needs, a portfolio of our Global Banking customers within our entities in Latin America was transferred from Global Banking and Markets to Commercial Banking for reporting purposes. Comparative data have been re-presented accordingly. Similar smaller transfers from Global Banking and Markets to Commercial Banking were also undertaken within our entities in Australia and Indonesia, where comparative data have not been re-presented.
Our global businesses
We provide a comprehensive range of banking and related financial services to our customers in our three global businesses. The products and services offered to customers are organised by these global businesses.
- Wealth and Personal Banking ('WPB') provides a full range of retail banking and wealth products to our customers from personal banking to ultra high net worth individuals. Typically, customer offerings include retail banking products, such as current and savings accounts, mortgages and personal loans, credit cards, debit cards and local and international payment services. We also provide wealth management services, including insurance and investment products, global asset management services, investment management and private wealth solutions for customers with more sophisticated and international requirements.
- Commercial Banking ('CMB') offers a broad range of products and services to serve the needs of our commercial customers, including small and medium-sized enterprises, mid-market enterprises and corporates. These include credit and lending, international trade and receivables finance, treasury management and liquidity solutions (payments and cash management and commercial cards), commercial insurance and investments. CMB also offers customers access to products and services offered by other global businesses, such as Global Banking and Markets, which include foreign exchange products, raising capital on debt and equity markets and advisory services.
- Global Banking and Markets ('GBM') provides tailored financial solutions to major government, corporate and institutional clients and private investors worldwide. The client-focused business lines deliver a full range of banking capabilities, including financing, advisory and transaction services, a markets business that provides services in credit, rates, foreign exchange, equities, money markets and securities services, and principal investment activities.
HSBC constant currency profit before tax and balance sheet data |
|||||
|
2023 |
||||
|
Wealth and Personal Banking |
Commercial Banking3 |
Global Banking and Markets3 |
Corporate Centre |
Total |
|
$m |
$m |
$m |
$m |
$m |
Net operating income/(expense) before change in expected credit losses and other credit impairment charges2 |
27,275 |
22,867 |
16,115 |
(199) |
66,058 |
- external |
19,107 |
24,209 |
28,021 |
(5,279) |
66,058 |
- inter-segment |
8,168 |
(1,342) |
(11,906) |
5,080 |
- |
- of which: net interest income/(expense)4 |
20,492 |
17,147 |
7,141 |
(8,984) |
35,796 |
Change in expected credit losses and other credit impairment charges |
(1,058) |
(2,062) |
(326) |
(1) |
(3,447) |
Net operating income/(expense) |
26,217 |
20,805 |
15,789 |
(200) |
62,611 |
Total operating expenses |
(14,738) |
(7,524) |
(9,865) |
57 |
(32,070) |
Operating profit/(loss) |
11,479 |
13,281 |
5,924 |
(143) |
30,541 |
Share of profit/(loss) in associates and joint ventures less impairment5 |
65 |
(1) |
- |
(257) |
(193) |
Constant currency profit before tax |
11,544 |
13,280 |
5,924 |
(400) |
30,348 |
|
% |
% |
% |
% |
% |
Share of HSBC's constant currency profit before tax |
38.0 |
43.8 |
19.5 |
(1.3) |
100.0 |
Constant currency cost efficiency ratio |
54.0 |
32.9 |
61.2 |
28.6 |
48.5 |
Constant currency balance sheet data |
$m |
$m |
$m |
$m |
$m |
Loans and advances to customers (net) |
454,878 |
309,422 |
173,966 |
269 |
938,535 |
Interests in associates and joint ventures |
551 |
28 |
111 |
26,654 |
27,344 |
Total external assets |
937,079 |
632,406 |
1,331,395 |
137,797 |
3,038,677 |
Customer accounts |
804,863 |
475,666 |
330,522 |
596 |
1,611,647 |
|
2022¹ |
||||
Net operating income/(expense) before change in expected credit losses and other credit impairment charges2 |
20,884 |
16,283 |
14,602 |
(1,898) |
49,871 |
- external |
18,299 |
16,973 |
18,744 |
(4,145) |
49,871 |
- inter-segment |
2,585 |
(690) |
(4,142) |
2,247 |
- |
- of which: net interest income/(expense)4 |
15,971 |
11,763 |
4,696 |
(2,668) |
29,762 |
Change in expected credit losses and other credit impairment charges |
(1,186) |
(1,862) |
(573) |
(9) |
(3,630) |
Net operating income/(expense) |
19,698 |
14,421 |
14,029 |
(1,907) |
46,241 |
Total operating expenses |
(14,248) |
(6,894) |
(9,338) |
(1,822) |
(32,302) |
Operating profit/(loss) |
5,450 |
7,527 |
4,691 |
(3,729) |
13,939 |
Share of profit/(loss) in associates and joint ventures |
30 |
- |
(2) |
2,574 |
2,602 |
Constant currency profit/(loss) before tax |
5,480 |
7,527 |
4,689 |
(1,155) |
16,541 |
|
% |
% |
% |
% |
% |
Share of HSBC's constant currency profit before tax |
33.1 |
45.6 |
28.3 |
(7.0) |
100.0 |
Constant currency cost efficiency ratio |
68.2 |
42.3 |
64.0 |
(96.0) |
64.8 |
Constant currency balance sheet data |
$m |
$m |
$m |
$m |
$m |
Loans and advances to customers (net) |
434,122 |
316,863 |
190,202 |
361 |
941,548 |
Interests in associates and joint ventures |
514 |
33 |
93 |
28,143 |
28,783 |
Total external assets |
893,867 |
620,193 |
1,341,575 |
152,049 |
3,007,684 |
Customer accounts |
793,310 |
472,424 |
332,303 |
458 |
1,598,495 |
HSBC constant currency profit before tax and balance sheet data (continued) |
|||||
|
2021 |
||||
|
Wealth and Personal Banking |
Commercial Banking |
Global Banking and Markets |
Corporate Centre |
Total |
|
$m |
$m |
$m |
$m |
$m |
Net operating income/(expense) before change in expected credit losses and other credit impairment charges2 |
20,972 |
12,699 |
13,086 |
(678) |
46,079 |
- external |
20,787 |
12,685 |
14,533 |
(1,926) |
46,079 |
- inter-segment |
185 |
14 |
(1,447) |
1,248 |
- |
- of which: net interest income/(expense)4 |
13,445 |
8,467 |
3,419 |
(714) |
24,617 |
Change in expected credit losses and other credit impairment charges |
195 |
339 |
221 |
3 |
758 |
Net operating income/(expense) |
21,167 |
13,038 |
13,307 |
(675) |
46,837 |
Total operating expenses |
(15,338) |
(6,691) |
(9,255) |
(960) |
(32,244) |
Operating profit/(loss) |
5,829 |
6,347 |
4,052 |
(1,635) |
14,593 |
Share of profit in associates and joint ventures |
36 |
1 |
- |
2,770 |
2,807 |
Constant currency profit/(loss) before tax |
5,865 |
6,348 |
4,052 |
1,135 |
17,400 |
|
% |
% |
% |
% |
% |
Share of HSBC's constant currency profit before tax |
33.7 |
36.5 |
23.3 |
6.5 |
100.0 |
Constant currency cost efficiency ratio |
73.1 |
52.7 |
70.7 |
(141.6) |
70.0 |
Constant currency balance sheet data |
$m |
$m |
$m |
$m |
$m |
Loans and advances to customers (net) |
473,304 |
340,603 |
196,193 |
712 |
1,010,812 |
Interests in associates and joint ventures |
493 |
31 |
101 |
27,036 |
27,661 |
Total external assets |
905,024 |
605,696 |
1,171,909 |
178,074 |
2,860,703 |
Customer accounts |
834,767 |
495,492 |
322,306 |
622 |
1,653,187 |
1 From 1 January 2023, we adopted IFRS 17 'Insurance Contracts', which replaced IFRS 4 'Insurance Contracts'. Comparative data for the financial year ended 31 December 2022 have been restated accordingly. Comparative data for the year ended 31 December 2021 are prepared on an IFRS 4 basis.
2 Net operating income before change in expected credit losses and other credit impairment charges, also referred to as revenue.
3 In the first quarter of 2023, following an internal review to assess which global businesses were best suited to serve our customers' respective needs, a portfolio of our customers within our entities in Latin America was transferred from GBM to CMB for reporting purposes. Comparative data have been re-presented accordingly.
4 Net interest expense recognised in Corporate Centre includes $8.7bn (2022: $2.5bn; 2021: undisclosed) of interest expense in relation to the internal cost to fund trading and fair value net assets; and the funding cost of foreign exchange swaps in our Markets Treasury function. In the second quarter of 2023, we implemented a consistent reporting approach across the most material entities that contribute to our trading and fair value net assets, which resulted in an increase to the associated funding costs reported through the intersegment elimination in Corporate Centre.
5 Includes an impairment loss of $3.0bn recognised in respect of the Group's investment in BoCom. See Note 18 on page 391.
Reported external net operating income is attributed to countries and territories on the basis of the location of the branch responsible for reporting the results or advancing the funds:
|
2023 |
2022¹ |
2021 |
|
$m |
$m |
$m |
Reported external net operating income/(expense) by country/territory2 |
66,058 |
50,620 |
49,552 |
- UK |
11,027 |
11,710 |
10,909 |
- Hong Kong |
20,185 |
15,454 |
14,245 |
- US |
3,816 |
3,893 |
3,795 |
- France |
4,208 |
(177) |
2,179 |
- other countries/territories |
26,822 |
19,740 |
18,424 |
1 From 1 January 2023, we adopted IFRS 17 'Insurance Contracts', which replaced IFRS 4 'Insurance Contracts'. Comparative data for the financial year ended 31 December 2022 have been restated accordingly. Comparative data for the year ended 31 December 2021 are prepared on an IFRS 4 basis.
2 Net operating income before change in expected credit losses and other credit impairment charges, also referred to as revenue.
Constant currency results reconciliation |
|||||||
|
2023 |
2022¹ |
2021 |
||||
|
Reported and constant currency |
Constant currency |
Currency translation |
Reported |
Constant currency |
Currency translation |
Reported |
|
$m |
$m |
$m |
$m |
$m |
$m |
$m |
Revenue2 |
66,058 |
49,871 |
(749) |
50,620 |
46,079 |
(3,473) |
49,552 |
ECL |
(3,447) |
(3,630) |
(46) |
(3,584) |
758 |
(170) |
928 |
Operating expenses |
(32,070) |
(32,302) |
399 |
(32,701) |
(32,244) |
2,376 |
(34,620) |
Share of profit in associates and joint ventures less impairment3 |
(193) |
2,602 |
(121) |
2,723 |
2,807 |
(239) |
3,046 |
Profit before tax |
30,348 |
16,541 |
(517) |
17,058 |
17,400 |
(1,506) |
18,906 |
1 From 1 January 2023, we adopted IFRS 17 'Insurance Contracts', which replaced IFRS 4 'Insurance Contracts'. Comparative data for the financial year ended 31 December 2022 have been restated accordingly. Comparative data for the year ended 31 December 2021 are prepared on an IFRS 4 basis.
2 Net operating income before change in expected credit losses and other credit impairment charges, also referred to as revenue.
3 Includes an impairment loss of $3.0bn recognised in respect of the Group's investment in BoCom. See Note 18 on page 391.
Constant currency balance sheet reconciliation |
|||||||
|
2023 |
2022¹ |
2021 |
||||
|
Reported and constant currency |
Constant currency |
Currency translation |
Reported |
Constant currency |
Currency translation |
Reported |
|
$m |
$m |
$m |
$m |
$m |
$m |
$m |
Loans and advances to customers (net) |
938,535 |
941,548 |
(17,987) |
923,561 |
1,010,812 |
35,002 |
1,045,814 |
Interests in associates and joint ventures |
27,344 |
28,783 |
471 |
29,254 |
27,661 |
1,948 |
29,609 |
Total external assets |
3,038,677 |
3,007,684 |
(58,398) |
2,949,286 |
2,860,703 |
97,236 |
2,957,939 |
Customer accounts |
1,611,647 |
1,598,495 |
(28,192) |
1,570,303 |
1,653,187 |
57,387 |
1,710,574 |
1 From 1 January 2023, we adopted IFRS 17 'Insurance Contracts', which replaced IFRS 4 'Insurance Contracts'. Comparative data for the financial year ended 31 December 2022 have been restated accordingly. Comparative data for the year ended 31 December 2021 are prepared on an IFRS 4 basis.
Notable items |
|||
|
2023 |
2022 |
2021 |
|
$m |
$m |
$m |
Year ended 31 Dec |
|
|
|
Notable items |
|
|
|
Revenue |
|
|
|
Disposals, acquisitions and related costs1,2 |
1,298 |
(2,737) |
- |
Fair value movements on financial instruments3 |
14 |
(618) |
(221) |
Restructuring and other related costs |
- |
(247) |
(307) |
Disposal losses on Markets Treasury repositioning |
(977) |
- |
- |
Operating expenses |
|
|
|
Disposals, acquisitions and related costs |
(321) |
(18) |
- |
Impairment of non-financial items |
- |
- |
(587) |
Restructuring and other related costs4 |
136 |
(2,882) |
(1,836) |
Impairment of interests in associates5 |
(3,000) |
- |
- |
1 Includes the impact of the sale of our retail banking operations in France.
2 Includes the provisional gain of $1.6bn recognised in respect of the acquisition of SVB UK.
3 Fair value movements on non-qualifying hedges in HSBC Holdings.
4 Amounts in 2023 relate to reversals of restructuring provisions recognised during 2022.
5 Relates to an impairment loss of $3.0bn recognised in respect of the Group's investment in BoCom. See Note 18 on page 391.
11 |
Trading assets |
|
2023 |
2022 |
|
$m |
$m |
Treasury and other eligible bills |
24,433 |
22,897 |
Debt securities |
106,108 |
78,126 |
Equity securities |
123,663 |
88,026 |
Trading securities |
254,204 |
189,049 |
Loans and advances to banks1 |
9,761 |
8,769 |
Loans and advances to customers1 |
25,194 |
20,275 |
Year ended 31 Dec |
289,159 |
218,093 |
1 Loans and advances to banks and customers include reverse repos, stock borrowing and other accounts.
12 |
Fair values of financial instruments carried at fair value |
Control framework
Fair values are subject to a control framework designed to ensure that they are either determined or validated by a function independent of the risk taker.
Where fair values are determined by reference to externally quoted prices or observable pricing inputs to models, independent price determination or validation is used. For inactive markets, HSBC sources alternative market information, with greater weight given to information that is considered to be more relevant and reliable. Examples of the factors considered are price observability, instrument comparability, consistency of data sources, underlying data accuracy and timing of prices.
For fair values determined using valuation models, the control framework includes development or validation by independent support functions of the model logic, inputs, model outputs and adjustments. Valuation models are subject to a process of due diligence before becoming operational and are calibrated against external market data on an ongoing basis.
Changes in fair value are generally subject to a profit and loss analysis process and are disaggregated into high-level categories including portfolio changes, market movements and other fair value adjustments.
The majority of financial instruments measured at fair value are in GBM. GBM's fair value governance structure comprises its Finance function, Valuation Committees and a Valuation Committee Review Group. Finance is responsible for establishing procedures governing valuation and ensuring fair values are in compliance with accounting standards. The fair values are reviewed by the Valuation Committees, which consist of independent support functions. These committees are overseen by the Valuation Committee Review Group, which considers all material subjective valuations.
Financial liabilities measured at fair value
In certain circumstances, HSBC records its own debt in issue at fair value, based on quoted prices in an active market for the specific instrument. When quoted market prices are unavailable, the own debt in issue is valued using valuation techniques, the inputs for which are either based on quoted prices in an inactive market for the instrument or are estimated by comparison with quoted prices in an active market for similar instruments. In both cases, the fair value includes the effect of applying the credit spread that is appropriate to HSBC's liabilities. The change in fair value of issued debt securities attributable to the Group's own credit spread is computed as follows: for each security at each reporting date, an externally verifiable price is obtained or a price is derived using credit spreads for similar securities for the same issuer. Then, using discounted cash flow, each security is valued using an appropriate market discount curve. The difference in the valuations is attributable to the Group's own credit spread. This methodology is applied consistently across all securities.
Structured notes issued and certain other hybrid instruments are reported as financial liabilities designated at fair value. The credit spread applied to these instruments is derived from the spreads at which HSBC issues structured notes.
Gains and losses arising from changes in the credit spread of liabilities issued by HSBC, recorded in other comprehensive income, reverse over the contractual life of the debt, provided that the debt is not repaid at a premium or a discount.
Fair value hierarchy
Fair values of financial assets and liabilities are determined according to the following hierarchy:
- Level 1 - valuation technique using quoted market price. These are financial instruments with quoted prices for identical instruments in active markets that HSBC can access at the measurement date.
- Level 2 - valuation technique using observable inputs. These are financial instruments with quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in inactive markets and financial instruments valued using models where all significant inputs are observable.
- Level 3 - valuation technique with significant unobservable inputs. These are financial instruments valued using valuation techniques where one or more significant inputs are unobservable.
-
Financial instruments carried at fair value and bases of valuation |
||||||||
|
2023 |
20221 |
||||||
|
Level 1 |
Level 2 |
Level 3 |
Total |
Level 1 |
Level 2 |
Level 3 |
Total |
|
$m |
$m |
$m |
$m |
$m |
$m |
$m |
$m |
Recurring fair value measurements at 31 Dec |
|
|
|
|
|
|
|
|
Assets |
|
|
|
|
|
|
|
|
Trading assets |
202,020 |
82,833 |
4,306 |
289,159 |
148,592 |
64,684 |
4,817 |
218,093 |
Financial assets designated and otherwise mandatorily measured at fair value through profit or loss |
27,030 |
63,825 |
19,788 |
110,643 |
23,146 |
59,548 |
17,407 |
100,101 |
Derivatives |
931 |
226,714 |
2,069 |
229,714 |
2,917 |
279,278 |
1,964 |
284,159 |
Financial investments |
215,228 |
76,591 |
2,618 |
294,437 |
181,659 |
71,040 |
2,961 |
255,660 |
Liabilities |
|
|
|
|
|
|
|
|
Trading liabilities |
53,354 |
19,318 |
478 |
73,150 |
44,787 |
27,092 |
474 |
72,353 |
Financial liabilities designated at fair value |
1,266 |
129,232 |
10,928 |
141,426 |
1,125 |
115,764 |
10,432 |
127,321 |
Derivatives |
1,918 |
230,285 |
2,569 |
234,772 |
2,399 |
280,443 |
2,920 |
285,762 |
1 From 1 January 2023, we adopted IFRS 17 'Insurance Contracts', which replaced IFRS 4 'Insurance Contracts'. We have restated 2022 comparative data.
The table below provides the fair value levelling of assets held for sale and liabilities of disposal groups that have been classified as held for sale in accordance with IFRS 5. For further details, see Note 23.
Financial instruments carried at fair value and bases of valuation - assets and liabilities held for sale |
||||||||
|
2023 |
2022 |
||||||
|
Level 1 |
Level 2 |
Level 3 |
Total |
Level 1 |
Level 2 |
Level 3 |
Total |
|
$m |
$m |
$m |
$m |
$m |
$m |
$m |
$m |
Recurring fair value measurements at 31 Dec |
|
|
|
|
|
|
|
|
Assets |
|
|
|
|
|
|
|
|
Trading assets |
2,403 |
61 |
- |
2,465 |
2,932 |
244 |
- |
3,176 |
Financial assets designated and otherwise mandatorily measured at fair value through profit or loss |
- |
15 |
49 |
64 |
- |
14 |
47 |
61 |
Derivatives |
- |
528 |
- |
528 |
- |
866 |
- |
866 |
Financial investments |
9,357 |
- |
28 |
9,385 |
11,184 |
- |
- |
11,184 |
Liabilities |
|
|
|
|
|
|
|
|
Trading liabilities |
1,352 |
64 |
- |
1,417 |
2,572 |
182 |
- |
2,754 |
Financial liabilities designated at fair value |
- |
2,370 |
- |
2,370 |
- |
3,523 |
- |
3,523 |
Derivatives |
- |
615 |
- |
615 |
- |
813 |
- |
813 |
Transfers between Level 1 and Level 2 fair values |
|||||||
|
Assets |
Liabilities |
|||||
|
Financial investments |
Trading assets |
Designated and otherwise mandatorily measured at fair value |
Derivatives |
Trading liabilities |
Designated at fair value |
Derivatives |
|
$m |
$m |
$m |
$m |
$m |
$m |
$m |
At 31 Dec 2023 |
|
|
|
|
|
|
|
Transfers from Level 1 to Level 2 |
13,200 |
8,066 |
1,709 |
- |
54 |
- |
- |
Transfers from Level 2 to Level 1 |
9,975 |
5,758 |
2,477 |
- |
309 |
- |
- |
At 31 Dec 2022 |
|
|
|
|
|
|
|
Transfers from Level 1 to Level 2 |
4,721 |
5,284 |
2,565 |
- |
113 |
- |
- |
Transfers from Level 2 to Level 1 |
8,208 |
5,964 |
3,340 |
- |
233 |
- |
- |
Transfers between levels of the fair value hierarchy are deemed to occur at the end of each quarterly reporting period. Transfers into and out of levels of the fair value hierarchy are primarily attributable to observability of valuation inputs and price transparency.
Fair value adjustments
We adopt the use of fair value adjustments when we take into consideration additional factors not incorporated within the valuation model that would otherwise be considered by a market participant. We classify fair value adjustments as either 'risk-related' or 'model-related'. The majority of these adjustments relate to GBM. Movements in the amount of fair value adjustments do not necessarily translate in equivalent movements of profits or losses within the income statement, as these movements can be compensated by other related profits or loss effects. For example, as models are enhanced, fair value adjustments may no longer be required. Similarly, fair value adjustments will decrease when the related positions are unwound, but this may not result in profit or loss.
Global Banking and Markets fair value adjustments |
|
|
|
|
|
2023 |
2022 |
||
|
GBM |
Corporate Centre |
GBM |
Corporate Centre |
|
$m |
$m |
$m |
$m |
Type of adjustment |
|
|
|
|
Risk-related |
692 |
41 |
650 |
40 |
- bid-offer |
414 |
- |
426 |
- |
- uncertainty |
75 |
3 |
86 |
- |
- credit valuation adjustment |
164 |
35 |
245 |
35 |
- debit valuation adjustment |
(54) |
- |
(175) |
- |
- funding fair value adjustment |
93 |
3 |
68 |
5 |
Model-related |
63 |
- |
61 |
- |
- model limitation |
63 |
- |
61 |
- |
Inception profit (Day 1 P&L reserves) |
86 |
- |
97 |
- |
At 31 Dec |
841 |
41 |
808 |
40 |
The increase in fair value adjustments was predominantly driven by the reduction in the debit valuation adjustment including a consideration of the overlap with the funding fair value adjustment. This was partly offset by reductions from changes to exposure, and tightening of credit and liquidity market spreads.
Bid-offer
IFRS 13 'Fair Value Measurement' requires the use of the price within the bid-offer spread that is most representative of fair value. Valuation models will typically generate mid-market values. The bid-offer adjustment reflects the extent to which bid-offer costs would be incurred if substantially all residual net portfolio market risks were closed using available hedging instruments or by disposing of or unwinding the position.
Uncertainty
Certain model inputs may be less readily determinable from market data and/or the choice of model itself may be more subjective. In these circumstances, an adjustment may be necessary to reflect the likelihood that market participants would adopt more conservative values for uncertain parameters and/or model assumptions than those used in HSBC's valuation model.
Credit and debit valuation adjustments
The credit valuation adjustment ('CVA') is an adjustment to the valuation of over-the-counter ('OTC') derivative contracts to reflect the possibility that the counterparty may default and that HSBC may not receive the full market value of the transactions.
The debit valuation adjustment ('DVA') is an adjustment to the valuation of OTC derivative contracts to reflect the possibility that HSBC may default, and that it may not pay the full market value of the transactions. The DVA considers the overlap with the funding fair value adjustment.
HSBC calculates a separate CVA and DVA for each legal entity, and for each counterparty to which the entity has exposure. With the exception of central clearing parties, all third-party counterparties are included in the CVA and DVA calculations, and these adjustments are not netted across Group entities.
HSBC calculates the CVA by applying the probability of default ('PD') of the counterparty, conditional on the non-default of HSBC, to HSBC's expected positive exposure to the counterparty and multiplying the result by the loss expected in the event of default. Conversely, HSBC calculates the DVA by applying the PD of HSBC, conditional on the non-default of the counterparty, to the expected positive exposure of the counterparty to HSBC and multiplying the result by the loss expected in the event of default. Both calculations are performed over the life of the potential exposure.
For most products HSBC uses a simulation methodology, which incorporates a range of potential exposures over the life of the portfolio, to calculate the expected positive exposure to a counterparty. The simulation methodology includes credit mitigants, such as counterparty netting agreements and collateral agreements with the counterparty.
The methodologies do not, in general, account for 'wrong-way risk'. Wrong-way risk is an adverse correlation between the counterparty's probability of default and the mark-to-market value of the underlying transaction. The risk can either be general, perhaps related to the currency of the issuer country, or specific to the transaction concerned. When there is significant wrong-way risk, a trade-specific approach is applied to reflect this risk in the valuation.
Funding fair value adjustment
The funding fair value adjustment ('FFVA') is calculated by applying future market funding spreads to the expected future funding exposure of any uncollateralised component of the OTC derivative portfolio. The expected future funding exposure is calculated by a simulation methodology, where available, and is adjusted for events that may terminate the exposure, such as the default of HSBC or the counterparty.
Model limitation
Models used for portfolio valuation purposes may be based upon a simplified set of assumptions that do not capture all current and future material market characteristics. In these circumstances, model limitation adjustments are adopted.
Inception profit (Day 1 P&L reserves)
Inception profit adjustments are adopted when the fair value estimated by a valuation model is based on one or more significant unobservable inputs. The accounting for inception profit adjustments is discussed in Note 1.
Fair value valuation bases
Financial instruments measured at fair value using a valuation technique with significant unobservable inputs - Level 3 |
|||||||||
|
Assets |
Liabilities |
|||||||
|
Financial investments |
Trading assets |
Designated and otherwise mandatorily measured at fair value through profit or loss |
Derivatives |
Total |
Trading liabilities |
Designated at fair value |
Derivatives |
Total |
|
$m |
$m |
$m |
$m |
$m |
$m |
$m |
$m |
$m |
Private equity including strategic investments |
507 |
7 |
17,640 |
- |
18,154 |
- |
1 |
- |
1 |
Asset-backed securities |
309 |
128 |
8 |
- |
445 |
- |
- |
- |
- |
Structured notes |
- |
- |
3 |
- |
3 |
- |
10,331 |
- |
10,331 |
Other derivatives |
- |
- |
- |
2,069 |
2,069 |
- |
- |
2,569 |
2,569 |
Other portfolios |
1,802 |
4,171 |
2,137 |
- |
8,110 |
478 |
596 |
- |
1,074 |
At 31 Dec 2023 |
2,618 |
4,306 |
19,788 |
2,069 |
28,781 |
478 |
10,928 |
2,569 |
13,975 |
|
|
|
|
|
|
|
|
|
|
Private equity including strategic investments |
647 |
19 |
15,653 |
- |
16,319 |
92 |
- |
- |
92 |
Asset-backed securities |
438 |
208 |
95 |
- |
741 |
- |
- |
- |
- |
Structured notes |
- |
- |
- |
- |
- |
- |
10,432 |
- |
10,432 |
Other derivatives |
- |
- |
- |
1,964 |
1,964 |
- |
- |
2,920 |
2,920 |
Other portfolios |
1,876 |
4,590 |
1,659 |
- |
8,125 |
382 |
- |
- |
382 |
At 31 Dec 2022 |
2,961 |
4,817 |
17,407 |
1,964 |
27,149 |
474 |
10,432 |
2,920 |
13,826 |
Level 3 instruments are present in both ongoing and legacy businesses. Loans held for securitisation, derivatives with monolines, certain 'other derivatives' and predominantly all Level 3 asset-backed securities are legacy positions. HSBC has the capability to hold these positions.
Private equity including strategic investments
The fair value of a private equity investment (including strategic investments) is estimated on the basis of an analysis of the investee's financial position and results, risk profile, prospects and other factors; by reference to market valuations for similar entities quoted in an active market; the price at which similar companies have changed ownership; or from published net asset values ('NAV') received. If necessary, adjustments are made to the NAV of funds to obtain the best estimate of fair value.
Asset-backed securities
While quoted market prices are generally used to determine the fair value of the asset-backed securities ('ABSs'), valuation models are used to substantiate the reliability of the limited market data available and to identify whether any adjustments to quoted market prices are required. For certain ABSs, such as residential mortgage-backed securities, the valuation uses an industry standard model with assumptions relating to prepayment speeds, default rates and loss severity based on collateral type, and performance, as appropriate. The valuations output is benchmarked for consistency against observable data for securities of a similar nature.
Structured notes
The fair value of Level 3 structured notes is derived from the fair value of the underlying debt security, and the fair value of the embedded derivative is determined as described in the paragraph below on derivatives. These structured notes comprise principally equity-linked notes issued by HSBC, which provide the counterparty with a return linked to the performance of equity securities and other portfolios.
Examples of the unobservable parameters include long-dated equity volatilities and correlations between equity prices, and interest and foreign exchange rates.
Derivatives
OTC derivative valuation models calculate the present value of expected future cash flows, based upon 'no arbitrage' principles. For many vanilla derivative products, the modelling approaches used are standard across the industry. For more complex derivative products, there may be some differences in market practice. Inputs to valuation models are determined from observable market data wherever possible, including prices available from exchanges, dealers, brokers or providers of consensus pricing. Certain inputs may not be observable in the market directly, but can be determined from observable prices via model calibration procedures or estimated from historical data or other sources.
Reconciliation of fair value measurements in Level 3 of the fair value hierarchy
Movement in Level 3 financial instruments |
|||||||
|
Assets |
Liabilities |
|||||
|
Financial investments |
Trading assets |
Designated and otherwise mandatorily measured at fair value through profit or loss |
Derivatives |
Trading liabilities |
Designated at fair value |
Derivatives |
|
$m |
$m |
$m |
$m |
$m |
$m |
$m |
At 1 Jan 2023 |
2,961 |
4,817 |
17,407 |
1,964 |
474 |
10,432 |
2,920 |
Total gains/(losses) recognised in profit or loss |
(44) |
266 |
921 |
692 |
75 |
97 |
910 |
- net income/(losses) from financial instruments held for trading or managed on a fair value basis |
- |
266 |
- |
692 |
75 |
97 |
910 |
- changes in fair value of other financial instruments mandatorily measured at fair value through profit or loss |
- |
- |
921 |
- |
- |
- |
- |
- gains less losses from financial investments at fair value through other comprehensive income |
(44) |
- |
- |
- |
- |
- |
- |
Total gains/(losses) recognised in other comprehensive income ('OCI')1 |
28 |
108 |
87 |
81 |
24 |
523 |
111 |
- financial investments: fair value gains/(losses) |
(44) |
- |
- |
- |
- |
335 |
- |
- exchange differences |
72 |
108 |
87 |
81 |
24 |
188 |
111 |
Purchases |
353 |
2,276 |
3,555 |
- |
291 |
- |
- |
New issuances |
- |
2 |
- |
- |
2 |
5,389 |
- |
Sales |
(290) |
(2,478) |
(658) |
- |
(320) |
(2) |
- |
Settlements |
(352) |
(872) |
(1,886) |
(1,018) |
(74) |
(3,258) |
(1,565) |
Transfers out |
(662) |
(922) |
(156) |
(240) |
(45) |
(2,881) |
(358) |
Transfers in |
624 |
1,109 |
518 |
590 |
51 |
628 |
551 |
At 31 Dec 2023 |
2,618 |
4,306 |
19,788 |
2,069 |
478 |
10,928 |
2,569 |
Unrealised gains/(losses) recognised in profit or loss relating to assets and liabilities held at 31 Dec 2023 |
- |
(152) |
82 |
737 |
- |
(433) |
(903) |
- net income/(losses) from financial instruments held for trading or managed on a fair value basis |
- |
(152) |
- |
737 |
- |
- |
(903) |
- changes in fair value of other financial instruments mandatorily measured at fair value through profit or loss |
- |
- |
82 |
- |
- |
(433) |
- |
At 1 Jan 2022 |
3,389 |
2,662 |
14,238 |
2,478 |
785 |
7,880 |
3,088 |
IFRS 17 impacts |
(12) |
- |
1,468 |
- |
- |
- |
- |
At 1 Jan 2022 (as restated) |
3,377 |
2,662 |
15,706 |
2,478 |
785 |
7,880 |
3,088 |
Total gains/(losses) recognised in profit or loss |
(4) |
(245) |
132 |
390 |
(52) |
(1,334) |
1,014 |
- net income/(losses) from financial instruments held for trading or managed on a fair value basis |
- |
(245) |
- |
390 |
(52) |
- |
1,014 |
- changes in fair value of other financial instruments mandatorily measured at fair value through profit or loss |
- |
- |
132 |
- |
- |
(1,334) |
- |
- gains less losses from financial investments at fair value through other comprehensive income |
(4) |
- |
- |
- |
- |
- |
- |
Total gains/(losses) recognised in other comprehensive income ('OCI')1 |
(325) |
(137) |
(217) |
(219) |
(11) |
(345) |
(226) |
- financial investments: fair value gains/(losses) |
(202) |
- |
- |
- |
- |
82 |
- |
- exchange differences |
(123) |
(137) |
(217) |
(219) |
(11) |
(427) |
(226) |
Purchases |
1,048 |
3,436 |
4,410 |
- |
178 |
- |
- |
New issuances |
1 |
- |
- |
- |
8 |
4,183 |
- |
Sales |
(240) |
(1,102) |
(801) |
- |
(152) |
(94) |
- |
Settlements |
(464) |
(1,273) |
(1,883) |
(918) |
(644) |
182 |
(993) |
Transfers out |
(489) |
(442) |
(76) |
(409) |
(18) |
(1,296) |
(632) |
Transfers in |
57 |
1,918 |
136 |
642 |
380 |
1,256 |
669 |
At 31 Dec 2022 |
2,961 |
4,817 |
17,407 |
1,964 |
474 |
10,432 |
2,920 |
Unrealised gains/(losses) recognised in profit or loss relating to assets and liabilities held at 31 Dec 2022 |
- |
(100) |
(158) |
707 |
2 |
100 |
2,779 |
- net income/(losses) from financial instruments held for trading or managed on a fair value basis |
- |
(100) |
- |
707 |
2 |
- |
2,779 |
- changes in fair value of other financial instruments mandatorily measured at fair value through profit or loss |
- |
- |
(158) |
- |
- |
100 |
- |
1 Included in 'financial investments: fair value gains/(losses)' in the current year and 'exchange differences' in the consolidated statement of comprehensive income.
Transfers between levels of the fair value hierarchy are deemed to occur at the end of each quarterly reporting period. Transfers into and out of levels of the fair value hierarchy are primarily attributable to observability of valuation inputs and price transparency.
Effect of changes in significant unobservable assumptions to reasonably possible alternatives
Sensitivity of fair values to reasonably possible alternative assumptions |
||||||||
|
2023 |
2022 |
||||||
|
Reflected in profit or loss |
Reflected in OCI |
Reflected in profit or loss |
Reflected in OCI |
||||
|
Favourable changes |
Un- favourable changes |
Favourable changes |
Un- favourable changes |
Favourable changes |
Un- favourable changes |
Favourable changes |
Un- favourable changes |
|
$m |
$m |
$m |
$m |
$m |
$m |
$m |
$m |
Derivatives, trading assets and trading liabilities1 |
492 |
(531) |
- |
- |
264 |
(291) |
- |
- |
Financial assets and liabilities designated and otherwise mandatorily measured at fair value through profit or loss |
1,092 |
(1,100) |
- |
- |
981 |
(978) |
- |
- |
Financial investments |
13 |
(12) |
61 |
(66) |
11 |
(11) |
65 |
(55) |
At 31 Dec |
1,597 |
(1,643) |
61 |
(66) |
1,256 |
(1,280) |
65 |
(55) |
1 'Derivatives, trading assets and trading liabilities' are presented as one category to reflect the manner in which these instruments are risk-managed.
The sensitivity analysis aims to measure a range of fair values consistent with the application of a 95% confidence interval. Methodologies take account of the nature of the valuation technique employed, as well as the availability and reliability of observable proxy and historical data.
When the fair value of a financial instrument is affected by more than one unobservable assumption, the above table reflects the most favourable or the most unfavourable change from varying the assumptions individually.
Key unobservable inputs to Level 3 financial instruments
The following table lists key unobservable inputs to Level 3 financial instruments and provides the range of those inputs at 31 December 2023.
Quantitative information about significant unobservable inputs in Level 3 valuations |
||||||||
|
Fair value |
|
|
2023 |
2022 |
|||
|
Assets |
Liabilities |
Key valuation techniques |
Key unobservable inputs |
Full range of inputs |
Full range of inputs |
||
|
$m |
$m |
Lower |
Higher |
Lower |
Higher |
||
Private equity including strategic investments |
18,154 |
1 |
See below |
See below |
|
|
|
|
Asset-backed securities |
445 |
- |
|
|
|
|
|
|
- collateralised loan/debt obligation |
44 |
- |
Market proxy |
Bid quotes |
- |
94 |
- |
92 |
- other ABSs |
401 |
- |
Market proxy |
Bid quotes |
- |
220 |
- |
99 |
Structured notes |
3 |
10,331 |
|
|
|
|
|
|
- equity-linked notes |
3 |
7,054 |
Model - Option model |
Equity volatility |
6% |
154% |
6% |
142% |
Model - Option model |
Equity correlation |
34% |
100% |
32% |
99% |
|||
- Foreign exchange-linked notes |
- |
1,733 |
Model - Option model |
Foreign exchange volatility |
1% |
34% |
3% |
37% |
- other |
- |
1,544 |
|
|
|
|
|
|
Derivatives |
2,069 |
2,569 |
|
|
|
|
|
|
- interest rate derivatives |
864 |
784 |
|
|
|
|
|
|
securitisation swaps |
146 |
136 |
Model - Discounted cash flow |
Prepayment rate |
5% |
10% |
5% |
10% |
long-dated swaptions |
57 |
69 |
Model - Option model |
Interest rate volatility |
11% |
37% |
8% |
53% |
other |
661 |
579 |
|
|
|
|
|
|
- Foreign exchange derivatives |
308 |
427 |
|
|
|
|
|
|
Foreign exchange options |
255 |
356 |
Model - Option model |
Foreign exchange volatility |
1% |
31% |
1% |
46% |
other |
53 |
71 |
|
|
|
|
|
|
- equity derivatives |
600 |
981 |
|
|
|
|
|
|
long-dated single stock options |
391 |
609 |
Model - Option model |
Equity volatility |
6% |
110% |
7% |
153% |
other |
209 |
372 |
|
|
|
|
|
|
- credit derivatives |
297 |
377 |
|
|
|
|
|
|
Other portfolios |
8,110 |
1,074 |
|
|
|
|
|
|
- repurchase agreements |
1,090 |
310 |
Model - Discounted cash flow |
Interest rate curve |
3% |
8% |
1% |
9% |
- bonds |
3,278 |
1 |
Market proxy |
Mid quotes |
- |
101 |
- |
102 |
- other1 |
3,742 |
763 |
|
|
|
|
|
|
At 31 Dec 2023 |
28,781 |
13,975 |
|
|
|
|
|
|
1 'Other' includes a range of smaller asset holdings.
The range of values above shows the highest and lowest unobservable inputs that have been used to value significant Level 3 exposures and reflects the diversity of the underlying financial instruments in scope and subsequent differentiation in pricing.
Private equity including strategic investments
Given the bespoke nature of the analysis in respect of each private equity holding, it is not practical to quote a range of key unobservable inputs. The valuation approach includes using a range of inputs that include company-specific financials, traded comparable companies multiples, published net asset values and qualitative assumptions, which are not directly comparable or quantifiable.
Prepayment rates
Prepayment rates are a measure of the anticipated future speed at which a loan portfolio will be repaid in advance of the due date. They vary according to the nature of the loan portfolio and expectations of future market conditions, and may be estimated using a variety of evidence, such as prepayment rates implied from proxy observable security prices, current or historical prepayment rates and macroeconomic modelling.
Market proxy
Market proxy pricing may be used for an instrument when specific market pricing is not available but there is evidence from instruments with common characteristics. In some cases it might be possible to identify a specific proxy, but more generally evidence across a wider range of instruments will be used to understand the factors that influence current market pricing and the manner of that influence.
Volatility
Volatility is a measure of the anticipated future variability of a market price. It varies by underlying reference market price, and by strike and maturity of the option. Certain volatilities, typically those of a longer-dated nature, are unobservable and are estimated from observable data. The range of unobservable volatilities reflects the wide variation in volatility inputs by reference market price.
Correlation
Correlation is a measure of the inter-relationship between two market variables and is expressed as a number between minus one and one. It is used to value more complex instruments where the payout is dependent upon more than one market variable. There is a wide range of instruments for which correlation is an input, and consequently a wide range of both same-asset correlations and cross-asset correlations is used. In general, the range of same-asset correlations will be narrower than the range of cross-asset correlations.
Unobservable correlations may be estimated based upon a range of evidence, including consensus pricing services, HSBC trade prices, proxy correlations and examination of historical price relationships. The range of unobservable correlations quoted in the table reflects the wide variation in correlation inputs by market variable pair.
Credit spread
Credit spread is the premium over a benchmark interest rate required by the market to accept lower credit quality. In a discounted cash flow model, the credit spread increases the discount factors applied to future cash flows, thereby reducing the value of an asset. Credit spreads may be implied from market prices and may not be observable in more illiquid markets.
Inter-relationships between key unobservable inputs
Key unobservable inputs to Level 3 financial instruments may not be independent of each other. As described above, market variables may be correlated. This correlation typically reflects the manner in which different markets tend to react to macroeconomic or other events. Furthermore, the effect of changing market variables on the HSBC portfolio will depend on HSBC's net risk position in respect of each variable.
HSBC Holdings
Basis of valuing HSBC Holdings' financial assets and liabilities measured at fair value |
||
|
2023 |
2022 |
|
$m |
$m |
Valuation technique using observable inputs: Level 2 |
|
|
Assets at 31 Dec |
|
|
- derivatives |
3,344 |
3,801 |
- designated and otherwise mandatorily measured at fair value through profit or loss |
59,879 |
52,322 |
Liabilities at 31 Dec |
|
|
- designated at fair value |
43,638 |
32,123 |
- derivatives |
6,090 |
6,922 |
13 |
Fair values of financial instruments not carried at fair value |
Fair values of financial instruments not carried at fair value and bases of valuation |
|||||
|
|
Fair value |
|||
|
Carrying amount |
Quoted market price Level 1 |
Observable inputs Level 2 |
Significant unobservable inputs Level 3 |
Total |
|
$m |
$m |
$m |
$m |
$m |
At 31 Dec 2023 |
|
|
|
|
|
Assets |
|
|
|
|
|
Loans and advances to banks |
112,902 |
2 |
111,263 |
1,479 |
112,744 |
Loans and advances to customers |
938,535 |
- |
13,258 |
911,124 |
924,382 |
Reverse repurchase agreements - non-trading |
252,217 |
- |
252,243 |
- |
252,243 |
Financial investments - at amortised cost |
148,326 |
115,383 |
30,765 |
440 |
146,588 |
Liabilities |
|
|
|
|
|
Deposits by banks |
73,163 |
- |
73,176 |
- |
73,176 |
Customer accounts |
1,611,647 |
- |
1,611,795 |
- |
1,611,795 |
Repurchase agreements - non-trading |
172,100 |
- |
172,081 |
- |
172,081 |
Debt securities in issue |
93,917 |
- |
93,196 |
706 |
93,902 |
Subordinated liabilities |
24,954 |
- |
27,151 |
- |
27,151 |
|
|
|
|
|
|
At 31 Dec 20221 |
|
|
|
|
|
Assets |
|
|
|
|
|
Loans and advances to banks |
104,475 |
4 |
103,641 |
814 |
104,459 |
Loans and advances to customers |
923,561 |
- |
8,791 |
903,107 |
911,898 |
Reverse repurchase agreements - non-trading |
253,754 |
- |
253,668 |
- |
253,668 |
Financial investments - at amortised cost |
109,066 |
84,087 |
21,850 |
475 |
106,412 |
Liabilities |
|
|
|
|
|
Deposits by banks |
66,722 |
- |
66,831 |
- |
66,831 |
Customer accounts |
1,570,303 |
- |
1,570,209 |
- |
1,570,209 |
Repurchase agreements - non-trading |
127,747 |
- |
127,500 |
- |
127,500 |
Debt securities in issue |
78,149 |
- |
76,640 |
381 |
77,021 |
Subordinated liabilities |
22,290 |
- |
22,723 |
- |
22,723 |
1 From 1 January 2023, we adopted IFRS 17 'Insurance Contracts', which replaced IFRS 4 'Insurance Contracts'. Comparative data for the financial year ended 31 December 2022 have been restated accordingly. Comparative data for the year ended 31 December 2021 are prepared on an IFRS 4 basis.
Fair values of financial instruments not carried at fair value and bases of valuation - assets and disposal groups held for sale |
|||||
|
|
Fair value |
|||
|
Carrying amount |
Quoted market price Level 1 |
Observable inputs Level 2 |
Significant unobservable inputs Level 3 |
Total |
|
$m |
$m |
$m |
$m |
$m |
At 31 Dec 2023 |
|
|
|
|
|
Assets |
|
|
|
|
|
Loans and advances to banks |
10,487 |
- |
10,487 |
- |
10,487 |
Loans and advances to customers |
73,376 |
- |
90 |
72,200 |
72,290 |
Reverse repurchase agreements - non-trading |
2,723 |
- |
2,723 |
- |
2,723 |
Financial investments - at amortised cost |
7,624 |
7,530 |
- |
5 |
7,535 |
Liabilities |
|
|
|
|
|
Deposits by banks |
78 |
- |
78 |
- |
78 |
Customer accounts |
85,950 |
- |
86,475 |
- |
86,475 |
Repurchase agreements - non-trading |
2,768 |
- |
2,768 |
- |
2,768 |
Debt securities in issue |
9,084 |
- |
8,820 |
- |
8,820 |
Subordinated liabilities |
8 |
- |
7 |
- |
7 |
|
|
|
|
|
|
At 31 Dec 2022 |
|
|
|
|
|
Assets |
|
|
|
|
|
Loans and advances to banks |
253 |
- |
257 |
- |
257 |
Loans and advances to customers |
80,687 |
- |
111 |
78,048 |
78,159 |
Reverse repurchase agreements - non-trading |
4,646 |
- |
4,646 |
- |
4,646 |
Financial investments - at amortised cost |
6,165 |
6,042 |
- |
- |
6,042 |
Liabilities |
|
|
|
|
|
Deposits by banks |
64 |
- |
64 |
- |
64 |
Customer accounts |
85,274 |
- |
85,303 |
- |
85,303 |
Repurchase agreements - non-trading |
3,266 |
- |
3,266 |
- |
3,266 |
Debt securities in issue |
12,928 |
- |
12,575 |
- |
12,575 |
Subordinated liabilities |
8 |
- |
7 |
- |
7 |
Other financial instruments not carried at fair value are typically short term in nature and reprice to current market rates frequently. Accordingly, their carrying amount is a reasonable approximation of fair value. They include cash and balances at central banks, items in the course of collection from and transmission to other banks, Hong Kong Government certificates of indebtedness and Hong Kong currency notes in circulation, all of which are measured at amortised cost.
Valuation
Fair value is an estimate of the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. This may be different from the theoretical economic value attributed from an instrument's cash flows over its expected future life. Our valuation methodologies and assumptions in determining fair values for which no observable market prices are available may differ from those of other companies.
Loans and advances to banks and customers
To determine the fair value of loans and advances to banks and customers, loans are segregated into portfolios of similar characteristics. Fair values are based on observable market transactions, when available. When they are unavailable, fair values are estimated using valuation models incorporating a range of input assumptions. These assumptions may include: value estimates from third-party brokers reflecting over-the-counter trading activity; forward-looking discounted cash flow models, taking account of expected customer prepayment rates, using assumptions that HSBC believes are consistent with those that would be used by market participants in valuing such loans; recent origination pricing for similar loans; and trading inputs from other market participants including observed primary and secondary trades. From time to time, we may engage a third-party valuation specialist to measure the fair value of a pool of loans.
The fair value of loans reflects expected credit losses at the balance sheet date and estimates of market participants' expectations of credit losses over the life of the loans, and the fair value effect of repricing between origination and the balance sheet date. For credit-impaired loans, fair value is estimated by discounting the future cash flows over the time period they are expected to be recovered.
Financial investments
The fair values of listed financial investments are determined using bid market prices. The fair values of unlisted financial investments are determined using valuation techniques that incorporate the prices and future earnings streams of equivalent quoted securities.
Deposits by banks and customer accounts
The fair values of on-demand deposits are approximated by their carrying amount. For deposits with longer-term maturities, fair values are estimated using discounted cash flows, applying current rates offered for deposits of similar remaining maturities.
Debt securities in issue and subordinated liabilities
Fair values in debt securities in issue and subordinated liabilities are determined using quoted market prices at the balance sheet date where available, or by reference to quoted market prices for similar instruments.
Repurchase and reverse repurchase agreements - non-trading
Fair values of repurchase and reverse repurchase agreements that are held on a non-trading basis provide approximate carrying amounts. This is due to the fact that balances are generally short dated.
HSBC Holdings
The methods used by HSBC Holdings to determine fair values of financial instruments for the purposes of measurement and disclosure are described above.
Fair values of HSBC Holdings' financial instruments not carried at fair value on the balance sheet |
||||
|
2023 |
2022 |
||
|
Carrying amount |
Fair value1 |
Carrying amount |
Fair value1 |
|
$m |
$m |
$m |
$m |
Assets at 31 Dec |
|
|
|
|
Loans and advances to HSBC undertakings |
27,354 |
27,878 |
26,765 |
26,962 |
Financial investments - at amortised cost |
19,558 |
19,531 |
19,466 |
19,314 |
Liabilities at 31 Dec |
|
|
|
|
Debt securities in issue |
65,239 |
65,172 |
66,938 |
65,364 |
Subordinated liabilities |
24,439 |
26,651 |
19,727 |
20,644 |
1 Fair values (other than Level 1 financial investments) were determined using valuation techniques with observable inputs (Level 2).
14 |
Financial assets designated and otherwise mandatorily measured at fair value through profit or loss |
|
2023 |
|
2022¹ |
|
||
|
Designated at fair value |
Mandatorily measured at fair value |
Total |
Designated at fair value |
Mandatorily measured at fair value |
Total |
|
$m |
$m |
$m |
$m |
$m |
$m |
Securities |
2,353 |
101,152 |
103,505 |
3,096 |
91,936 |
95,032 |
- treasury and other eligible bills |
695 |
724 |
1,419 |
649 |
869 |
1,518 |
- debt securities |
1,658 |
60,045 |
61,703 |
2,447 |
56,633 |
59,080 |
- equity securities |
- |
40,383 |
40,383 |
- |
34,434 |
34,434 |
Loans and advances to banks and customers |
371 |
5,495 |
5,866 |
- |
3,455 |
3,455 |
Other |
- |
1,272 |
1,272 |
- |
1,614 |
1,614 |
At 31 Dec |
2,724 |
107,919 |
110,643 |
3,096 |
97,005 |
100,101 |
1 From 1 January 2023, we adopted IFRS 17 'Insurance Contracts', which replaced IFRS 4 'Insurance Contracts'. We have restated 2022 comparative data.
15 |
Derivatives |
Notional contract amounts and fair values of derivatives by product contract type held by HSBC |
||||||||
|
Notional contract amount |
Fair value - Assets |
Fair value - Liabilities |
|||||
|
Trading |
Hedging |
Trading |
Hedging |
Total |
Trading |
Hedging |
Total |
|
$m |
$m |
$m |
$m |
$m |
$m |
$m |
$m |
Foreign exchange |
9,463,768 |
63,547 |
99,014 |
935 |
99,949 |
99,949 |
780 |
100,729 |
Interest rate |
14,853,397 |
361,312 |
223,534 |
5,119 |
228,653 |
225,443 |
4,080 |
229,523 |
Equities |
677,149 |
- |
14,427 |
- |
14,427 |
17,603 |
- |
17,603 |
Credit |
153,606 |
- |
1,351 |
- |
1,351 |
1,861 |
- |
1,861 |
Commodity and other |
90,007 |
- |
1,820 |
- |
1,820 |
1,542 |
- |
1,542 |
Gross total fair values |
25,237,927 |
424,859 |
340,146 |
6,054 |
346,200 |
346,398 |
4,860 |
351,258 |
Offset (Note 31) |
|
|
|
|
(116,486) |
|
|
(116,486) |
At 31 Dec 2023 |
25,237,927 |
424,859 |
340,146 |
6,054 |
229,714 |
346,398 |
4,860 |
234,772 |
|
|
|
|
|
|
|
|
|
Foreign exchange |
8,434,453 |
38,924 |
122,206 |
525 |
122,731 |
123,088 |
166 |
123,254 |
Interest rate |
15,213,232 |
276,589 |
285,449 |
5,066 |
290,515 |
287,876 |
3,501 |
291,377 |
Equities |
570,410 |
- |
9,325 |
- |
9,325 |
9,176 |
- |
9,176 |
Credit |
183,995 |
- |
1,091 |
- |
1,091 |
1,264 |
- |
1,264 |
Commodity and other |
78,414 |
- |
1,484 |
- |
1,484 |
1,678 |
- |
1,678 |
Gross total fair values |
24,480,504 |
315,513 |
419,555 |
5,591 |
425,146 |
423,082 |
3,667 |
426,749 |
Offset (Note 31) |
|
|
|
|
(140,987) |
|
|
(140,987) |
At 31 Dec 2022 |
24,480,504 |
315,513 |
419,555 |
5,591 |
284,159 |
423,082 |
3,667 |
285,762 |
1 From 1 January 2023, we adopted IFRS 17 'Insurance Contracts', which replaced IFRS 4 'Insurance Contracts'. We have restated 2022 comparative data.
The notional contract amounts of derivatives held for trading purposes and derivatives designated in hedge accounting relationships indicate the nominal value of transactions outstanding at the balance sheet date. They do not represent amounts at risk.
Derivative assets and liabilities decreased during 2023, driven by yield curve movements and changes in foreign exchange rates.
Notional contract amounts and fair values of derivatives by product contract type held by HSBC Holdings with subsidiaries |
||||||||
|
Notional contract amount |
Assets |
Liabilities |
|||||
|
Trading |
Hedging |
Trading |
Hedging |
Total |
Trading |
Hedging |
Total |
|
$m |
$m |
$m |
$m |
$m |
$m |
$m |
$m |
Foreign exchange |
66,711 |
- |
486 |
- |
486 |
1,705 |
- |
1,705 |
Interest rate |
33,480 |
92,268 |
1,730 |
1,128 |
2,858 |
747 |
3,638 |
4,385 |
At 31 Dec 2023 |
100,191 |
92,268 |
2,216 |
1,128 |
3,344 |
2,452 |
3,638 |
6,090 |
|
|
|
|
|
|
|
|
|
Foreign exchange |
60,630 |
- |
502 |
- |
502 |
1,683 |
- |
1,683 |
Interest rate |
34,322 |
81,873 |
2,386 |
913 |
3,299 |
826 |
4,413 |
5,239 |
At 31 Dec 2022 |
94,952 |
81,873 |
2,888 |
913 |
3,801 |
2,509 |
4,413 |
6,922 |
Use of derivatives
For details regarding the use of derivatives, see page 220 under 'Market risk'.
Trading derivatives
Most of HSBC's derivative transactions relate to sales and trading activities. Sales activities include the structuring and marketing of derivative products to customers to enable them to take, transfer, modify or reduce current or expected risks. Trading activities include market-making and risk management. Market-making entails quoting bid and offer prices to other market participants for the purpose of generating revenue based on spread and volume. Risk management activity is undertaken to manage the risk arising from client transactions, with the principal purpose of retaining client margin. Other derivatives classified as held for trading include non-qualifying hedging derivatives.
Substantially all of HSBC Holdings' derivatives entered into with subsidiaries are managed in conjunction with financial liabilities.
Hedge accounting derivatives
HSBC applies hedge accounting to manage the following risks: interest rate and foreign exchange risks. Further details of how these risks arise and how they are managed by the Group can be found in the 'Risk review'.
Hedged risk components
HSBC designates a portion of cash flows of a financial instrument or a group of financial instruments for a specific interest rate or foreign currency risk component in a fair value or cash flow hedge. The designated risks and portions are either contractually specified or otherwise separately identifiable components of the financial instrument that are reliably measurable. Risk-free or benchmark interest rates generally are regarded as being both separately identifiable and reliably measurable, except for the Interest Rate Benchmark Reform Phase 2 transition where HSBC designates alternative benchmark rates as the hedged risk which may not have been separately identifiable upon initial designation, provided HSBC reasonably expects it will meet the requirement within 24 months from the first designation date. The designated risk components account for a significant portion of the overall changes in fair value or cash flows of the hedged items.
HSBC uses net investment hedges to hedge the structural foreign exchange risk related to net investments in foreign operations including subsidiaries and branches whose functional currencies are different from that of the parent. When hedging with foreign exchange forward contracts, the spot rate component of the foreign exchange risk is designated for an amount of net assets as the hedged risk.
Sources of hedge ineffectiveness may arise from basis risk, including but not limited to the discount rates used for calculating the fair value of derivatives, hedges using instruments with a non-zero fair value, and notional and timing differences between the hedged items and hedging instruments.
Fair value hedges
HSBC enters into fixed-for-floating-interest-rate swaps to manage the exposure to changes in fair value caused by movements in market interest rates on certain fixed-rate financial instruments that are not measured at fair value through profit or loss, including debt securities held and issued.
HSBC hedging instrument by hedged risk |
|||||
|
Hedging instrument |
||||
|
|
Carrying amount |
|
|
|
|
Notional amount1 |
Assets |
Liabilities |
Balance sheet presentation |
Change in fair value2 |
Hedged risk |
$m |
$m |
$m |
$m |
|
Interest rate3 |
172,985 |
3,729 |
2,965 |
Derivatives |
(1,043) |
At 31 Dec 2023 |
172,985 |
3,729 |
2,965 |
|
(1,043) |
|
|
|
|
|
|
Interest rate3 |
162,062 |
4,973 |
2,573 |
Derivatives |
4,064 |
At 31 Dec 2022 |
162,062 |
4,973 |
2,573 |
|
4,064 |
1 The notional contract amounts of derivatives designated in qualifying hedge accounting relationships indicate the nominal value of transactions outstanding at the balance sheet date. They do not represent amounts at risk.
2 Used in effectiveness testing, which uses the full fair value change of the hedging instrument not excluding any component.
3 The hedged risk 'interest rate' includes inflation risk.
HSBC hedged item by hedged risk |
||||||||
|
Hedged item |
Ineffectiveness |
||||||
|
Carrying amount |
Accumulated fair value hedge adjustments included in carrying amount1 |
|
Change in fair value2 |
Recognised in profit and loss |
|
||
|
Assets |
Liabilities |
Assets |
Liabilities |
Balance sheet presentation |
Profit and loss presentation |
||
Hedged risk |
$m |
$m |
$m |
$m |
$m |
$m |
||
Interest rate3 |
82,321 |
|
(2,282) |
|
Financial investments - measured at fair value through other comprehensive income |
2,053 |
5 |
Net income from financial instruments held for trading or managed on a fair value basis |
514 |
|
32 |
|
Financial investments - measured at amortised cost |
32 |
|||
4,701 |
|
(18) |
|
Loans and advances to customers |
122 |
|||
- |
|
- |
|
Reverse repurchase agreements - non-trading |
15 |
|||
|
64,269 |
|
(2,147) |
Debt securities in issue |
(1,179) |
|||
|
- |
|
- |
Deposits by banks |
- |
|||
|
- |
|
- |
Subordinated liabilities |
5 |
|
|
|
At 31 Dec 2023 |
87,536 |
64,269 |
(2,268) |
(2,147) |
|
1,048 |
5 |
|
HSBC hedged item by hedged risk (continued) |
||||||||
|
Hedged item |
Ineffectiveness |
||||||
|
Carrying amount |
Accumulated fair value hedge adjustments included in carrying amount1 |
|
Change in fair value2 |
Recognised in profit and loss |
|
||
|
Assets |
Liabilities |
Assets |
Liabilities |
Balance sheet presentation |
Profit and loss presentation |
||
Hedged risk |
$m |
$m |
$m |
$m |
$m |
$m |
||
Interest rate3 |
82,792 |
|
(5,100) |
|
Financial investments - measured at fair value through other comprehensive income |
(8,005) |
(59) |
Net income from financial instruments held for trading or managed on a fair value basis |
3,415 |
|
(210) |
|
Loans and advances to customers |
(233) |
|||
519 |
|
(18) |
|
Reverse repurchase agreements - non-trading |
(17) |
|||
|
49,180 |
|
(2,006) |
Debt securities in issue |
4,138 |
|||
|
83 |
|
- |
Deposits by banks |
(5) |
|
||
At 31 Dec 2022 |
86,726 |
49,263 |
(5,328) |
(2,006) |
|
(4,122) |
(59) |
|
1 The accumulated amount of fair value adjustments remaining in the statement of financial position for hedged items that have ceased to be adjusted for hedging gains and losses were liabilities of $136m (2022: $252m) for FVOCI assets and liabilities of $1,256m (2022: $916m) for debt issued.
2 Used in effectiveness testing, which comprise an amount attributable to the designated hedged risk that can be a risk component.
3 The hedged risk 'interest rate' includes inflation risk.
HSBC Holdings hedging instrument by hedged risk |
|||||
|
Hedging instrument |
||||
|
|
Carrying amount |
|
|
|
|
Notional amount1,2 |
Assets |
Liabilities |
Balance sheet presentation |
Change in fair value3 |
Hedged risk |
$m |
$m |
$m |
$m |
|
Interest rate4 |
92,268 |
1,128 |
3,638 |
Derivatives |
1,426 |
At 31 Dec 2023 |
92,268 |
1,128 |
3,638 |
|
1,426 |
|
|
|
|
|
|
Interest rate4 |
81,873 |
913 |
4,413 |
Derivatives |
(5,599) |
At 31 Dec 2022 |
81,873 |
913 |
4,413 |
|
(5,599) |
1 The notional contract amounts of derivatives designated in qualifying hedge accounting relationships indicate the nominal value of transactions outstanding at the balance sheet date. They do not represent amounts at risk.
2 The notional amount of non-dynamic fair value hedges is equal to $92,268m (2022: $81,873m), of which the weighted-average maturity date is May 2029 and the weighted-average swap rate is 2.46% (2022: 2.33%). The majority of these hedges are internal to the Group.
3 Used in effectiveness testing, comprising the full fair value change of the hedging instrument not excluding any component.
4 The hedged risk 'interest rate' includes foreign exchange risk.
HSBC Holdings hedged item by hedged risk |
||||||||
|
Hedged item |
Ineffectiveness |
||||||
|
Carrying amount |
Accumulated fair value hedge adjustments included in carrying amount1 |
|
Change in fair value2 |
Recognised in profit and loss |
|
||
|
Assets |
Liabilities |
Assets |
Liabilities |
Balance sheet presentation |
Profit and loss presentation |
||
Hedged risk |
$m |
$m |
$m |
$m |
$m |
$m |
||
Interest rate3 |
|
80,889 |
|
(2,971) |
Debt securities in issue |
(1,716) |
29 |
Net income from financial instruments held for trading or managed on a fair value basis |
7,772 |
|
(490) |
|
Loans and advances to banks |
319 |
|
||
At 31 Dec 2023 |
7,772 |
80,889 |
(490) |
(2,971) |
|
(1,397) |
29 |
|
|
|
|
|
|
|
|
|
|
Interest rate3 |
|
68,223 |
|
(3,829) |
Debt securities |
6,258 |
(34) |
Net income from financial instruments held for trading or managed on a fair value basis |
6,812 |
|
(789) |
|
Loans and advances to banks |
(693) |
|
||
At 31 Dec 2022 |
6,812 |
68,223 |
(789) |
(3,829) |
|
5,565 |
(34) |
|
1 The accumulated amount of fair value adjustments remaining in the statement of financial position for hedged items that have ceased to be adjusted for hedging gains and losses were liabilities of $1,299m (2022: $971m) for debt issued.
2 Used in effectiveness testing, comprising amount attributable to the designated hedged risk that can be a risk component.
3 The hedged risk 'interest rate' includes foreign exchange risk.
For some debt securities held, HSBC manages interest rate risk in a dynamic risk management strategy. The assets in scope of this strategy are high-quality fixed-rate debt securities, which may be sold to meet liquidity and funding requirements.
The interest rate risk of the HSBC fixed-rate debt securities issued is managed in a non-dynamic risk management strategy.
Cash flow hedges
HSBC's cash flow hedging instruments consist principally of interest rate swaps and cross-currency swaps that are used to manage the variability in future interest cash flows of non-trading financial assets and liabilities, arising due to changes in market interest rates and foreign-currency basis.
HSBC applies macro cash flow hedging for interest rate risk exposures on portfolios of replenishing current and forecasted issuances of non-trading assets and liabilities that bear interest at variable rates, including rolling such instruments. The amounts and timing of future cash flows, representing both principal and interest flows, are projected for each portfolio of financial assets and liabilities on the basis of their contractual terms and other relevant factors, including estimates of prepayments and defaults. The aggregate cash flows representing both principal balances and interest cash flows across all portfolios are used to determine the effectiveness and ineffectiveness. Macro cash flow hedges are considered to be dynamic hedges.
HSBC also hedges the variability in future cash flows on foreign-denominated financial assets and liabilities arising due to changes in foreign exchange market rates with cross-currency swaps, which are considered dynamic hedges.
Hedging instrument by hedged risk |
||||||||
|
Hedging instrument |
Hedged item |
Ineffectiveness |
|||||
|
|
Carrying amount |
|
Change in fair value2 |
Change in fair value3 |
Recognised in profit and loss |
Profit and loss presentation |
|
|
Notional amount1 |
Assets |
Liabilities |
Balance sheet presentation |
||||
Hedged risk |
$m |
$m |
$m |
$m |
$m |
$m |
||
Foreign currency |
29,772 |
935 |
257 |
Derivatives |
977 |
977 |
- |
Net income from |
Interest rate |
188,327 |
1,390 |
1,116 |
Derivatives |
1,542 |
1,512 |
30 |
|
At 31 Dec 2023 |
218,099 |
2,325 |
1,373 |
|
2,519 |
2,489 |
30 |
|
Foreign currency |
8,781 |
418 |
166 |
Derivatives |
659 |
659 |
- |
Net income from financial instruments held for trading or managed on a fair value basis |
Interest rate |
114,527 |
93 |
950 |
Derivatives |
(4,997) |
(4,973) |
(24) |
|
At 31 Dec 2022 |
123,308 |
511 |
1,116 |
|
(4,338) |
(4,314) |
(24) |
|
1 The notional contract amounts of derivatives designated in qualifying hedge accounting relationships indicate the nominal value of transactions outstanding at the balance sheet date. They do not represent amounts at risk.
2 Used in effectiveness testing, comprising the full fair value change of the hedging instrument not excluding any component.
3 Used in effectiveness assessment, comprising amount attributable to the designated hedged risk that can be a risk component.
Reconciliation of equity and analysis of other comprehensive income by risk type |
||
|
Interest rate |
Foreign currency |
|
$m |
$m |
Cash flow hedging reserve at 1 Jan 2023 |
(3,387) |
(421) |
Fair value gains/(losses) |
1,512 |
977 |
Fair value (gains)/losses reclassified from the cash flow hedge reserve to the income statement in respect of: |
|
|
Hedged items that have affected profit or loss1 |
2,196 |
(718) |
Income taxes |
(937) |
(29) |
Others |
(285) |
59 |
Cash flow hedging reserve at 31 Dec 2023 |
(901) |
(132) |
|
|
|
Cash flow hedging reserve at 1 Jan 2022 |
8 |
(205) |
Fair value gains/(losses) |
(4,973) |
659 |
Fair value (gains)/losses reclassified from the cash flow hedge reserve to the income statement in respect of: |
|
|
Hedged items that have affected profit or loss |
325 |
(926) |
Income taxes |
1,123 |
28 |
Others |
130 |
23 |
Cash flow hedging reserve at 31 Dec 2022 |
(3,387) |
(421) |
1 Hedged items that have affected profit or loss are primarily recorded within interest income.
Net investment hedges
The Group applies hedge accounting in respect of certain net investments in non-US dollar functional currency foreign operations for changes in spot exchange rates only. Hedging could be undertaken for Group structural exposure to changes in the US dollar to foreign currency exchange rates using forward foreign exchange contracts or by financing with foreign currency borrowings. An economic relationship exists between the hedged net investment and hedging instrument due to the shared foreign currency risk exposure. For further details of our structural foreign exchange exposures, see page 205.
The aggregate positions at the reporting date and the performance indicators of both live and de-designated hedges are summarised below.
Hedges of net investment in foreign operations |
||||||
|
Carrying amount |
Nominal amount |
Amounts recognised in OCI1 |
Change in fair value2 |
Hedge ineffectiveness recognised in income statement |
|
|
Derivative assets |
Derivative liabilities |
||||
Description of hedged risk |
$m |
$m |
$m |
$m |
$m |
$m |
2023 |
|
|
|
|
|
|
Pound sterling-denominated structural foreign exchange |
|
(404) |
16,415 |
604 |
(843) |
- |
Swiss franc-denominated structural foreign exchange |
|
(23) |
526 |
49 |
(62) |
- |
Hong Kong dollar-denominated structural foreign exchange |
|
- |
5,792 |
- |
2 |
- |
Other structural foreign exchange3 |
|
(96) |
11,042 |
477 |
102 |
- |
Total |
- |
(523) |
33,775 |
1,130 |
(801) |
- |
2022 |
|
|
|
|
|
|
Pound sterling-denominated structural foreign exchange |
264 |
- |
14,000 |
1,447 |
1,573 |
- |
Swiss franc-denominated structural foreign exchange |
- |
(21) |
727 |
111 |
10 |
- |
Hong Kong dollar-denominated structural foreign exchange |
- |
(19) |
4,597 |
(2) |
(7) |
- |
Other structural foreign exchange3 |
- |
(117) |
10,819 |
375 |
369 |
- |
Total |
264 |
(157) |
30,143 |
1,931 |
1,945 |
- |
1 Amount recognised in OCI for Swiss franc includes $110m (2022: $110m) related to de-designated hedge.
2 Used in effectiveness assessment, comprising amount attributable to the designated hedged risk that can be a risk component.
3 Other currencies include euro, New Taiwan dollar, Singapore dollar, Canadian dollar, Omani rial, South Korean won, UAE dirham, Indian rupee, Chinese renminbi, Kuwaiti dinar, Qatari riyal, Saudi riyal, Indonesian rupiah and Philippine peso.
Interest rate benchmark reform: Amendments to IFRS 9 and IAS 39 'Financial Instruments'
HSBC has applied both the first set of amendments ('Phase 1') and the second set of amendments ('Phase 2') to IFRS 9 and IAS 39 applicable to hedge accounting. The hedge accounting relationships that are affected by Phase 1 and Phase 2 amendments are presented in the balance sheet as 'Financial assets designated and otherwise mandatorily measured at fair value through other comprehensive income', 'Loans and advances to customers', 'Debt securities in issue' and 'Deposits by banks'. The notional value of the derivatives impacted by the Ibor reform, including those designated in hedge accounting relationships, is disclosed in Note 32. For further details of Ibor transition, see 'Ibor transition' on page 139.
For some of the Ibors included under the 'Other' header in the table below, judgement has been needed to establish whether a transition is required, since there are Ibor benchmarks that are subject to computation methodology improvements and insertion of fallback provisions without full clarity being provided by their administrators on whether these Ibor benchmarks will be demised.
The notional amounts of interest rate derivatives designated in hedge accounting relationships do not represent the extent of the risk exposure managed by the Group but they are expected to be directly affected by market-wide Ibor reform and in scope of Phase 1 amendments and are shown in the table below. The cross-currency swaps designated in hedge accounting relationships and affected by Ibor reform are not significant and have not been presented below.
Hedging instrument impacted by Ibor reform |
|||||||
|
Hedging instrument |
||||||
|
Impacted by Ibor reform |
Not impacted by Ibor reform |
Notional amount3 |
||||
|
€1 |
£ |
$ |
Other2 |
Total |
||
|
$m |
$m |
$m |
$m |
$m |
$m |
$m |
Fair value hedges |
16,907 |
- |
- |
4,384 |
21,291 |
151,694 |
172,985 |
Cash flow hedges |
10,850 |
- |
- |
3,504 |
14,354 |
173,973 |
188,327 |
At 31 Dec 2023 |
27,757 |
- |
- |
7,888 |
35,645 |
325,667 |
361,312 |
|
|
|
|
|
|
|
|
Fair value hedges |
12,756 |
- |
2,015 |
12,643 |
27,414 |
134,648 |
162,062 |
Cash flow hedges |
8,865 |
- |
- |
27,830 |
36,695 |
77,832 |
114,527 |
At 31 Dec 2022 |
21,621 |
- |
2,015 |
40,473 |
64,109 |
212,480 |
276,589 |
1 The notional contract amounts of euro interest rate derivatives impacted by Ibor reform consist of hedges with a Euribor benchmark.
2 Other benchmarks impacted by Ibor reform consist mainly of Emirates interbank offered rate, Mexican interbank equilibrium interest rate ('TIIE') and Korean won-related derivatives. In 2022, the Hong Kong interbank offered rate ('HIBOR') was included in 'Other' given that reform in the benchmark was considered possible. At 31 December 2023, HIBOR was no longer expected to be directly affected by Ibor reform following the successful transition of all Libor settings and the HKMA's affirmation that there are no plans to discontinue HIBOR. As a result HIBOR has been moved from 'Other' to 'Not impacted by Ibor reform'.
3 The notional contract amounts of interest rate derivatives designated in qualifying hedge accounting relationships indicate the nominal value of transactions outstanding at the balance sheet date and they do not represent amounts at risk.
3
Hedging instrument impacted by Ibor reform held by HSBC Holdings |
|||||||
|
Hedging instrument |
||||||
|
Impacted by Ibor reform |
Not impacted by Ibor reform |
Notional amount |
||||
|
€ |
£ |
$ |
Other |
Total |
||
|
$m |
$m |
$m |
$m |
$m |
$m |
$m |
Fair value hedges |
19,614 |
- |
- |
583 |
20,197 |
72,071 |
92,268 |
At 31 Dec 2023 |
19,614 |
- |
- |
583 |
20,197 |
72,071 |
92,268 |
|
|
|
|
|
|
|
|
Fair value hedges |
15,210 |
- |
2,000 |
1,336 |
18,546 |
63,327 |
81,873 |
At 31 Dec 2022 |
15,210 |
- |
2,000 |
1,336 |
18,546 |
63,327 |
81,873 |
16 |
Financial investments |
Carrying amount of financial investments |
||
|
2023 |
2022¹ |
|
$m |
$m |
Financial investments measured at fair value through other comprehensive income |
294,437 |
255,660 |
- treasury and other eligible bills |
102,438 |
86,749 |
- debt securities |
190,119 |
167,107 |
- equity securities |
1,447 |
1,696 |
- other instruments |
433 |
108 |
Debt instruments measured at amortised cost |
148,326 |
109,066 |
- treasury and other eligible bills |
30,733 |
34,507 |
- debt securities |
117,593 |
74,559 |
At 31 Dec |
442,763 |
364,726 |
1 From 1 January 2023, we adopted IFRS 17 'Insurance Contracts', which replaced IFRS 4 'Insurance Contracts'. We have restated 2022 comparative data.
Equity instruments measured at fair value through other comprehensive income |
||
|
Fair value |
Dividends recognised |
Type of equity instruments |
$m |
$m |
Investments required by central institutions |
609 |
27 |
Business facilitation |
793 |
35 |
Others |
45 |
2 |
At 31 Dec 2023 |
1,447 |
64 |
|
|
|
Investments required by central institutions |
690 |
24 |
Business facilitation |
954 |
28 |
Others |
52 |
2 |
At 31 Dec 2022 |
1,696 |
54 |
Weighted average yields of investment debt securities |
||||
|
Up to 1 year |
1 to 5 years |
5 to 10 years |
Over 10 years |
|
Yield |
Yield |
Yield |
Yield |
|
% |
% |
% |
% |
Debt securities measured at fair value through other comprehensive income |
|
|
|
|
US Treasury |
2.1 |
2.0 |
2.0 |
2.4 |
US Government agencies |
3.6 |
3.1 |
3.3 |
3.0 |
US Government-sponsored agencies |
1.0 |
2.6 |
2.1 |
1.8 |
UK Government |
0.2 |
2.8 |
0.8 |
2.5 |
Hong Kong Government |
1.0 |
1.4 |
1.6 |
- |
Other governments |
3.2 |
3.5 |
3.3 |
2.9 |
Asset-backed securities |
1.4 |
6.6 |
4.8 |
5.3 |
Corporate debt and other securities |
5.5 |
3.1 |
3.1 |
2.4 |
|
|
|
|
|
Debt securities measured at amortised cost |
|
|
|
|
US Treasury |
8.9 |
3.7 |
3.7 |
2.1 |
US Government agencies |
7.9 |
7.8 |
5.8 |
4.5 |
US Government-sponsored agencies |
2.3 |
3.7 |
3.4 |
2.9 |
UK Government |
- |
- |
0.9 |
4.5 |
Hong Kong Government |
- |
2.6 |
- |
- |
Other governments |
2.7 |
3.5 |
5.3 |
- |
Asset-backed securities |
4.7 |
- |
7.7 |
- |
Corporate debt and other securities |
2.6 |
2.6 |
3.5 |
5.2 |
The maturity distributions of ABSs are presented in the above table on the basis of contractual maturity dates. The weighted average yield for each range of maturities is calculated by dividing the annualised interest income for the year ended 31 December 2023 by the book amount of debt securities at that date. The yields do not include the effect of related derivatives.
HSBC Holdings
HSBC Holdings carrying amount of financial investments |
||
|
2023 |
2022 |
|
$m |
$m |
Debt instruments measured at amortised cost |
|
|
- treasury and other eligible bills |
15,629 |
12,796 |
- debt securities |
3,929 |
6,670 |
At 31 Dec |
19,558 |
19,466 |
Weighted average yields of investment debt securities |
||||
|
Up to 1 year |
1 to 5 years |
5 to 10 years |
Over 10 years |
|
Yield |
Yield |
Yield |
Yield |
|
% |
% |
% |
% |
Debt securities measured at amortised cost |
|
|
|
|
US Treasury |
3.2 |
4.3 |
- |
- |
The weighted average yield for each range of maturities is calculated by dividing the annualised interest income for the year ended 31 December 2023 by the book amount of debt securities at that date. The yields do not include the effect of related derivatives.
17 |
Assets pledged, collateral received and assets transferred |
Assets pledged1
Financial assets pledged as collateral |
||
|
2023 |
2022 |
|
$m |
$m |
Treasury bills and other eligible securities |
20,504 |
18,364 |
Loans and advances to banks |
13,636 |
10,198 |
Loans and advances to customers |
27,490 |
27,627 |
Debt securities |
88,367 |
60,542 |
Equity securities |
40,280 |
26,902 |
Other |
61,223 |
67,576 |
Assets pledged at 31 Dec |
251,500 |
211,209 |
Assets pledged as collateral include all assets categorised as encumbered in the disclosure on page 27 of the Pillar 3 Disclosures at 31 December 2023, except for assets held for sale.
The amount of assets pledged to secure liabilities may be greater than the book value of assets utilised as collateral. For example, in the case of securitisations and covered bonds, the amount of liabilities issued plus mandatory over-collateralisation is less than the book value of the pool of assets available for use as collateral. This is also the case where assets are placed with a custodian or a settlement agent that has a floating charge over all the assets placed to secure any liabilities under settlement accounts.
These transactions are conducted under terms that are usual and customary for collateralised transactions including, where relevant, standard securities lending and borrowing, repurchase agreements and derivative margining. HSBC places both cash and non-cash collateral in relation to derivative transactions.
Hong Kong currency notes in circulation are secured by the deposit of funds in respect of which the Hong Kong Government certificates of indebtedness are held.
Financial assets pledged as collateral which the counterparty has the right to sell or repledge |
||
|
2023 |
2022 |
|
$m |
$m |
Trading assets |
77,847 |
56,894 |
Financial investments |
39,324 |
27,841 |
At 31 Dec |
117,171 |
84,735 |
Collateral received1
The fair value of assets accepted as collateral relating primarily to standard securities lending, reverse repurchase agreements, swaps of securities and derivative margining that HSBC is permitted to sell or repledge in the absence of default was $495,653m (2022: $449,896m). The fair value of any such collateral sold or repledged was $284,108m (2022: $228,245m).
HSBC is obliged to return equivalent securities. These transactions are conducted under terms that are usual and customary to standard securities lending, reverse repurchase agreements and derivative margining.
Assets transferred1
The assets pledged include transfers to third parties that do not qualify for derecognition, notably secured borrowings such as debt securities held by counterparties as collateral under repurchase agreements and equity securities lent under securities lending agreements, as well as swaps of equity and debt securities. For secured borrowings, the transferred asset collateral continues to be recognised in full while a related liability, reflecting the Group's obligation to repurchase the assets for a fixed price at a future date, is also recognised on the balance sheet.
Where securities are swapped, the transferred asset continues to be recognised in full. There is no associated liability as the non-cash collateral received is not recognised on the balance sheet. The Group is unable to use, sell or pledge the transferred assets for the duration of the transaction, and remains exposed to interest rate risk and credit risk on these pledged assets.
Transferred financial assets not qualifying for full derecognition and associated financial liabilities |
||
|
Carrying amount of: |
|
|
Transferred assets |
Associated liabilities |
|
$m |
$m |
At 31 Dec 2023 |
|
|
Repurchase agreements |
81,486 |
74,517 |
Securities lending agreements |
46,663 |
3,826 |
|
|
|
At 31 Dec 2022 |
|
|
Repurchase agreements |
52,604 |
48,501 |
Securities lending agreements |
39,134 |
4,613 |
1 Excludes assets classified as held for sale.
18 |
Interests in associates and joint ventures |
Carrying amount of HSBC's interests in associates and joint ventures |
|
|
|
2023 |
2022 |
|
$m |
$m |
Interests in associates |
27,200 |
29,127 |
Interests in joint ventures |
144 |
127 |
Interests in associates and joint ventures |
27,344 |
29,254 |
Principal associates of HSBC |
|||||
|
|
2023 |
2022 |
||
|
|
Carrying amount |
Fair value1 |
Carrying amount |
Fair value1 |
|
|
$m |
$m |
$m |
$m |
Bank of Communications Co., Limited |
|
21,210 |
8,812 |
23,307 |
8,141 |
Saudi Awwal Bank |
|
4,659 |
6,438 |
4,494 |
6,602 |
1 Principal associates are listed on recognised stock exchanges. The fair values are based on the quoted market prices of the shares held (Level 1 in the fair value hierarchy).
|
At 31 Dec 2023 |
||
|
Jurisdiction of incorporation and principal place of business |
Principal activity |
HSBC's interest1 % |
Bank of Communications Co., Limited |
Mainland China |
Banking services |
19.03 |
Saudi Awwal Bank |
Saudi Arabia |
Banking services |
31.00 |
1 There has been no percentage change in HSBC's shareholding interest in the principal associates when compared with 2022.
Share of profit in associates and joint ventures |
|
|
|
2023 |
2022 |
|
$m |
$m |
Bank of Communications Co., Limited |
2,250 |
2,377 |
Saudi Awwal Bank |
538 |
342 |
Other associates and joint ventures |
19 |
4 |
Share of profit in associates and joint ventures |
2,807 |
2,723 |
Less: Impairment of interest in BoCom |
(3,000) |
- |
A list of all associates and joint ventures is set out in Note 40.
Bank of Communications Co., Limited
We maintain a 19.03% interest in Bank of Communications Co., Limited ('BoCom'). The Group's investment in BoCom is classified as an associate. Significant influence in BoCom was established with consideration of all relevant factors, including representation on BoCom's Board of Directors and participation in a resource and experience sharing agreement ('RES'). Under the RES, HSBC staff have been seconded to assist in the maintenance of BoCom's financial and operating policies. Investments in associates are recognised using the equity method of accounting in accordance with IAS 28 'Investments in Associates and Joint Ventures', whereby the investment is initially recognised at cost and adjusted thereafter for the post-acquisition change in the Group's share of associate's net assets. An impairment test is required if there is any indication of impairment.
Impairment testing
The fair value of the Group's investment in BoCom had been below the carrying amount for approximately 12 years. We have previously disclosed that the excess of the value in use ('VIU') calculation over its balance sheet value has been marginal in recent years, and that reasonably possible changes in assumptions could generate an impairment.
Recent macroeconomic, policy and industry-wide factors resulted in a wider range of possible VIU calculation outcomes, and our VIU calculation uses both historical experience and market participant views to estimate future cash flows, relevant discount rates and associated capital assumptions. At 31 December 2023, the Group performed an impairment test on the carrying amount, which resulted in an impairment of $3.0bn, as the recoverable amount as determined by a VIU calculation was lower than the carrying value.
|
At 31 Dec 2023 |
At 31 Dec 2022 |
||||
|
VIU |
Carrying value |
Fair value |
VIU |
Carrying value |
Fair value |
|
$bn |
$bn |
$bn |
$bn |
$bn |
$bn |
BoCom |
21.2 |
21.2 |
8.8 |
23.5 |
23.3 |
8.1 |
The impairment test will be updated in future periods, reflecting updated assumptions in the VIU impairment calculation. Going forward, the carrying value will be aligned to the updated VIU calculation and capped at carrying value that would have been determined had no impairment loss been recognised, rather than at cost and adjusted thereafter for the post-acquisition change in the Group's share of associate's net assets, and therefore there is a risk of reversals or further impairments in future periods.
The VIU may increase or decrease depending on the effect of changes to model inputs. The main model inputs are described below and are based on factors observed at period-end. The factors that could result in increases or reductions in the VIU include changes in BoCom's short-term performance, a change in regulatory capital requirements or revisions to the forecast of BoCom's future profitability.
If the Group did not have significant influence in BoCom, the investment would be carried at fair value rather than the current carrying value.
Basis of recoverable amount
The impairment test was performed by comparing the recoverable amount of BoCom, determined by a VIU calculation, with its carrying value. The VIU calculation uses discounted cash flow projections based on management's best estimates of future earnings available to ordinary shareholders prepared in accordance with IAS 36 'Impairment of Assets'. Significant management judgement is required in arriving at the best estimate.
There are two main components to the VIU calculation. The first component is management's best estimate of BoCom's earnings. Forecast earnings growth over the short to medium term is lower than recent (within the last five years) actual growth, and reflects the impact of recent macroeconomic, policy and industry factors in mainland China. As a result of management's intent to continue to retain its investment, earnings beyond the short to medium term are then extrapolated into perpetuity using a long-term growth rate to derive a terminal value, which comprises the majority of the VIU. The second component is the capital maintenance charge ('CMC'), which is management's forecast of the earnings that need to be withheld in order for BoCom to meet capital requirements over the forecast period, meaning that CMC is deducted when arriving at management's estimate of future earnings available to ordinary shareholders. The CMC reflects the revised capital requirements arising from revisions of the ratio of risk-weighted assets to total assets assumption. The principal inputs to the CMC calculation include estimates of asset growth, the ratio of risk-weighted assets to total assets and the expected capital requirements. An increase in the CMC as a result of a change to these principal inputs would reduce VIU. Additionally, management considers other qualitative factors, to ensure that the inputs to the VIU calculation remain appropriate.
Key assumptions in value in use calculation
We used a number of assumptions in our VIU calculation, in accordance with the requirements of IAS 36:
- Long-term profit growth rate: 3% (2022: 3%) for periods after 2027, which does not exceed forecast GDP growth in mainland China and is similar to forecasts by external analysts.
- Long-term asset growth rate: 3% (2022: 3%) for periods after 2027, which is the rate that assets are expected to grow to achieve long-term profit growth of 3%.
- Discount rate: 9.00% (2022: 10.04%), which is based on a capital asset pricing model ('CAPM'), using market data. The discount rate used is within the range of 7.9% to 9.7% (2022: 8.4% to 10.4%) indicated by the CAPM, and decreased as a consequence of a market-driven reduction in beta. While the CAPM range sits at the lower end of the range adopted by selected external analysts of 8.8% to 13.5% (2022: 8.8% to 13.5%), we continue to regard the CAPM range as the most appropriate basis for determining this assumption.
- Expected credit losses ('ECL') as a percentage of loans and advances to customers: ranges from 0.80% to 0.97% (2022: 0.99% to 1.05%) in the short to medium term, reflecting reported credit experience in mainland China. For periods after 2027, the ratio is 0.97% (2022: 0.97%), which is higher than BoCom's average ECL as a percentage of loans and advances to customers in recent years prior to the pandemic.
- Risk-weighted assets as a percentage of total assets: ranges from 62.0% to 63.7% (2022: 61.0% to 64.4%) in the short to medium term, reflecting higher risk-weights in the short term followed by an expected reversion to recent historical levels. For periods after 2027, the ratio is 62.0% (2022: 61.0%), which is similar to BoCom's actual results in recent years.
- Loans and advances to customers growth rate: ranges from 9.0% to 10.0% (2022: 7.1% to 11.0%) in the short to medium term, reflecting higher growth rate in loans and advances to customers as a result of recent macroeconomic, policy and industry factors in mainland China. Increases in the forecast growth rate of loans and advances to customers results in higher forecast ECL.
-
- Operating income growth rate: ranges from -0.4% to 9.7% (2022: 1.9% to 7.7%) in the short to medium term, which is lower than BoCom's actual results in recent years, and is impacted by projections of net interest income in the short term as a consequence of recent macroeconomic, policy and industry factors in mainland China.
- Cost-income ratio: ranges from 35.5% to 39.8% (2022: 35.5% to 36.3%) in the short to medium term. These ratios are higher than BoCom's actual results in recent years and forecasts disclosed by external analysts.
- Effective tax rate ('ETR'): ranges from 5.3% to 15.0% (2022: 4.4% to 15.0%) in the short to medium term, reflecting BoCom's actual results and an expected increase towards the long-term assumption through the forecast period. For periods after 2027, the rate is 15.0% (2022: 15.0%), which is higher than the recent historical average, and aligned to the minimum tax rate as proposed by the OECD/Group of 20 ('G20') Inclusive Framework on Base Erosion and Profit Shifting.
- Capital requirements: capital adequacy ratio of 12.5% (2022: 12.5%) and tier 1 capital adequacy ratio of 9.5% (2022: 9.5%), based on BoCom's capital risk appetite and capital requirements respectively.
The following table further illustrates the impact on VIU of reasonably possible changes to key assumptions. This reflects the sensitivity of the VIU to each key assumption on its own and it is possible that more than one favourable and/or unfavourable change may occur at the same time. Loans and advances to customers growth rate has been added to the list of key assumptions detailed in the table to reflect the greater potential variability associated with the assumption as a result of recent macroeconomic, policy and industry factors in mainland China. The selected rates of reasonably possible changes to key assumptions are based on external analysts' forecasts, statutory requirements and other relevant external data sources, which can change period to period. Unless specified, favourable and unfavourable changes are consistently applied throughout short-to-medium and long-term forecast years, based on a straight-line average of the base case assumption.
Sensitivity of VIU to reasonably possible changes in key assumptions |
||||||
|
Favourable change |
Unfavourable change |
||||
|
|
Increase in VIU |
VIU |
|
Decrease in VIU |
VIU |
|
bps |
$bn |
$bn |
bps |
$bn |
$bn |
At 31 Dec 2023 |
|
|
|
|
|
|
Long-term profit growth rate1 |
58 |
3.3 |
24.5 |
(79) |
(3.4) |
17.8 |
Long-term asset growth rate1 |
(79) |
4.5 |
25.7 |
58 |
(4.0) |
17.2 |
Discount rate |
(110) |
4.5 |
25.7 |
280 |
(6.1) |
15.1 |
Expected credit losses as a percentage of loans and advances to customers |
2023 to 2027: 78 2028 onwards: 91 |
2.9 |
24.1 |
2023 to 2027: 120 2028 onwards: 104 |
(4.4) |
16.8 |
Risk-weighted assets as a percentage of total assets |
(150) |
0.9 |
22.1 |
216 |
(1.6) |
19.6 |
Loans and advances to customers growth rate |
(213) |
3.2 |
24.4 |
207 |
(2.9) |
18.3 |
Operating income growth rate |
57 |
2.6 |
23.8 |
(81) |
(2.6) |
18.6 |
Cost-income ratio |
(212) |
0.8 |
22.0 |
99 |
(2.9) |
18.3 |
Long-term effective tax rate |
(426) |
1.6 |
22.8 |
1,000 |
(3.5) |
17.7 |
Capital requirements - capital adequacy ratio |
- |
- |
21.2 |
215 |
(7.5) |
13.7 |
Capital requirements - tier 1 capital adequacy ratio |
- |
- |
21.2 |
248 |
(3.7) |
17.5 |
At 31 Dec 2022 |
|
|
|
|
|
|
Long-term profit growth rate1 |
75 |
3.6 |
27.1 |
(71) |
(2.7) |
20.8 |
Long-term asset growth rate1 |
(71) |
3.1 |
26.6 |
75 |
(4.1) |
19.4 |
Discount rate |
(164) |
6.9 |
30.4 |
136 |
(3.7) |
19.8 |
Expected credit losses as a percentage of loans and advances to customers |
2022 to 2026: 95 2027 onwards: 91 |
1.9 |
25.4 |
2022 to 2026: 120 2027 onwards: 104 |
(2.9) |
20.6 |
Risk-weighted assets as a percentage of total assets |
(118) |
0.1 |
23.6 |
239 |
(2.3) |
21.2 |
Loans and advances to customers growth rate |
(75) |
1.1 |
24.6 |
295 |
(3.2) |
20.3 |
Operating income growth rate |
44 |
1.3 |
24.8 |
(83) |
(2.5) |
21.0 |
Cost-income ratio |
(122) |
1.0 |
24.5 |
174 |
(2.1) |
21.4 |
Long-term effective tax rate |
(426) |
1.5 |
25.0 |
1,000 |
(3.6) |
19.9 |
Capital requirements - capital adequacy ratio |
- |
- |
23.5 |
191 |
(6.3) |
17.2 |
Capital requirements - tier 1 capital adequacy ratio |
- |
- |
23.5 |
266 |
(3.2) |
20.3 |
1 The favourable and unfavourable ranges of the long-term profit growth rate and long-term asset growth rate assumptions reflect the close relationship between these assumptions, which would result in offsetting changes to each assumption.
Considering the interrelationship of the changes set out in the table above, management estimates that the reasonably possible range of VIU is $13.1bn to $28.8bn (2022: $16.9bn to $28.7bn), acknowledging that the fair value of the Group's investment has ranged from $6.8bn to $11.6bn over the last five years as at the date of the impairment tests. The possible range of VIU is based on impacts set out in the table above arising from the favourable/unfavourable change in the earnings in the short to medium term, the long-term expected credit losses as a percentage of loans and advances to customers, and a 50bps increase/decrease in the discount rate. All other long-term assumptions, and the basis of the CMC have been kept unchanged when determining the reasonably possible range of the VIU.
Selected financial information of BoCom
The statutory accounting reference date of BoCom is 31 December. For the year ended 31 December 2023, HSBC included the associate's results on the basis of the financial statements for the 12 months ended 30 September 2023, taking into account any known changes in the subsequent period from 1 October 2023 to 31 December 2023 that would have materially affected the results.
Selected balance sheet information of BoCom |
||
|
At 30 Sep |
At 31 Dec |
|
2023 |
2022 |
|
$m |
$m |
Cash and balances at central banks |
112,800 |
116,942 |
Due from and placements with banks and other financial institutions |
100,464 |
100,160 |
Loans and advances to customers |
1,087,613 |
1,035,151 |
Other financial assets |
587,949 |
583,898 |
Other assets |
59,215 |
48,796 |
Total assets |
1,948,041 |
1,884,947 |
Due to and placements from banks and other financial institutions |
292,065 |
295,205 |
Deposits from customers |
1,216,611 |
1,153,184 |
Other financial liabilities |
251,246 |
249,230 |
Other liabilities |
36,776 |
37,153 |
Total liabilities |
1,796,698 |
1,734,772 |
Total equity |
151,343 |
150,175 |
Reconciliation of BoCom's total shareholders' equity to the carrying amount in HSBC's consolidated financial statements |
||
|
At 30 Sep |
|
|
2023 |
2022 |
|
$m |
$m |
HSBC's share of total shareholders' equity |
23,746 |
22,828 |
Goodwill originally arising on acquisition |
464 |
479 |
Impairment |
(3,000) |
- |
Carrying amount |
21,210 |
23,307 |
Selected income statement information of BoCom |
||
|
For the 9 months ended 30 Sep |
|
|
2023 |
2022 |
|
$m |
$m |
Net interest income |
17,519 |
19,004 |
Net fee and commission income |
4,815 |
5,181 |
Credit and impairment losses |
(6,836) |
(7,641) |
Depreciation and amortisation |
(1,977) |
(1,785) |
Tax expense |
(552) |
(436) |
Profit for the year |
9,835 |
10,102 |
Other comprehensive income |
631 |
(37) |
Total comprehensive income |
10,466 |
10,065 |
Dividends received from BoCom |
736 |
749 |
Saudi Awwal Bank
The Group's investment in Saudi Awwal Bank ('SAB') is classified as an associate. HSBC is the largest shareholder in SAB with a shareholding of 31%. Significant influence in SAB is established via representation on the Board of Directors. Investments in associates are recognised using the equity method of accounting in accordance with IAS 28, as described previously for BoCom.
Impairment testing
There were no indicators of impairment at 31 December 2023. The fair value of the Group's investment in SAB of $6.4bn was above the carrying amount of $4.7bn.